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Abstract 
Disulphide bonds form within the endoplasmic reticulum (ER) during the oxidative folding of 
secretory and membrane proteins. These bonds confer structural stability, bind the subunits 
of multimeric proteins and can be involved in redox dependent activities.  
Our aim was to investigate the biochemical and molecular aspects of ER disulphide 
formation of nascent proteins. To specifically analyse this process, we developed a modified 
rabbit reticulocyte lysate (RRL) in vitro translation system. Glucose-6-phosphate (G6P) was 
added to this lysate and was found to prevent the formation of disulphides out with a source 
of ER by biochemically supporting the thioredoxin reductive pathway. Disulphides were, 
however, able to form within the ER sources of dog pancreas microsomes (DPMs) or semi 
permeabilised (SP) cells supplemented to the lysate. Furthermore, the disulphides that 
formed within these sources closely resembled disulphide formation in cells that has been 
reported from a pulse-chase study. The G6P supported RRL was thus shown to be a 
physiologically relevant system for analysing ER disulphide formation.  
The enzymatic sources of de novo disulphide formation were then investigated by analysing 
disulphide formation within preprolactin (PPL) in a lysate supplemented with DPMs in which 
selected enzymes involved in this de novo synthesis were inhibited or chemically inactivated. 
It was found that inhibition of Ero1, but not VKOR caused substantial impairment of 
disulphide formation if the DPMs were first subjected to a brief reductive challenge. This 
finding reinforces the perception that Ero1 is a key generator of disulphides but suggest that 
alternative pathways of PDI oxidation can compensate for its loss. VKOR has been shown 
previously to contribute to disulphide formation within albumin in human hepatoma cells. The 
lack of observed contribution to PPL disulphide formation in DPMs therefore suggests that 
VKOR activity may be limited to particular cell types or substrates. 
We also investigated the interaction between PDI and nascent PPL during and following 
translocation of the protein into the ER. This was assessed by translating PPL, or a 
translationally stalled PPL, in the presence of SP cells over-expressing a substrate trapping 
PDI mutant. The translationally stalled PPL was only partially exposed to the ER and thus 
resembled a partially translocated state. PDI was found to interact with both stalled and non-
stalled PPL however the nature of the interaction appeared to be different.  These findings 
suggest the oxidative folding of nascent secretory proteins begins during translocation and 
that different forms of interaction with PDI may arise during or following translocation into the 
ER. 
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1.1 The Secretory Pathway 
The secretory pathway is the name given to the specific route that secretory and membrane 
proteins of eukaryotic cells transverse during their trafficking to the outside of the cell (Karp, 
2008). The proteins targeted for the pathway comprise a substantial proportion of the cellular 
proteome. It has been predicted from sequence analysis that 11% of the proteome are 
soluble secreted proteins and a further 20% are membrane proteins which are targeted to 
this pathway (Kanapin et al, 2003). The pathway contains two major cellular organelles, 
namely the endoplasmic reticulum and the Golgi complex (Fig 1.1). The nascent proteins 
undergo a range of post-translational modifications as they travel through these organelles, 
allowing the proteins to develop into their mature forms before either being secreted from the 
cell or embedded in cellular membranes (Lodish, 2008). 
1.1.1 The endoplasmic reticulum  
The endoplasmic reticulum (ER) is the first organelle of the secretory pathway. The ER 
consists of a single continuous membrane which forms a network of flattened enclosed 
sheets and tubules. These sheets and tubules form layers within the cell (Fig 1.1) which are 
known as cisternae. The ER is continuous with the nuclear envelope and regions are also 
closely associated with the plasma membrane as well as other cellular organelles including 
the Golgi apparatus, vacuoles, mitochondria, peroxisomes, late endosomes and lysosomes 
(Voeltz et al, 2002). 
There are two major structurally and functionally distinct regions of endoplasmic reticulum 
known as the rough (R) and smooth (S) ER. The most obvious structural difference between 
the two is the presence of ribosomes on the outer surface of RER membranes but not SER. 
The cisternae of the SER is also more convoluted than that of the RER while the RER is 
more granular in texture (Voeltz et al, 2002).  Both the SER and RER membranes have a 
thickness of 6nm (Sadava, 1993) and the cisternae space typically has a diameter of 50nm 
in animal cells (Westrate et al, 2015).  
The primary function of the RER is the maturation of membrane and secretory proteins.  This 
process involves multiple post-translational modifications that occur within the lumen of the 
organelle. This includes disulphide bond formation, N-linked glycosylation and proline 
hydroxylation (Lodish, 2008). The SER has a wide range of functional roles that includes 
drug detoxification, lipid and steroid synthesis and calcium storage and signalling (Voeltz et 
al, 2002). 
The ER provides an environment that is both chemically and enzymatically distinct from the 
cytosol to facilitate its functions. Notably, the ER is prevalent in a specific subset of enzymes 
involved in the folding and maturation of secretory proteins. This includes the PDI 
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oxidoreductase family, BiP chaperone, and the calnexin and calreticulin lectins. In addition, 
the cellular buffer glutathione is far more oxidised in the ER than the cytosol allowing these 
enzymes to function optimally for the process of disulphide bond formation (Oka & Bulleid, 
2013). 
The cellular abundance of RER and SER correlates with the cellular functions. All cells 
contain at least a discernible amount of RER for the production of basal plasma membrane 
proteins as well as secreted and extracellular matrix proteins. However the RER is extensive 
in cell types specialised in the production of secretory proteins such as the cells of the 
pancreatic islets of Langerhans which synthesize insulin and glucagon (Lodish, 2008). The 
SER is only abundant in particular cells types such as liver cells and muscle cells. In liver 
cells extensive SER is required for chemical detoxification processes while muscles cells 
contain a special type of SER called sarcoplasmic reticulum that is involved in the regulation 
of intracellular calcium concentrations for the processes of muscle contraction (Voeltz et al, 
2002). 
1.1.2 Golgi Apparatus 
The Golgi apparatus is the second organelle of the eukaryotic secretory pathway. The Golgi 
has a distinct morphology which is composed of a series of flattened cisternae with dilated 
rims that are arranged in orderly stacks. These cisternae are also surrounded by vesicles 
that are also considered part of the organelle. The cisternae of the Golgi apparatus are 
larger than that of the ER with diameters typically in the range of 0.5 to 1.0µm. Different cell 
types differ widely in the abundance of the Golgi. Some contain only a few Golgi stacks while 
others may contain as many as several thousand stacks (Karp, 2008; Lodish, 2008).  
There are several functionally distinct types of cisternae in the Golgi apparatus. The 
cisternae of each Golgi stack are spatial ordered. The cisternae that are closest to the face 
of the ER and which receive incoming proteins are known as the cis cisternae. The cisternae 
on the exit face of the Golgi stacks are known as the trans cisternae and the cisternae that 
residue between these two groups are known as the medial cisternae. Each of these types 
of cisternae contains different luminal enzymes involved in modifying the maturing secretory 
and membrane proteins. The maturing proteins progress through each of these cisternae 
types as they travel through the Golgi apparatus and are modified by the glycosidase and 
glycosyl transferase enzymes resident at each cisternae. Each protein is modified differently 
by these enzymes in a manner depending upon the proteins structure and final destination 
(Karp, 2008; Lodish, 2008). 
Two sorting stations composed of vesicles and tubules reside on either side of the cisternae 
stacks. The vesicles and tubules next to the cis face is known as the cis Golgi network 
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(CGN) while those next to the trans side are known as the trans Golgi network (TGN). The 
CGN is involved in the transport of proteins from the ER to Golgi by anterograde (forward-
moving) transport vesicles. It is also involved in returning ER components that have been 
localised to the Golgi via retrograde (backwards-moving) transport vesicles. (Karp, 2008)  
The TGN contains three different types of vesicles for transport of proteins from the 
secretory pathway. These three types are termed exocytotic, secretory and lysosomal 
vesicles. Exocytotic vesicles are involved in the constitutive secretory pathway and 
immediately move towards and fuse with the plasma membrane. Secretory vesicles are 
involved in the regulated secretion process. These vesicles bud off but are not secreted until 
a particular signalling mechanism is activated. The secretory vesicles that control insulin 
secretion function in this way. Lysosomal vesicles contain digestive enzymes or other 
proteins targeted for degradation. These vesicles are first targeted to the late endosome 
before being transferred to the lysosome. In addition to these functions, the TGN also 
functions as an acceptor region of endosomal traffic (De Matteis & Luini, 2008; Karp, 2008; 
Lodish, 2008).  
Further to the N-linked glycosylation that occurs in the ER, proteins processed within the 
Golgi also undergo O-linked glycosylation. This glycosylation is name O-linked because the 
glycans are attached to the proteins at the hydroxyl (OH) side chain groups of serine and 
threonine amino acids residues within the target proteins. O-linked glycans are smaller than 
N-linked glycans and typically contain between one and four sugar residues. Both the N and 
O-linked glycan groups undergo a diverse range of editing within the Golgi apparatus 
resulting in a wide range of glycan arrangements in the mature secreted proteins. O-linked 
glycosylation has a diverse range of functional roles and is involved in processes such as 
protein localisation and trafficking, recognition of membrane antigens and cell to cell 
interactions (Karp, 2008; Lodish, 2008). 
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Figure 1.1: The secretory pathway. Nascent secretory and membrane protein are modified within 
the ER and Golgi apparatus. Transport to and from these organelles is mediated by cellular vesicles. 
The above figure was adapted from a figure originally shown by Lodish  (Lodish, 2000). 
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1.2 Translocation to the ER 
The translocation of nascent membrane and secretory proteins to the ER is directed by a 
signal sequence which is usually located at the N-terminus of these proteins. The signal 
sequence is generally between 16 and 30 amino acids in length. This sequence is 
predominately composed of hydrophobic amino acids, but also contains one or more 
positively charged residues.  A cytosolic ribonucleoprotein called the signal recognition 
particle (SRP) binds the signal sequence and directs the ribosome/nascent protein complex 
to the Sec61 translocon channel located in the ER membrane (Fig 1. 2). A cycle of GTP 
binding and hydrolysis drives the docking and dissociation of the ribosome, SRP and Sec61. 
The ribosome/nascent protein complex is initially docked and bound to the Sec61 channel by 
interactions between SRP and Sec61. Subsequently, interactions between the ribosome and 
Sec61 then bind the two components. The nascent protein then enters and the channel and 
translocates across the membrane and into the ER. The signal sequence is cleaved from the 
protein during entry by an ER membrane enzyme called signal peptidase. These 
translocation events occur while the nascent protein is being synthesised on the ribosome 
and as such the process is referred to as co-translational translocation (Lodish, 2008; 
Rapoport, 2008). 
There also exists an alternative pathway of translocation to the ER within eukarytoes which 
occurs post-translationally. This pathway involves an ER membrane channel containing 
Sec62/63 and may also involve the Sec 61 protein. Translocation is mediated by a ratcheting 
mechanism with the ER luminal protein BiP serving as the ratchet (Rapoport, 2008). It 
should be noted however that the majority of secretory and membrane proteins are 
translocated to the ER by the co-translational pathway (Jan et al, 2014). 
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Figure 1.2: Co-translational translocation of nascent proteins to the ER. Co-translational 
translocation is mediated by SRP binding and docking the nascent protein to the SRP receptor of the 
ER membrane. This figure was adapated from a figure shown by Rapoport (Rapoport, 2007). 
1.3 N-linked glycosylation 
N-linked glycosylation is a prominent ER post-translational modification which involves the 
addition of carbohydrate groups to the amide (NH) group of certain asparagine side chains. 
This modification occurs to the vast majority of secretory and membrane proteins. N-linked 
glycosylation has several functions; it promotes proper folding and confers structurally 
stability and enhances protein solubility. Membrane proteins expressing glycans can also act 
as antigens and/or be involved in cell-to-cell adhesion (Aebi et al, 2010; Lodish, 2008).  
N-linked oligosaccharide synthesis beings with the formation of an oligosaccharide precursor 
on the cytosolic surface of the rough ER membrane (Fig 1.3). This precursor forms upon a 
dolichol phospholipid located in the ER membrane. Dolichol phosphate phospholipids are 
strongly hydrophobic. The precursor is composed of glucose, mannose and N-acetyl 
glucosamine sugar residues which are attached to the dolichol phosphate by a 
pyrophosphate linkage. After the addition of the first 7 sugar residues the oligosaccharide 
precursor is flipped to face the luminal side of the ER membrane before a further 7 sugar 
residues are added. The oligosaccharide may then be transferred from the dolichol carrier to 
asparagine residues of a nascent protein entering the ER lumen. This transfer reaction is 
catalysed by an ER membrane protein complex called oligosaccharyltransferase (OST). The 
oligosaccharide may only be attached to asparagines residues in a three amino acid 
consensus sequence consisting of of Asn-X-Ser or Asn-X-Thr (where X is any non-proline 
amino acid). Not all of these consensus sites are glycosylated as rapid folding of protein 
segments containing these amino acid sequences can prevent their glycosylation.  
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Addition of the completed oligosaccharide presents a site in which the ER lectin chaperones 
chaperones calnexin (CNX) and calreticulin (CRT) can bind and assist in folding of the 
protein. These two chaperones bind to glycan groups in only one of the three terminal 
glucose residues are present. Removal of this final glucose residue causes release from 
these lectins. The removal of these three residues and the readdition of the third most 
terminal residues are catalysed by α-glucosidase I and II and UGT1. The nascent protein 
exists in a flux state that may pass through cycles of CNX/CRT binding during the folding 
process (Aebi et al, 2010; Lodish, 2008; Tannous et al, 2014). 
 
Figure 1.3: Synthesis and addition of N-glycans to nascent proteins. The figure shown was adapated 
from a figure shown by Lodish (Lodish, 2008) and a figure on the website of Prof William Clemons 
(California Institute of Technology) (http://clemonslab.caltech.edu/n-linked-glycosylation.html). 
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1.4 Protein folding and quality control in the ER 
The folding of secretory protein begins as soon as they are synthesised. Initially folding 
within the ribosome and Sec61 translocon only allows the adoption of α-helical 
conformations as the space available within tunnels of these structures is limited. The range 
of potential conformations greatly expands upon entry of the secretory proteins to the ER 
lumen (Braakman & Bulleid, 2011). 
Within the ER lumen protein folding is assisted by folding factors and chaperones. This 
includes the PDI oxidioreductases, peptidyl prolyl isomerases, calnexin and calreticulin and 
BiP. The protein disulphide isomerises (PDIs) are a family of enzymes that catalyse the 
formation, removal and rearrangement of disulphide bonds in nascent substrates. The 
peptidyl prolyl isomerases (PPIs) catalyse the rotation of peptidyl bonds of proline residues 
between cis and trans conformations (Fig 1.4). There are eight PPIs resident in the ER. Both 
the formation of disulphides and the rotation of proline peptidyl bonds are rate-limiting steps 
in protein folding and as such these enzymes greatly accelerate the folding process. 
Calnexin/calreticulin and BiP are key enzymes of the two primary chaperone systems of the 
ER. Calnexin and calreticulin are lectins (carbohydrate binding proteins) that bind to the 
glycan groups of unfolded proteins. BiP (immunoglobulin heavy-chain binding protein) on the 
other hand is an Hsp70 chaperone that binds to hydrophobic regions of proteins in an ATP 
dependent manner (Behnke et al, 2015; Tannous et al, 2014). 
The folding factors and chaperones of the ER act in combination to facilitate the correct 
folding of nascent proteins within the ER. However, as protein folding is a stochastic process 
correct folding does not always occur. As such, the ER contains machinery to distinguish 
between correctly folded and misfolded proteins and to process these proteins accordingly. 
Proteins that fold correctly may progress to the Golgi by anterograde transport. Misfolded 
proteins are sequestered within the ER by interactions with chaperones and are ultimately 
degraded if native folding cannot be achieved (Fig 1.5) (Braakman & Bulleid, 2011; Tannous 
et al, 2014). 
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Figure 1.4: Disulphide formation and proly-peptidyl rotation. The rate-limiting steps of disulphide 
bond formation (A) and rotation or peptidyl bonds of proline residues (B) are catalysed by the PDI 
family and PPI family respectively. This figure was adapated from a figure by Tannous (Tannous et al, 
2014). 
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Figure 1.5: Pathways of protein folding and misfolding in the ER. Proteins that fold correctly are 
recognised by ER cargo receptor proteins and are transported to the Golgi in anterograde vesicles. 
Misfolded proteins are either exported from the ER to be degraded in the proteosome or may form 
aggregates which are later destroyed in autophagic processes. This figure was adapated from a 
figure by Braakman and Bulleid (Braakman & Bulleid, 2011). 
1.4.1 Calnexin/Calreticulin Cycle 
Calnexin (CNX) and calreticulin (CRT) bind to the newly synthesised glycan groups shortly 
after their addition to nascent proteins (Fig 1.6). The binding of these two lectins to nascent 
glycoproteins is dependent upon the number of terminal glucose residues exposed on each 
glycan group. The use of this glycan code allows CNX and CRT to distinguish between 
proteins that have fully folded and those which are unfolded or misfolded (Tannous et al, 
2014). 
Binding of CNX and CRT has several functional purposes. Firstly it influences protein folding 
and prevents aggregation by shielding regions of the unfolded protein. Secondly, CNX and 
CRT are also associated with ERp57 (a PDI family member) and as such binding of these 
lectins facilitates interaction of the nascent protein with this enzyme. This binding allows 
ERp57 mediated disulphide formation and rearrangement of disulphides to occur. And 
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thirdly, CNX and CRT sequester nascent proteins that have not completed folding within the 
ER (Tamura et al, 2010). 
Proteins that become terminally misfolded eventually exit the CNX/CRT cycle by undergoing 
trimming of mannose residues from their glycans. This mannose trimming identifies these 
proteins as targets for degradation (Benyair et al, 2015). 
 
 
Figure 1.6: The calnexin/calreticulin cycle. The terminal two glucose residues of glycans are 
removed by glucosidases I and II which allows binding of CNX and CRT. Cleavage of the third terminal 
glucose reside by glucosidase II causes release from the lectins. UGT1 can however reattach glucose 
reside to glycan groups near exposed hydrophobic regions. This causes rebinding of CNX and CRT to 
proteins that have not achieved native folding. This figure was adapated and modified from a figure 
by Tamura et al (Tamura et al, 2010). 
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1.4.2 BiP chaperone system 
Similarly to CNX and CRT BiP binds to nascent or unfolded proteins but unlike these lectin 
chaperones BiP does not bind to proteins via the glycan groups but rather binds to 
hydrophobic regions of the folding polypeptide. BiP contains a substrate binding domain and 
a nucleotide binding domain which are joined via a linker sequence. The activity of BiP is 
regulated by a cycle of ATP binding, hydrolysis and nucleotide exchange and also 
interaction with co-factors (Fig 1.7) (Behnke et al, 2015) 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: BiP interaction with unfolded protein substrates. (a) When levels of unfolded protein 
are low a large proportion of BiP exists as inactive oligomers that are ADP-ribosylated and 
phosphorylated. (b) In the presence of its substrates BiP becomes ATP bound and induced into a 
monomeric active state. The substrate binding domain adopts an open conformation allowing 
interaction with the substrate. (c) Substrate proteins are targeted to BiP from multiple co-chaperone 
enzymes that contain a DnaJ domain. (d) Hydrolysis of ATP to ADP causes BiP to enter a more stable 
bound state with its substrate. The conformation adopted by BiP in this state differs between 
elongated and globular substrates. Exchange of ADP for ATP causes release of the substrate and 
allows BiP to become available for subsequent rounds of substrate binding. The exchange of ADP for 
ATP is facilitated by the nucleotide exchange factors (NEFs) Grp170 and Sil1. Note that the substrate 
binding domain of BiP is shown in blue and nucleotide binding domain is shown in maroon. This 
figure was adapated from a figure by Behnke et al (Behnke et al, 2015). 
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1.5 ER associated degradation 
Proteins that fail to fold correctly are retrotranslocated from the ER to the cytosol and 
targeted to the proteasome for degradation in a process known as ER associated 
degradation (ERAD) (Fig 1.8). Misfolded proteins can be recognised by ER chaperones and 
lectins by several distinctive motifs. Mannose trimmed glycan groups is one of these motifs 
and other include hydrophobic patches, unpaired sulphydryls and exposed sequences that 
would normally be processed. The type of misfolding motif expressed on each protein 
correlates with the protein that identifies the misfolded protein and also the type of ERAD 
protein complexes encounter by these proteins on the ER membrane (Hegde & Ploegh, 
2010; Lemus & Goder, 2014).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Functional overview of ERAD. Misfolded protein substrates are recognised by “adaptor” 
proteins which are lectins and chaperones such as PDI. Adaptors and their protein substrates are 
then targeted to membrane embedded complexes containing an ubiquitin ligase embedded in the 
ER membrane. p97 is also recruited to the complex. The substrates are then retrotranslocated with 
the ATPase activity of p97 supplying the energy for the process. The substrates are ubiquitinated on 
the cytosolic face of the membrane during this process. Lastly the protein substrates are transferred 
to the proteasome in the cytosol for degredation. This figure was adapated from a figure by Hedge 
and Ploegh (Hegde & Ploegh, 2010). 
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1.6 Unfolded Protein Response 
The quality control mechanisms of the ER and the processes of ERAD enable eukaryotic 
cells to identify and degrade misfolded proteins which commonly form within the organelle. 
In some instances however stress conditions can cause the protein folding load of the ER to 
exceed the folding capacity. This results in the toxic accumulation and aggregation of 
misfolded proteins within the organelle. This type of ER dysfunction can be caused by a 
variety of cellular stresses including viral infection, glucose deprivation, redox imbalance and 
hypoxia. It is also common in many disease states. Under such circumstances the unfolded 
protein response (UPR) pathway is activated which enables the ER to adapt to the stress 
conditions and match protein folding capacity to secretory demand (Chakrabarti et al, 2011; 
Maly & Papa, 2014). 
Signalling of the UPR is mediated by three ER membrane proteins, namely pancreatic ER 
kinase (PERK), activating transcription factor 6 (ATF6) and inositol requiring enzyme 1 α 
(IRE1) (Fig 1.9). Each of these receptors is capable of sensing misfolded proteins through 
their association with BiP. In each case the receptors are inactive when bound to BiP but 
become activated following dissociation from BiP. This mechanism allows the receptors to 
only signal when the level of misfolded proteins exceeds a critical threshold in which much of 
the BiP protein is bound to the exposed hydrophobic regions of these proteins and not to 
these three receptors. In addition, misfolded proteins may themselves also act as ‘activating 
ligands’ of IRE1 and PERK by direct binding to the luminal regions of the receptors 
(Chakrabarti et al, 2011; Senft & Ronai, 2015). 
Activated PERK, ATF6 and IRE1 each have complex downstream signalling mechanisms. 
Collectively they invoke an adaptive response to ER stress to restore secretory homeostasis. 
Activate PERK results in a global reduction in protein synthesis.  This reduces the protein 
folding load of the ER by decreasing the influx of newly synthesized proteins and allowing 
time for existing proteins within the ER to be correctly folded or degraded. The activation of 
both ATF6 and IRE1 results in up regulation of the expression of ER chaperones as well as 
protein involved in ERAD, thus increasing the capacity of the ER to fold as well as degrade 
proteins. However, in circumstances in which ER stress is particularly high or is chronic the 
UPR can also lead to the activation of mitochondrial apoptotic pathways resulting in cellular 
destruction (Chakrabarti et al, 2011; Maly & Papa, 2014). 
 
 
 
27 
 
 
 
 
 
 
 
 
 
Figure 1.9. Overview of the unfolded protein response.  UPR signalling is initiated by the ER 
membrane receptors IRE, PERK and ATF6. Accumulation of unfolded proteins within the ER is 
detected by sensing mechanisms in the luminal domain of these receptors and results in signal 
transduction via their cytosolic effector domains. Signal transduction either results in an adaptive 
response to restore protein homeostasis or to initiation of cell degeneration and apoptotic 
pathways. This figure was adapated from a figure by Maly and Papa (Maly & Papa, 2014). 
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1.7 Disulphide bond formation 
Disulphide bonds form in nascent membrane and secretory proteins following entry of these 
proteins to the lumen of the rough ER. The formation of disulphide bonds is an important 
event in the maturation of these proteins and constitutes part of the protein folding process. 
In addition, disulphides confer structural stability and also bind together the subunits of 
mulitmeric proteins (Lodish, 2008). Disulphides are introduced to nascent proteins in the ER 
by thiol-disulphide exchange reactions with the PDI family of oxidoreductases (Fig 1.10) 
(Tavender & Bulleid, 2010a).  
1.7.1 The PDI family 
The mammalian PDI family is made of up of twenty different enzymes located within the ER 
(Fig 1.11). In addition to their cellular location the family members are defined by the 
presence of at least one domain that contains a thioredoxin-like structural fold. This feature 
is an αβ fold that contains a mixed β-sheet core (Fig 1.12). The thioredoxin-like domains of 
the PDI family members can be categorised depending on whether they are catalytically 
active or not. The catalytically active domains contain a CXXC motif involved in thiol-
disulphide exchange reactions (Hatahet & Ruddock, 2007; Kozlov et al, 2010). Domains 
containing a CXXS or SXXC may also be considered as catalytically active as mixed 
disulphide species have been detected for family members containing these motifs, such as 
PDILT (van Lith et al, 2005). The catalytically inactive domains of the PDI family members 
are often involved in substrate binding and chaperone activities. These non-catalytic 
domains have a greater diversity in sequence and structure than the catalytic domains 
(Kozlov et al, 2010). 
A current research goal is to understand the functional roles of the PDI family members 
(Kozlov et al, 2010). Emerging evidence suggests that different family members may have 
different niche roles within this process. One difference identified between the family 
members is in their substrate specificities. ERp57 for example has been found to 
preferentially interact with substrates that are glycosylated and requires the assistant of 
calnexin or calreticulin for these interactions (Jessop et al, 2009a). Another known difference 
between the family members is in their preference to oxidation of thiol groups or reduction of 
disulphides. Most of the PDI family members appear to favour oxididation of thiols, however, 
certain PDI family members, particularly ERdj5, favour action as a reductase (Oka & Bulleid, 
2013; Oka et al, 2013). 
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Figure 1.10: Thiol-disulphide exchange reactions. Disulphide bonds can be exchange between 
proteins in thiol-disulphide exchange reactions. In these reactions a disulphide bond is effectively 
donated from one protein to another causing the two cysteines of the target protein to become 
oxidised to a disulphide while the disulphide of the donating protein becomes reduced to a thiol 
group. Disulphide bonds are introduced into nascent proteins by thiol-disulphide exchange reactions 
with the PDI family members. This figure was adapated from a figure originally shown by Tavender 
and Bulleid (Tavender & Bulleid, 2010a). 
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Figure 1.11: Domain structure of the PDI family. The catalytic thioredoxin-like a domains are shown 
in pink while non-catalytic b domains are shown in blue and light blue. The only exception to this is 
the a domain of PDILT which is not catalytically active however is hatched as it has a strong similarity 
to the a domain of PDI. X-linker regions are shown in yellow. PDI family members embedded in the 
ER membrane have the TMX designation and their transmembrane domains are shown by white 
boxes. Non-standard PDI domains such as the DnaJ domain of ERdj5 and the helical domain of ERp29 
are shown in green. ERp27 and ERp29 are shown in a separate division of the table as they do not 
contain catalytically active thioreodoxin-like domains. This figure was adapted from a figure 
originally shown by Kozlov et al. The domain structural diagrams are as originally shown by Kozlov et 
al (Kozlov et al, 2010).  
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Figure 1.12: Structure of human thioredoxin 1. The image shown was produced using DeepView 
and represents the structure of reduced human thioredoxin 1 (3TRX). The ribbon form of the protein 
backbone is shown in light blue and the two catalytic cysteines (C32 and C35) of the CXXC motfi are 
shown in red. The secondary structure of this protein is comprised of a αβ fold that contains a mixed 
β-sheet core surrounded α helices. This structural motif is a common within the thioredoxin 
superfamily which includes the PDI family of oxidoreductases. The structure shown was originally 
solved by Forman-Kay et al by NMR spectroscopy (Forman-Kay et al, 1991) 
1.7.2 De novo sources of disulphides 
In order for the PDI family to continuously introduce disulphide bonds into substrates the 
catalytic disulphides of the PDI enzymes must themselves be regenerated. Endoplasmic 
reticulum oxidoreductase 1 (Ero1 ) is an enzyme commonly regarded as being the primary 
de novo enzymatic generator of ER disulphides (Tavender & Bulleid, 2010a). Peroxiredoxin 
IV (PrxIV) is also well established as an additional enzymatic contributor to PDI oxidation 
(Tavender & Bulleid, 2010b).  Furthermore, several other enzymes; namely VKOR, QSOX 
and GPx7/8 have been identified as potential contributors to disulphide bond formation 
within the ER (Fig 1.13) (Bulleid & Ellgaard, 2011).  
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Figure 1.13: Known and hypothesised sources of de novo disulphide bond formation within the ER. 
Disulphide bonds are introduced into nascent proteins within the ER by thiol-disulphide exchange 
reactions with members of the PDI family. The catalytic disulphides of PDI are themselves 
regenerated by thiol-disulphide exchange reactions with enzymes capable of de novo generation of 
disulphides. Ero1 and PrxIV are established de novo generators of ER disulphides with strong in vitro 
and in vivo evidence supporting their involvement. The enzymes and chemicals shown in dashed 
boxes are hypothesised contributors to this process. In most cases their contribution to this process 
is supported by in vitro but not in vivo evidence. VKOR is the exception to this as there is in vivo data 
supporting evidence for VKOR contribution to disulphide formation, however this evidence comes 
from a single study using a hepatoma cell line (Rutkevich and Williams, 2012). As such it is unkown if 
VKOR contributes to disulphide formation in other tissues. To distinguish VKOR from the other 
hypothesised disulphide generators it is shown in a box with longer dashes. QSOX is shown in a 
separate position from the other disulphide generators as it has been shown in vitro to be both 
capable of disulphide generation and transfer of disulphides to nascent proteins without the need 
for interaction with PDI. The reduced and oxidised form of each member of these redox pathways is 
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shown in red and blue respectively. The figure was adapated and modified from a figure shown by 
Bulleid and Ellgaard (Bulleid & Ellgaard, 2011). 
1.7.3 Endoplasmic reticulum oxidoreductase 1 
Ero1 is a flavoenzyme that couples the oxidation of the catalytic cysteines of PDI to the 
reduction of molecular oxygen to hydrogen peroxide. The flavine adenine dinucleotide (FAD) 
moiety of Ero1 is involved in the transfer of electrons to oxygen during this reaction. The 
enzymatic activity of Ero1 is tightly regulated by an intricate mechanism involving the 
formation/breakage of regulatory disulphide bonds which effectively switches the molecule 
into an active or inactive catalytic state in response to the redox conditions of the ER. 
Functionally, this regulatory mechanism appears to exist to prevent excessive generation of 
hydrogen peroxide and thus prevent oxidative stress (Tavender & Bulleid, 2010a). This is of 
importance as the activity of Ero1 produces one molecule of hydrogen peroxide for every 
disulphide it introduces. It has been estimated that Ero1 activity accounts for 25% of the 
hydrogen peroxide produced during cellular protein synthesis (Tu & Weissman, 2004). 
Ero1 is the most evolutionary conserved of the PDI oxidants. It is essential for disulphide 
formation in simple eukaryotes such as yeast and worms but not more complex eukaryotes 
such as mammals in which alternative oxidases exist. Two isoforms of Ero1 exist in 
vertebrates designated Ero1α and Ero1β. Ero1α is expressed throughout the body however 
expression of Ero1β is enriched in secretory cells. The activity of β is also greater than α as 
β does not contain the regulatory disulphides found in α (Zito, 2015).  
1.7.4 Peroxiredoxin IV 
PrxIV is an ER resident protein that exists as a ring shaped disulphide bonded homo 
decamer. The peroxiredoxins are a family of highly expressed antioxidant enzymes that 
metabolise hydrogen peroxide. There are six members of the family in humans, however, 
PrxIV is the only member that resides within the ER. PrxIV has an intriguing functional 
mechanism by which it reduces hydrogen peroxide to water with the concurrent oxidation of 
PDI, P5 or ERp46. This utilisation of hydrogen peroxide by PrxIV as a reactant lessens the 
oxidative stress causes by the activity of Ero1. In addition, its activity in combination with that 
of Ero1 potentially allows two disulphide bonds to be formed following the reduction of one 
molecule of oxygen to water (Cao et al, 2014; Tavender & Bulleid, 2010b; Tavender et al, 
2008; Zito et al, 2010b). 
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1.7.5 Vitamin K epoxide reductase 
Vitamin K epoxide reductase (VKOR) is an ER membrane protein that plays a key role in the 
vitamin K cycle and blood coagulation. VKOR enzymatically reduces vitamin K epoxide to 
vitamin K hydroquinone, however, during this reaction key catalytic cysteines of a CXXC 
motif of VKOR become oxidised forming a disulphide (Van Horn, 2013). It is currently 
unknown how this disulphide is reduced to allow further catalytic cycles. However, a study 
involving over expression of a CXXA substrate trapping form of VKOR found that VKOR can 
form mixed disulphides with the membrane bound PDI family members TMX, and TMX4 as 
well as the luminal PDI family member ERp18. The mixed disulphide interaction with TMX 
was found to be particularly strong (Schulman et al, 2010). This indicates that VKOR may be 
involved in redox reactions with these PDI family members which are oxidised while the 
disulphide of VKOR is reduced. Interestingly, the same study reported that Ero1α interacts 
poorly with the membrane bound PDI family members suggesting that Ero1 and VKOR may 
act as oxidases for different subsets of the PDI family (Schulman et al, 2010). Analysis of 
VKOR mRNA expression in various human tissues has indicated that VKOR is ubiquitously 
expressed, but is particularly abundant in liver cells (Wang et al, 2005). This suggests that 
the involvement of VKOR in ER disulphide bond formation may be particularly prominent in 
liver cells.  
1.7.6 Quiescin sulfhydryl oxidase 
Quiescin sulfhydryl oxidase (QSOX), like Ero1, is a flavoprotein capable of catalysing 
disulphide bond formation with the concurrent reduction of oxygen to hydrogen peroxide 
(Kodali & Thorpe, 2010). There are two isoforms of QSOX expressed in mammalian cells; 
namely QSOX1 and QSOX2. QSOX1 is expressed at higher levels in most tissues than 
QSOX2 (Coppock & Thorpe, 2006) and has so far been the focus of the majority of QSOX 
research (Kodali & Thorpe, 2010). QSOX has been shown in vitro to be capable of 
introducing disulphide bonds into various substrates (Hoober et al, 1999; Hoober & Thorpe, 
1999). In addition, in yeast over expression of QSOX1 has been found to suppress the 
lethality of Ero1 deletion suggesting the two enzymes share functional roles (Chakravarthi et 
al, 2007). However, QSOX is predominantly located in the Golgi apparatus and also cellular 
secretions suggesting that its primary role is not in the ER (Mairet-Coello et al, 2004; 
Ostrowski & Kistler, 1980). Recently, QSOX1 depleted cell cultures have been shown to 
have a defective extracellular matrix (ECM). Experimental evidence strongly suggests that 
this defect is due to a lack of QSOX1 catalysed disulphide bond formation of the α4 laminin 
and other components of the ECM (Ilani et al, 2013). This evidence now suggests that the 
functional activity of QSOX is primarily extracellular.  
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1.7.7 Glutathione Peroxidases 7 and 8 
Glutathione peroxidises (GPx) 7 and 8 are ER resident enzymes that despite their names 
are inefficient enzymes for the reduction of oxidised glutathione. GPx7 and 8 have been 
shown in vitro to increase the rate of oxidative refolding of denatured protein by 
approximately 2 fold in the presence of PDI and a hydrogen peroxide generating system 
(Nguyen et al, 2011). Recently reports using pulse chase methodology indicate that over 
expression of GPx7 accelerates disulphide formation in vivo following DTT treatment (Wang 
et al, 2014). The current model of GPx7/8 activity is that these enzymes assist oxidative 
folding by catalysing the oxidation of PDI disulphides with the concurrent reduction of Ero1 
generated hydrogen peroxide. The catalytic rate of GPx7/8 in these reactions however 
appears slow (Nguyen et al, 2011), and therefore these reactions perhaps make only a 
minor contribution to ER disulphide formation. 
1.8 Thiol-dependent redox systems 
Mammalian cells contain two major thiol-dependent redox systems, namely the glutathione 
and thioredoxin systems. Both of these systems are key factors in cellular thiol and 
disulphide redox biology. 
1.8.1 Glutathione 
Glutathione (GSH) is a ubiquitous cellular tripeptide molecule that is composed of the amino 
acids, glutamate, cysteine and glycine. This molecule is present at millimolar concentrations 
(up to 10mM) within the cell and has several functions including protecting against oxidative 
stress (Anderson, 1998; Chakravarthi et al, 2006).  
GSH is synthesised in two ATP dependent reactions. Firstly, a dipeptide is formed between 
glutamate and cysteine. The γ-glutamylcysteine produced then reacts with glycine at the C-
terminus to produce GSH. These two reactions are catalysed by the enzymes γ-glutamyl 
cysteine synthetase and glutathione synthetase respectively. The GSH tripeptide produced 
contains an unusual γ-peptide bond between the amine group of cysteine and the carboxylic 
acid group of the side chain of the glutamate. The presence of this γ peptide bond greatly 
reduces glutathione degradation by cellular peptidases (Anderson, 1998; Lehninger et al, 
2005). 
Glutathione can exist in both a reduced and oxidised state. Loss of an electron by oxidation 
causes GSH to readily react with another oxidised GSH molecule to form glutathione 
disulphide (GSSG) (Lehninger et al, 2005). Due to the high concentration of glutathione and 
its ability to exist in these two states under physiological conditions glutathione is a major 
cellular redox buffer (Hwang et al, 1992). The high concentration of cellular GSH allows it to 
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react non-enzymatically with reactive oxygen species (ROS) as part of the cellular ROS 
scavenging mechanisms. This causes neutralisation of the ROS and the formation of GSSG 
(Apel & Hirt, 2004). GSH can also reduce the ROS hydrogen peroxide to water 
enzymatically in a reaction catalysed by the glutathione peroxidise. Despite this and other 
mechanisms that lead to GSSG production, the concentrations of GSSG within the cytosol 
are maintained at low levels by the action of the enzyme glutathione reductase which 
continuously converts GSSG back to GSH (Fig 1.14) (Lehninger et al, 2005). 
 
 
 
 
 
 
 
 
 
Figure 1.14: Cytosolic glutathione is maintained in a reduced state. GSSG produced in the cytosol is 
converted back to GSH by the action of glutathione reductase. NAPDH produced during the 
oxidation of glucose-6-phosphate acts a cofactor in this reaction. GR: glutathione reductase, G6PD: 
glucose-6-phosphate dehydrogenase (Lehninger et al, 2005).   
The ratios of concentration of GSH to GSSG varies between different compartments within 
the cell. Within the cytosol the GSH/GSSG ratio is very high and has been found to range 
from 30:1 to 100:1. Within the organelles of the secretory pathway however the GSH/GSSG 
is far lower and has been found to range from 1:1 to 3:1 (Go & Jones, 2008). As such, the 
luminal environment of the ER and Golgi is more oxidising than that of the cytosol. Both the 
metabolism of GSH/GSSG within the ER and its transport to and from the organelle are 
poorly understood. Key questions remain regarding how the oxidised GSH/GSSG is 
maintained in the ER, whether GSSG can be reduced to GSH by an ER resident enzyme 
and how GSH/GSSG is transported across the ER membrane (Chakravarthi et al, 2006)?   
For many years glutathione (in addition to thioredoxin) has been regarded as being involved 
in maintaining thiol groups within a reduced state within the cytosol (Lopez-Mirabal & 
Winther, 2008). This paradigm has been challenged in recent years as it has been reported 
that thiol-redox control is unaffected in yeast cells depleted of, or expressing toxic levels of 
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glutathione (Kumar et al, 2011). Glutathione is, however, widely regarded as playing an 
important role in the oxidative folding process within the ER (Fig 1.15) (Chakravarthi et al, 
2006). This perception is based on several findings. The oxidising GSH/GSSG ratio within 
the ER appears to be optimal for the enzymatic introduction of disulphide bonds to nascent 
proteins by PDI (Lyles & Gilbert, 1991). GSH is also thought to be a key component of the 
disulphide reduction pathway within the ER and there is evidence that GSH is involved in the 
reduction of non-native disulphides (Chakravarthi & Bulleid, 2004; Molteni et al, 2004).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15: Model of glutathione metabolism within the ER. ER luminal glutathione is thought to 
be involved in several redox reactions. These include reduction and oxidisation of PDI and 
neutralisation of luminal ROS. The luminal GSH/GSSG could be maintained by either flux from the 
cytosol via unidentified glutathione transporters or by conversion of GSSH to GSH by an unidentified 
ER resident glutathione reductase enzyme. The figure was adapated from a figure shown by 
Chakravarthi et al (Chakravarthi et al, 2006). 
1.8.2 Thioredoxin 
The thioredoxin system, like the glutathione system, is a major regulator of cellular redox 
homeostasis and antioxidant defence. The components of this system are NADPH, 
thioredoxin reductase and thioredoxin itself. These components are involved in a redox 
pathway that causes the reduction of disulphide bonds in the target proteins and molecules 
of thioredoxin. Thioredoxins are small, ubiquitous enzymes of about 12kDa that catalyse 
disulphide reduction. The thioredoxins are maintained in a reduced state by thioredoxin 
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reductase which in turn has its catalytic site reduced by NADPH (Fig 1.16) (Lu & Holmgren, 
2014).  
There are two isoforms of thioredoxin (Trx) within mammalian cells termed Trx1 and Trx2. 
Trx1 is mainly a cytosolic enzyme, but, under certain circumstances it can also be 
translocated to the nucleus or secreted from the cell. Trx2 is located within the mitochondria 
(Lu & Holmgren, 2014). Thioredoxin reductase (TrxR) is a selenium containing enzymes 
responsible for maintaining the cellular pool of reduced thioredoxin. There are three isoforms 
of TrxR in mammalian cells; TrxR1 which is located in the cytosol, TrxR2 which is located in 
the mitochondira and TGR, a testis-specific thioredoxin glutathione reductase. Both the 
TrxR1 and TrxR2 isoforms also have several splice variants. Two of the TrxR2 splice 
variants do not contain mitochondrial targeting sequences and consequently these variants 
are located in the cytosol. Both Trx1 and Trx2 enzymes operate as homodimeric enzymes in 
their respective cellular compartments. These enzymes have overall structures similar to 
glutathione reductase and contain interface domains as well as FAD and NADPH binding 
domains (Lu & Holmgren, 2014).   
The thioredoxin system has a broad range of downstream targets and reduces several key 
redox enzymatic systems within this cell (Fig 1.17). This includes the peroxiredoxins (Prx), 
methionine sulphoxide (Msr), and ribonucleotide reductase (RNR) enzymes. These target 
enzymes are responsible for reduction of hydrogen peroxide to water, reduction of 
methionine sulphoxide to methionine and converting ribonucleotides to deoxyribonucleotides 
respectively. The thioredoxin system also supports the reduction of several redox sensitive 
molecules within the cell including ASK1, Txnip and PTEN. ASK1 and Txnip are involved in 
apoptotic signalling while PTEN is involved in the opposing anti-apoptotic Akt signalling 
pathway. Due to the hierarchical nature of the redox homeostasis of these enzymes and 
molecules that is mediated by the thioredoxin, the thioredoxin system plays a major role in 
maintaining reducing conditions within the cell and protecting the cell from oxidative stress 
that could lead to apoptosis (Lee et al, 2013). 
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Figure 1.16: Disulphide bonds are reduced within the cytoplasm by the thioredoxin redox system. 
A redox relay pathway catalyses disulphide reduction. The above figure is above was adapated from 
a figure shown by Lee et al (Lee et al, 2013).  
 
 
 
 
 
 
 
 
 
 
Figure 1.17: Thioredoxin reduces the disulphides bonds of a broad range of substrate enzymes and 
molecules. Thioredoxin has a prominent position in the cellular redox hierarchy. As such the 
thioredoxin reductive pathway is important for numerous cellular processes. This figure was 
adapated from a figure originally shown by Lee et al (Lee et al, 2013). 
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1.9 In Vitro Translation 
The experiments described in this thesis were conducted using a rabbit reticulocyte lysate 
translation system. This system was supplemented with either microsomes or semi-
permeabilised cells for the majority of experiments which acted as a source of ER and 
enabled ER processing events to occur to the proteins synthesised within the lysate. 
1.9.1 Rabbit Reticulocyte Lysate 
The rabbit reticulocyte lysate (RRL) translation system is one of most commonly used cell 
free protein synthesis systems in use. This system has been used in a wide range of 
investigations including analysis of transcriptional and translational control, targeting of 
nascent proteins to the ER and processing events within the ER. The latter two of these 
processes have been investigated by the addition of microsomal membranes or SP cells to 
the lysate (Chong, 2014; Titus & Promega Corporation., 1991). 
The reticulocytes from which RRL is derived are immature red blood cells (Weissbach & 
Pestka, 1977). These cells were chosen as a source of lysate as they are a type of 
mammalian cell which have the desirable property of having particularly low ribonuclease 
activity (Hulea & Arnstein, 1977). Therefore, there will be little degradation of mRNA added 
to the lysate during in vitro translation reactions. 
The RRL translation system currently used is largely unchanged from the system developed 
by Pelham and Jackson in 1976 (Pelham & Jackson, 1976). The lysate of this system comes 
from the reticulocyte cells of New Zealand White rabbits (Titus & Promega Corporation., 
1991). The procedure for producing rabbit reticulocyte involves first making rabbits anaemic. 
One method of doing this is to inject the rabbits with acetylphenylhydrazine which causes the 
destruction of erythrocytes (Stewart et al, 1953). The rabbit are then bled a few days after 
the treatment. As the rabbits are recovering their blood contains a high proportion of 
reticulocytes. The reticulocytes are lysed by osmotic lysis and the lysate is centrifuged at 
30,000 xg for 15 min and the supernatant removed and the cellular debris discarded (Hunt & 
Jackson, 1974).  The lysate is usually treated with micrococal nuclease to degrade 
endogenous mRNA within the lysate, thereby reducing background translation (Titus & 
Promega Corporation., 1991). The lysate is then stored at -70°C until required for 
experimental use. 
The Promega Corporation is a major supplier of commercially available RRL. The RRL 
contains the components required for protein synthesis such as ribosomes, tRNA, amino 
acids and initiation, elongation and termination factors. The Promega RRL has been 
optimised for in vitro translation by the addition of several components. This includes hemin 
which is added to prevent inhibition of initiation factor eIF-2α, a phosphocreatine kinase and 
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phosphocreatine energy generating system, and additional tRNAs from calf liver to 
supplement the endogenous tRNAs within the lysate. A “Flexi RRL” is also available in which 
any additional Mg2+ K+ or DTT that is required to be added to the system is added separately 
by the user (Titus & Promega Corporation., 1991). This can be very useful as the Mg2+ and 
K+ concentration often have to be optimised for translation of each mRNA to maximise 
translation efficiency. It is also useful for the addition of DTT to be optional if disulphide bond 
formation is being analysed in the translation reaction as DTT will interfere with this process. 
All the translation reactions described in this thesis are carried out using a Flexi lysate 
system purchased from Promega.  
1.9.2 Microsomes 
Microsomes are vesicle fragments of the rough ER that are produced when cells are 
homogenised (Lodish, 2008). These vesicles are about 100nm in diameter (Avers, 1986). 
Microsomes can be isolated from the other cellular components of cellular homogenates by 
equilibrium density gradient centrifugation (Sadava, 1993). The ribosomes that are bound to 
the outer surface of microsomes derived from the rough ER which gives these microsomes a 
high density (Avers, 1986). Aside from existing as vesicles rather than as a reticulum the 
microsomes are structurally and functionally very similar to that of the ER. Despite the 
breakage and formation of vesicles the interior of microsomes remains equivalent to the ER 
lumen (Avers, 1986). Due to these properties microsomes are a valuable research tool for 
researching the ER. Microsomes are often supplemented to cell-free protein synthesis 
(CFPS) systems to act as a source of ER to allow post-translational modifications to occur 
within secretory proteins synthesised within these systems (Titus & Promega Corporation., 
1991). 
Microsomes are commonly purified from dog pancreas as the pancreas tissue has high 
secretory output and as such the cells of this tissue has a well-developed secretory pathway 
allowing for high yields of microsomes from this tissue. In addition, dog pancreas tissue also 
has the desirable property of having high levels of endogenous ribonuclease inhibitor which 
preserves the integrity of the polysomes bound to the microsomes (Kaderbhai et al, 1995; 
Walter & Blobel, 1983). 
1.9.3 Semi-permeabilised cells 
Semi-permeabilised cells (SP cells) were first developed to act as a source of partially 
isolated ER in which the ER remains intact in the form of a reticular network as it is found in 
the cell. The original purpose of this was to act as a tool for investigating vesicle trafficking 
between the ER and the Golgi apparatus. Becker et al first generated SP cells by treating 
cells with the mild detergent digitonin which selectively permeabilised the cholesterol rich 
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plasma membrane but not the membranes of the ER and the Golgi (Beckers et al, 1987). 
This treatment caused the loss of the cytosolic components from the cells but retention of 
the morphologically intact and functional ER and Golgi. Becker et al used the SP cells to 
investigate the influence of cytosolic factors upon ER and Golgi transport. Using this 
approach, they discovered that transport between the ER and Golgi requires cytosolic 
proteins as well as energy in the form of ATP (Beckers et al, 1987). 
SP cells were later adapted for use in CFPS systems to act as a source of ER in a similar 
manner to the use of microsomes in such systems (Wilson et al, 1995). Initial 
characterisation of SP cells within RRL and wheat germ CFPS systems found that SP cells 
were capable of translocation, disulphide formation, hydroxylation and glycosylation of 
nascent membrane and soluble secretory proteins synthesised within these lysates (Wilson 
et al, 1995).  
SP cells have several benefits over the use of microsomes within CFPS systems. They can 
be readily produced from tissue culture while purification of microsomes from tissues (von 
Jagow et al, 1965) or from cell culture (Sukhodub & Burchell, 2005) is a more laborious 
process. The most significant advantage is that the ER of SP cells contain any manipulations 
in protein expression that is present in the cell line from which they are derived.  This allows 
for a greater range of experimental manipulations for the investigation of particular proteins 
in ER biological processes. SP cells have been used in this way in a range of studies 
(Jessop et al, 2009b; Lang et al, 2012).  
1.10 Translation substrates 
mRNA encoding sequences of the haemagglutinin, preprolactin and cVIMP-Cys were used 
as translation substrates in this thesis. 
1.10.1 Haemagglutinin 
Haemagglutinin (HA) is one of the three proteins expressed on the surface of influenza A 
virus particles. The other two are neuraminidase and the M2 proton channel (Russell et al, 
2008). HA has two functions in the life cycle of an influenza virus. The first is to bind 
sialylated glycoprotein receptors on the target cells of the virus. The second is involved in 
the fusion of virus particles with the cell membranes following uptake of the virus into a cell 
by endocytosis (Skehel & Wiley, 2000). 
An HA monomer typically contains 540 to 550 amino acids and contains a N-terminal ER 
signal sequence and a C-terminal membrane anchor. The mature HA protein is a trimer 
made up of three identical HA subunits (Fig 1.18). HA maturation and formation of the trimer 
occurs within the ER of a host cell (Webster et al, 2013). 
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Sixteen different subtype of HA have been identified. These are distinguished from one and 
other by their structure and antigenicity (Webster et al, 2013). The subtype of HA used in this 
thesis is from the Japan strain of H2N2 Influenza A virus which contains 562 amino acids 
(Gething et al, 1980). Based upon sequence analysis and comparison with other HA 
subtypes it has been inferred that this subtype contains 7 N-linked glycosylation sites and six 
intra-chain disulphide bonds and has a signal peptide length of 15 amino acids. The six intra-
chain disulphides are formed between cysteines 19-477, 57-288, 70-82, 105-149, 292-316 
and 484-488 (uniprot). 
HA has been used as model protein for investigation of oxidative folding in both pulse chase 
studies and using RRL in vitro translation systems (Braakman et al, 1991; Marquardt et al, 
1993). The extensive glycosylation which HA undergoes allows the HA that has been 
processed by the ER to be easily distinguished. In addition, as HA forms multiple intra-
chains disulphide bonds it passes through several disulphide bonded intermediates before 
forming a native oxidised form. Due to these properties HA is an effective substrate for 
investigations requiring a substrate with a complex oxidative folding pathway.      
 
 
 
 
 
 
 
 
 
Figure 1.18: Structure of a haemagglutinin trimer. The image shown was produced using DeepView 
and represents the ribbon form of structure of H2 haemagglutinin (3KU5). The monomer units that 
make up the trimer are shown in yellow, light blue and red respectively. The globular head contain 
the receptor binding region while the lower proportion of the stem region contains the 
transmembrane region of the protein.  The structure shown was originally solved by Xu et al by X-ray 
crystallography (Xu et al, 2010).  
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1.10.2 Preprolactin 
Prolactin, along with the closely related growth hormone, placental lactogen, is part of a 
family of long-chain cytokines. Prolactin is a multifaceted hormone that is found in all 
vertebrates and which has over three hundred separate known functions within these 
species. The major functions are the stimulation of growth and differentiation of the 
mammary epithelia and stimulation of lactation. Prolactin is primarily secreted from the 
anterior pituitary gland but can also be secreted from other cells and tissues. Prolactin 
secreted by the pituitary acts via a classic endocrine pathway in which it is secreted from the 
gland, travels through the circulatory system and acts on target cells by the activation of 
specific receptors on the plasma membrane. The prolactin secreted from cells and tissues 
other than the pituitary acts in an autocrine or paracrine fashion where it may function in 
roles including acting as a growth factor or an immune-modulator (Bole-Feysot et al, 1998). 
Preprolactin contains a signal sequence which targets the nascent protein to the 
endoplasmic reticulum. In human preprolactin this signal sequence comprises the first 28 
amino acids of the protein while the signal sequence of bovine preprolactin comprises the 
first 30 amino acids (Cooke et al, 1981; Graf et al, 1970). In both human and bovine prolactin 
the corresponding cysteines residues and disulphide bonds of the mature proteins are in the 
same positions. If the signal sequence is omitted from the numbering then in both cases the 
disulphides are formed between cysteines 4-11, 58-174 and 191-199. The mature protein 
itself has a molecular weight of 23kDa. Overall the sequences of prolactin between humans 
and bovine species are highly conserved with a sequence identity of 74% being shared 
between the two species (Miller et al, 1981). 
The structure of human prolactin in solution has been solved by NMR (Fig 1.19) (Teilum et 
al, 2005). The most obvious structural features of prolactin are its four major α-helices. 
These four α-helices are composed of two antiparallel helix pairs. The first and fourth helices 
form a pair, as do the second and third helix. Each of the helices is packed more closely to 
its pairing helix then to the other two helices. The fourth helix is bound to the linker region of 
the first and second helix disulphide bond between cysteines 58 and cysteine 174. The N-
terminus and C-terminus also both contain short-ranged disulphide bonds that are formed 
between residues 4 and 11, and 191 and 199 respectively. The C-terminal disulphide causes 
the last five residues to pack closely to the fourth helix (Teilum et al, 2005).  
Bovine preprolactin has been used as a model protein for investigation of disulphide bond 
formation within the ER. A historical reason for this is that PPL could be readily isolated in 
high yields from the bovine pituitary gland and thus provided a convenient source of mRNA 
for a translation substrate before in vitro transcription became a common place laboratory 
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technique (Nilson et al, 1979). Bovine PPL also has two other properties that make it model 
protein for investigation of disulphide formation. Firstly, bovine PPL unlike many other 
species of PPL is not glycosylated and thus the disulphide bond formation of bovine PPL is 
simplified as the addition of glycan groups is not a factor. And secondly, the disulphide bond 
formation within prolactin causes a clear and obvious shift in electrophoretic mobility making 
this modification easy to detect (Kaderbhai & Austen, 1985).     
 
 
 
 
 
 
 
 
 
 
Figure 1.19: Structure of human prolactin. The image shown was produced using DeepView and 
represents the structure of human prolactin (IRW5). The ribbon form of the protein backbone is 
shown in light blue. The four α helices of the protein can be clearly seen. The six disulphide paining 
cysteine residues and the three disulphide bonds they form are highlighted in red and are numbered 
by their positions in the protein sequence. These three disulphides are formed between cysteines 4-
11, 58-174 and 191-199 respectively. Disulphide one and three are short range and can be seen to 
affect the local structure. Disulphide two is a long range disulphide and connects the linker sequence 
between the first and second α helices with the backbone of the fourth α helix. The structure shown 
was originally solved by Teilum et al by NMR spectroscopy (Teilum et al, 2005). 
1.10.3 cVIMP-Cys 
VIMP (VCP-interacting membrane protein) also known as SelS is a selenoprotein located in 
the ER membrane. VIMP is involved in linking microtubules to the ER and thus is important 
for formation and maintenance of the intracellular structure of the ER (Noda et al, 2014). 
VIMP has also been hypothesised to act as a reductase of disulphide bonds in proteins 
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retrotranslocated from the ER lumen to the cytosol during the process of ER associated 
degradation (Christensen et al, 2012). Structurally VIMP contains both a short region 
exposed to the ER lumen and a longer region exposed to the cytosol (Fig 1.20). The ER 
transmembrane domain lies between these two regions. The cytosolic region contains a 
selenocysteine at the penultimate C-terminal amino acid residue.  
cVIMP-Cys is a recombinant protein that is a shortened version of the human VIMP protein. 
This recombinant protein was created by the laboratory of Lars Ellgaard (University of 
Copenhagen) as a tool to investigate the structure and function of human VIMP (Christensen 
et al, 2012). cVIMP-Cys contains only the cytosolic region of VIMP. In addition, the 
selenocysteine of VIMP has been replaced with a standard cysteine residue. cVIMP-Cys, 
therefore, contains two cysteine residues at positions 174 and 188 which may form a single 
intra-chain disulphide bond. It was shown by Christensen et al that the formation this intra-
chain disulphide causes a small but detectable shift in electrophoretic mobility when 
analysed by SDS-PAGE electrophoresis. Structural analysis of cVIMP-Cys indicates that the 
N-terminal half is comprised of two α-helices, while its C-terminal region is intrinsically 
disordered (Christensen et al, 2012).  
 
 
Figure 1.20: Structural model of human VIMP: Structural model of VIMP based upon findings from 
NMR and CD spectroscopy (Christensen et al, 2012). The above figure was adapated from a figure 
shown by Christensen et al (Christensen et al, 2012). N.B. The cVIMP-Cys recombinant protein 
differes from the VIMP model shown; it does not contain the ER luminal or transmembrane region 
and the selium cysteine is replaced with a sulphur cysteine residue. 
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1.11 Thesis aims 
The overall goal of this thesis is to advance the understanding of the biochemical and 
molecular aspects of disulphide bond formation and oxidative protein folding within the ER. 
The research described in each of the three results chapters (chapters 3-5) had a specific 
aim to further this goal: 
1. Develop a modified RRL in vitro translation system capable of specifically analysing 
nascent protein disulphide formation within a source of ER (chapter 3). 
2. Assess the contribution of known and potential ER enzymatic de novo sources of 
disulphides to disulphide formation in nascent secretory proteins (chapter 4). 
3. Analyse the interactions of nascent proteins with PDI during and following 
translocation to the ER lumen (chapter 5). 
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Chapter 2: Materials and Methods 
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2.1 Cell lines 
Semi-permeabilised cells (SP cells) were generated from cell cultures of either wild-type 
HT1080 human fibrosarcoma cells, H1080 cells over expressing V5-tagged PDI, or HT1080 
cells over expressing V5-tagged PDI in which both active sites of the enzyme have had their 
CXXC active site mutated to CXXA (stPDI). Both of the PDI overexpressing cell lines were 
generated by Catherine Jessop and have been described previously (Jessop et al, 2009b).  
2.2 Generation of semi-permeabilised cells 
SP cells were generated using a previously described protocol (Wilson et al, 1995). A 
confluent T75 flask of cells was washed with phosphate buffered saline (PBS) and 
trypsinised. The cells were then resuspended in 8 ml KHM buffer (20 mM HEPES buffer pH 
7.2, containing 110 mM potassium acetate, 2 mM magnesium acetate and 100 µg/ml 
soybean trypsin inhibitor). The cells were centrifuged at 460 xg for 3 min and the pelleted 
cells were resuspended in 6 ml KHM containing 40 µg/ml digitonin and incubated for 5 min. 
A further 8 ml of KHM buffer was added before isolating the cells again by centrifugation and 
resuspending in HEPES buffer (50 mM HEPES, pH 7.2, 90 mM potassium acetate) for 10 
min. The cells were next isolated by centrifugation and resuspended in 100µl KHM buffer. 
The cells were incubated at room temperature for 12 min in the presence of 1 mM CaCl and 
10 µg/ml staphylococcal nuclease in order to degrade endogenous mRNA. EGTA was 
added to a concentration of 4 mM and the cells isolated by centrifugation and resupended in 
100 µl KHM to be used in translation reactions. The cells were kept on ice throughout the 
procedure except during incubation with CaCl and staphylococcal nuclease. 
2.3 Preparation of rough dog pancreas microsomes 
Rough dog pancreas microsomes (DPMs) were prepared by established methodology 
(Austen et al, 1984; Scheele et al, 1980; Walter & Blobel, 1983; Yang & Braciale, 1995). Dog 
pancreases were washed twice in homogenisation buffer (50 mM Tris buffer pH 7.5, 
containing 0.25 M sucrose, 25 mM KCl, 5 mM MgCl2.6H20 and 200 µM 
phenylmethanesulfonylfluoride [PMSF]) and minced before being forced through a tissue 
press (Biospec products). The pancreas was then homogenised by eight passes through a 
Potter Elvejham homogeniser in a volume of homogenising buffer equal to the wet weight of 
the pancreas. The resulting homogenate was then centrifuged at 13,000 xg for 10 min, the 
pellet and any floating lipid was discarded. The supernatant was layered over a sucrose step 
gradient of 1.65 M and 2.1 M sucrose dissolved in TMK buffer (50 mM Tris pH 7.5, 5 mM 
MgCl2.6H20, and 25 mM KCl) and centrifuged at 200,000 xg for 3.5 h. The DPMs were 
recovered from the interface of the 1.65 M and 2.1 M Sucrose TMK buffers using a wide 
bore syringe. The DPMs were then diluted with 3 times volume of TMK buffer. The DPMs 
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were then pelleted by centrifugation at 20,000 xg for 1 hour and resuspended in buffer B (20 
mM HEPES, pH 7.5, 0.25 M sucrose) at a concentration with an optical density of 50 
units/ml at 260 nm. The DPMs were nuclease treated prior to use in translation reactions by 
incubation with 1 mM CaCl and 10 µg/ml staphylococcal nuclease for 12 min at room 
temperature. EGTA was then added at a concentration of 4mM.  The microsomes were 
centrifuged at 150,000g for 10min and resuspended in buffer B. The DPMs were kept on ice 
throughout the procedure except during incubation with CaCl and staphylococcal nuclease. 
2.4 mRNA sequences used for in vitro translation 
mRNA encoding influenza virus haemagglutinin (A/Japan/305/57 H2N2 strain), bovine 
preprolacin (Uniprot entry: P01239) and cVIMP-cys was synthesised from plasmid vectors. 
The plasmid vector encoding the haemagglutinin, bovine preprolactin cVIMP-cys were gifts 
from Mary Jane Gething (University of Melbourne), Stephen High (University of Manchester) 
and Lars Ellgaard (University of Copenhagen) respectively. The haemagglutinin and cVIMP-
cys sequences have been described previously (Christensen et al, 2012; Gething et al, 
1980). In addition to these 3 sequences we also engineered a DNA sequence of preprolactin 
that lacked a stop codon and as such would become stalled during translation (tsPPL). As 
with the other sequences mRNA was generated from this sequence by in vitro transcription. 
We termed this mRNA sequence the tsPPL sequence. 
2.5 Generation of translationally stalled PPL mRNA 
The traslationally stalled preprolactin (tsPPL) construct was generated as follows. A pGEM 
plasmid in which the bovine preprolactin gene was inserted (PPLpGEM) was used as a 
template for a PCR reaction with a forward primer annealing to a T7 promoter region 
upstream of the PPL sequence (T7 primer: 5’-TAATACGACTCACTATAGGG-3’) and a 
reverse promoter annealing to the 3’ end of the PPL sequence up to but not including the 
termination codon (Reverse primer:5’-GCAGTTGTTGTTGTAGATGATTCTG-3’). This PCR 
reaction produced a DNA sequence of bovine preprolactin that lacked a stop codon. This 
sequence was used as template for in vitro transcription to produce tsPPL mRNA. 
2.6 Rabbit reticulocyte lysate translation reactions 
A volume of 16.5 µl Flexi RRL (Promega) was aliquoted and the following reagents added to 
a final volume of 25 µl at the indicated final concentrations: KCL at 40 µM, amino acids 
minus methionine (Promega) at 20 µM and EasyTagTM EXPRESS35S Protein Labelling Mix 
(PerkinElmer), at 16.3 kBq/µl. Except where stated otherwise, the lysate mixture was also 
supplemented with glucose-6-phosphate (G6P) at a final concentration of 0.5 mM. mRNA 
(1µl) encoding the sequence of the protein to be translated was added to initiate translation. 
For reactions with SP-cells, 4.6 µl of the 100 µl produced during the generation of SP cells 
51 
 
procedure (approximately 150,000 cells) were used for each 25 µl translation reaction. For 
reactions involving DPMs the total 25 µl reaction volume contained 1.0 µl of DPMs with an 
absorbance at 260 nm of 50 units/ml. The only exception to this was for the experiments in 
which the luminally depleted DPMs were used and experiments in which de novo sources of 
disulphide bond formation were inhibited. For these experiments the 1 µl volume of DPMs 
added to the lysate was 5 times the concentration of the stock DPMs. H2O was added to the 
translation mixture to bring the total volume of the mixture up to 25µl. 
All translation reactions were incubated at 30°C in a water bath for the times indicated. 
Reactions were terminated by the addition of the thiol alkylating agent N-ethylmaleimide 
(NEM) (Thermo Scientific) to a final concentration of 50 mM (Braakman et al, 1992). For 
RRL samples containing no SP cells or DPMs, 2 ul of the lysate sample was added to SDS-
PAGE loading buffer. Samples containing DPMs were centrifuged at 12,470 xg for 10 min 
and the supernatant removed before adding SDS-PAGE loading buffer to the samples. 
Samples containing SP cells were pulse centrifuged at 12,470 xg for a few second to pellet 
the cells. The lysate was then removed and 100 µl of KHM buffer was added. The pulse 
centrifugation was repeated and the KHM buffer was removed and SDS-PAGE loading 
buffer was added. Dithiothreitol (DTT) was added to a final concentration of 50 mM to 
indicated samples and all samples were heated to 105°C for 5 min. The samples were then 
run on a SDS-PAGE gel. The percentage of acrylamide used in the resolving regions of 
each SDS-PAGE was varied depending on the mRNA sequence used in the translation 
reaction: 7.5% acryladmide was use to resolve samples in which haemagglutinin was 
translated while 15% acrylamide was used for samples were preprolactin or cVIMP-cys was 
translated. The gels were then incubated with 10% acetic acid and 10% methanol solution 
for 20 minutes, dried and exposed to either a a phosphorimager plate or a BioMax MR film 
(Kodak). Lastly, the images captured using a phosphorimager plate were scaned using a 
FLA-7000 bioimager (Fujifilm). 
2.7 Time synchronised translations 
Aurintricarboxylic acid (ATCA) was added to the translation mixture of indicated reactions at 
a final concentration of 75 µM 5 min after incubation of the mixture in the 30°C water bath. 
ATCA prevents the re-initiation of translation, thus allowing the progression of disulphide 
bond formation in a synchronized set of nascent polypeptides to be analyzed (Stewart et al, 
1971). 
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2.8 Inhibition of glucose-6-phosphate dehydrogenase, thioredoxin reductase and 
gluatathione reductase 
The enzymes glucose-6-phosphate dehydrogenase, thioredoxin reductase and glutathione 
reductase were inhibited in the rabbit reticulocyte lysate by addition of the inhibitors 
dehydroepiandrosterone (DHEA), auranofin and carmustine respectively. Stock solutions of 
DHEA (Sigma-Aldrich) and auranofin (Sigma-Aldrich) were made up in dimethyl sulfoxide 
(DMS0) while stock solutions of carmustin (Sigma-Aldrich) were made up in ethanol. A 
volume of 2 ul of DHEA (3.4 mM) was added to RRL. A range of stock concentrations of 
auranofin and carmustine were made up and in each case 1 µl of the stock contributed to 
the 25 µl translation mixture volume. The translation mixture was incubated for 10 min on ice 
before translation reactions were initiated by adding mRNA and incubating the mixture at 
30°C in a water bath. The translation reactions were then processed as described above.  
2.9 Luminal depletion of DPMs 
Crude saponin purchased from Signal-Aldrich was dissolved in buffer B (20 mM HEPES 
buffer pH 7.5 containing 0.25 M sucrose). Positively and negatively charged constituents 
were removed by passing the saponin mixture through SP and Q sepharose cation and 
anion exchange columns. The purified saponin was used to deplete the DPMs of luminal 
proteins by a methodology similar to previously described reports (Bulleid & Freedman, 
1990). The DPMs were incubated on ice with 0.5% w/v of purified saponin for 10 min. The 
DPMs were then layered over a 0.5 M sucrose cushion and isolated by centrifugation at 
109,000 xg for 10 min. The DPM pellet was resuspended in buffer B at one fifth their volume 
prior to depletion. The luminally depleted DPMs were added to the 25µl translation mixtures. 
2.10 Determination of DPM luminal depletion by western blotting and coomassie blue 
staining 
In order to determine the effectiveness of luminal depletion of DPMs by saponin treatment, 
supernatant (sn) and cell pellet (p) fractions of these depletion steps were retained for 
western blotting and Coomassie blue staining. The following primary antibodies were used 
for western blotting: calnexin rabbit polyclonal antibody (Sigma), PDI rabbit polyclonal 
(described previously) (John et al, 1993) and anti-ERp57 antibody (gifted from Dr. T. 
Wileman, University of East Angelia). In all cases the primary antibodies were incubated with 
the samples overnight. Anti-rabbit 800 nm fluorescent secondary antibody (Licor) was then 
used and the target proteins were detected using an Odyssey Sa Infrared Imaging System 
(Licor). Samples of sn and p fractions as well as untreated DPMs were separated by SDS 
PAGE electrophoresis. The SDS PAGE gel was then stained overnight in Coomassie blue 
and destained in water.  
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2.11 Inhibition of the de novo sources of disulphide bond formation in DPMs 
The Ero1 inhibitor, QM295 was purchased from the ChemBridge Corporation in 10 mM stock 
solutions dissolved in DMSO. Stock solutions (200 µM) of the VKOR inhibitor warfarin were 
made up in DMSO. Where indicated QM295, and/or warfarin were added to DPMs at 
concentrations of 50µM each. The samples were mixed by gently pipetting and incubated on 
ice for 5 min. Due to the DMSO present in the warfarin and QM295 stock the DPMs resided 
in 25.5% (v/v) DMSO and 74.5%(v/v) buffer B (25mM HEPES pH 7.5, 50 mM KCL and 0.25 
M Sucrose) during this incubation step. DPM samples that were not incubated with QM295 
or Warfarin were instead incubated with 25.5% (v/v) DMSO and 74.5% (v/v) buffer B. 
DTT (10 mM) was added to the indicated samples followed by incubating on ice for a further 
10 min. Samples that were not subjected to the DTT treatment were incubated on ice without 
the addition of the DTT. The DPMs were then layered over a 0.5 M sucrose cushion and 
isolated by centrifugation at 109,000 xg for 10 min before being resuspended in buffer B at 5 
times their original concentration. 1µl of the treated DPMs were then added to each 25µl 
translation mixture. QM295 and warfarin were also added to the translation mixture at a final 
concentration of 50 µM. Due to the presence of DMSO in inhibitor stock solutions the 
translation mixtures contained a final concentration 4% DMSO. DMSO was also added to a 
final concentration of 4% to DPM samples to which QM295 and warfarin were not added. 
Translation reactions and processing of samples then proceeded as described above. 
2.12 Inhibition of the de novo sources of disulphide bond formation in SP cells 
QM295 and warfarin were added as indicated indicated to SP cells at a concentration of 50 
µM each. The SP cells were then incubated on ice for 5 min. DTT was added as indicated to 
samples of SP cells on ice at a final concentration of 10 mM for 10 min. SP cells were 
isolated by pulse centrifugation 12,470 xg for few second.  The SP cells were resuspended 
in KHM buffer at their original volume. The SP cells were then added to translation mixtures.  
2.13 Determination of PDI expression by western blotting 
PDI expression was compared between untransfected H1080 cells (UT) and HT1080 cells 
over expressing the substrate trapping (ST) V5-tagged PDI mutant. Samples of WT and ST 
cells were loaded in duplicate on a SDS-PAGE gel. The samples were transferred to a 
nitrocellulose membrane and the membrane was cut to allow each of the duplicate samples 
to be probed separately with either anti-PDI antibody or anti-V5 antibody. The anti-V5 
antibody was used to detect the exogenously expressed V5-tagged PDI. Each of the two 
nitrocellulose membranes was cut again using the molecular weight markers as a guide. The 
lower half of the nitrocellulose membranes was then probed for GAPDH which was used as 
loading control. Anti-PDI was detected with an anti-rabbit secondary antibody while anti-V5 
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and anti-GAPDH were detected with anti-mouse secondary antibodies. The 800nm 
fluorescence of the bound secondary antibodies was then detected by scanning with an 
Odyssey Sa Infrared Imaging System (Licor). 
2.14 Release of translationally stalled prolactin 
Prolactin synthesised from the translationally stalled (ts) PPL mRNA sequence is not 
released from the ribosome due to the lack of a stop codon in the sequence. The stalled 
prolactin nascent chain was released by treatment with the enzyme RNase A. The RNase A 
digested the ribosome causing release of the stalled peptide. RNase A (1µl of the 1mg/ml 
dissolved in water) was added to a 25µl RRL translation mixture programmed with tsPPL 
mRNA 20 min after the mixture was incubated at 30°C in a water bath. The mixture was 
gently mixed by pipetting and the incubation was continued for a further 20 min. The sample 
was then NEM treated and processed as described above. 
2.15 Immunoisolation of prolactin bound to the substrate trapping PDI mutant 
Translation reactions programmed with prolactin mRNA were conducted in the presence of 
HT080 cells overexpressing V5 tagged substrate trapping (st) PDI in which both PDI activate 
sites had CXXA mutations. Following completion of the translation reactions the samples 
were NEM-treated and the SP cells were isolated by centrifugation at 12,470 xg for a few 
seconds. The supernatant was removed and KHM buffer was added. The centrifugation was 
repeated and the KHM buffer was removed. IP buffer (500 µl) (50 mM Tris buffer pH 7.5, 
containing 1% Triton X-100, 150 mM NaCl, 2 mM EDTA, 0.5 mM PMSF and 0.02% Na-
azide) was then added to the pellet of SP cells. The samples were incubated in the IP buffer 
for 1 h on ice with occasional vortexing. This caused most of the SP cell pellet to become 
dissolved into the IP buffer. The samples were then centrifuged at 12,470 xg for 10 min and 
the supernatant was transferred to a fresh tube. A 10% suspension of protein A Sepharose 
was incubated for 30 min with 1% (w/v) BSA dissolved in PBS. The samples of dissolved SP 
cells were then incubated with the BSA treated protein A Sepharose for 30 min at 4°C on a 
rock and roller. The protein A Sepharose was then isolated by centrifugation at 1540 xg for 3 
min. The supernatant was transferred to fresh tubes containing 50 µl of 10% protein 
sepharose that had also been pretreated with 1% BSA. The SP cell samples were then 
incubated overnight with V5 antibody (1 µl). The samples were then put through 3 wash 
cycles in which the protein A Sepharose was pelleted by centrifugation at 1540 xg for 3 min, 
the supernatant removed, and 1ml of IP buffer added and the sample mixed by vortex. 
Following the final wash the protein A Sepharose was pelleted and SDS-PAGE loading 
buffer was added to the sample. The sample was then heated for 10 min on a heating block 
at 105°C. Samples were split in two for reduced and non-reduced conditions. DTT was 
55 
 
added to a final concentration of 50 mM in samples that were to be reduced. Both the 
reduced and non-reduced samples were then returned to the heating block for a further 5 
min. The samples were then processed by SDS-PAGE electrophoresis and the gels 
processed in the same way as described above.  
Note that where indicated RIPA buffer (50mM Tris buffer pH 7.5, containing 150mM NaCl, 
1% Triton, 1% deoxycholic acid and 0.1% SDS) was used instead of IP buffer for antibody 
incubation and/or washing steps. 
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Chapter 3: Results 1: A rabbit reticulocyte 
lysate translation system optimised for 
investigation of disulphide bond formation 
within the endoplasmic reticulum 
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3.1 Summary 
The use of a cell lysate from rabbit reticulocytes for conducting in vitro translation reactions 
is a well established research method that is highly amenable to experimental manipulation 
of its biochemical and molecular components. This system has been used for investigation 
of a variety of cellular processes, including protein translation, protein targeting, and 
disulphide bond formation. The system however has limitations in investigation of redox-
dependent processes such as ER localised disulphide bond formation as the system 
becomes oxidised during translation reactions. This oxidation causes disulphide bonds to 
form within newly synthesised protein even in the absence of a supplemented source of ER. 
This problem has commonly been circumvented by the addition of dithiothreitol (DTT) to the 
lysate at millimolar concentrations. The reducing agent prevents oxidation in the system 
however it is not an ideal solution as the action of the reductant differs from cellular redox 
homeostasis in several ways and limits certain experimental manipulations. We sought to 
develop a more effective RRL translation system for investigation of ER disulphide bond 
formation and disulphide interactions. We found that addition of glucose-6-phosphate (G6P) 
at a concentration of 0.5mM to the lysate prevented disulphide bond formation from 
occurring out with a source of ER but allows disulphide bonds to form within a source of ER 
in the form of SP cells. We found that under these conditions ER disulphide bond formation 
resembles cellular disulphide bond formation reported from pulse chase experimentation. 
Furthermore, we show that G6P mediates the prevention of disulphide bond formation out 
with the ER in the lysate by supporting the thioredoxin reductive pathway. 
3.2 Introduction 
In vitro translation systems are effective tools for the investigation of a variety of cellular 
processes including protein translation, targeting of proteins to the ER and disulphide bond 
formation. Theoretically the lysate of any cell type could be used for such systems however 
a few particular cell types have been optimised and are commonly used in scientific studies . 
The lysates of these systems provide a quasi cellular environment for protein synthesis and 
maturation. A key benefit of using an in vitro translation system is the components of the 
system are highly amenable to manipulation, thus allowing the involvement of specific 
molecular or biochemical components in biological processes to be investigated (Chong, 
2014; Titus & Promega Corporation., 1991). 
The RRL system is commonly chosen for studies investigating mammalian biological 
processes. Much of the development and optimisation of RRL translation systems was 
carried out during the late 1970s and early 1980s (Jackson et al, 1983a; Pelham & Jackson, 
1976; Wu, 1981). Early studies found that lysate translation systems could be used to 
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investigate processing of nascent proteins in the ER if the system was supplemented with 
microsomes (Shields & Blobel, 1978). It was later found that SP cells derived from tissue 
culture could also be used an alternative source of ER material (Wilson et al, 1995). 
Investigations into the RRL translation system by Richard Jackson, Tim Hunt, and others 
provided great insight into the biochemical requirements of the lysate (Hunt et al, 1983; 
Jackson et al, 1983a; Jackson et al, 1983b). A key finding of these papers was that in order 
for protein synthesis to be maintained, the redox systems of the lysate needed to be 
adequately supported (Jackson et al, 1983a; Jackson et al, 1983b). It was found that this 
could be achieved by addition of DTT or certain sugar phosphates capable of generating 
NADPH (Jackson et al, 1983a). DTT has since been commonly added to RRL reactions at 
millimolar concentrations for this purpose (Marquardt et al, 1993). DTT however also causes 
reduction of the luminal proteins of microsomes (Marquardt et al, 1993). As disulphide bonds 
are redox sensitive they cannot be maintained in proteins in the presence of a strong 
reductant such as DTT (Cleland, 1964). Thus it is not possible to analyse disulphide bond 
formation in nascent proteins in the lysate under such conditions. This problem has been 
circumvented by also adding millimolar concentrations of GSSG to the lysate which allow 
disulphide bonds to form and be maintained even in the presence of millimolar 
concentrations of DTT (Scheele & Jacoby, 1982). The DTT/GSSG system has since been 
commonly used in RRL translation reactions in experiments supplemented with microsomes 
in which disulphide bond formation in the nascent translated proteins is being analysed 
(Kaderbhai & Austen, 1985; Marquardt et al, 1993).  
The DTT/GSSG RRL system however has several problems, particularly in the analysis of 
disulphide bond formation. Firstly, it is known that oxidised glutathione induces disulphide 
bond formation in purified proteins in the absence of oxidoreductase enzymes (Kaderbhai & 
Austen, 1985) . Therefore it should be considered that the disulphide bond formation in 
microsomes in RRL supplemented with GSSG may be partially attributed to the oxidising 
effect of GSSG in the absence of PDI and not just to the enzymatic action of PDI family 
members. Secondly, as the GSSG is present throughout the lysate and not localised to 
supplemented ER luminal components it may also induce intra and intermolecular disulphide 
bonds prior to the nascent peptides being translocated into the ER luminal component. This 
also deviates from the current in vivo model of ER disulphide bonds formation where the 
disulphides are predicted to be introduced co-translationally during translocation to the ER 
(Chen et al, 1995; Molinari & Helenius, 1999). Thirdly, this method relies on millimolar 
concentrations of DTT being present during the reaction. DTT is a non-physiological 
chemical and is also known to cause reduction of the ER lumen and thus also perturb the 
system (Marquardt et al, 1993). Furthermore DTT also causes hydrogen peroxide to be 
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produced as it is a substrate of Ero1 (Gross et al, 2006). This also perturbs the redox 
conditions of the system. These three points indicate that using DTT/GSSG in RRL is likely 
to result in a system of disulphide bond formation that is distorted from how this process 
occurs in vivo. A forth criticism is that use of the DTT/GSSG also limits the range of 
biochemical and molecular experimental manipulations available for investigation. For 
example, it would be problematic to investigate the influence of particular chemicals or 
enzymes on disulphide bond formation using this system. This is because the presence of 
GSSG and particularly DTT greatly perturb the disulphide bond formation of the system and 
therefore would reduce the biological validity of the findings. 
Considering these problems, some investigations have not used the DTT/GSSG system in 
studies using RRL to investigate protein disulphide formation/interactions (Alvares et al, 
1999; Chambers et al, 2008). However, this can result in aberrant disulphide bond formation 
due to the oxidising conditions of the lysate during translation reactions. For example, one 
investigation in which the DTT/GSSG system was not used, a substantial proportion of the 
translated protein formed multiple high molecular weight mixed disulphide species under 
non-reducing conditions (Chambers et al, 2008). The authors of this investigation 
acknowledge that the disulphide interactions identified in the investigation were likely to have 
been influenced by the oxidising conditions of the lysate (Chambers et al, 2008). This further 
stresses the problems of using the RRL system for investigation of disulphide bond 
interactions. 
The early papers by Tim Hunt, Richard Jackson and others provided important indications of 
a more elegant method of supporting the redox system of RRL during translation reactions. 
They found that the addition of NADPH generating metabolites to the lysate, particularly G6P 
appeared to support the thioredoxin redox system of the lysate and found that this may 
reduce aberrant disulphide bond formation in the lysate (Jackson et al, 1983a). Indications 
that G6P prevented disulphide bond formation came from two experiments using RRL 
filtered of low molecular weight components. Firstly, it was found that when the filtered lysate 
was treated with radiolabelled (C14) N-ethylmaleimide (NEM) following a translation reaction 
in which oxidised insulin was also added, a greater amount of C14 NEM covalently modified 
the insulin if 0.2mM G6P was also present during the reaction (Jackson et al, 1983b). NEM 
reacts with reduced thiols, but not those which have formed disulphides (Winther & Thorpe, 
2014). Therefore, this suggested that the thiol groups of the insulin become more reduced 
during incubation of the lysate with G6P (Jackson et al, 1983b). Similarly, a second C14 
incorporation experiment found that an unidentified 24kDa protein that is present in the 
lysate has a lower propensity to form disulphide bonds during lysate translation reactions if 
G6P is present (Jackson et al, 1983b). Thus it was shown that G6P supports the redox 
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system of the lysate, both in its ability to remove disulphides from oxidised protein and 
prevent disulphide formation in reduced protein (Jackson et al, 1983b).  
While the indications of these early experiments from Hunt, Jackson and others are 
insightful, subsequent experimental improvements now allow us to make a more direct 
analysis of the effect of G6P on disulphide bond formation on a RRL translation system. The 
results in this chapter clearly show that when used in RRL translation reactions at a 
concentration of 0.5 mM, G6P specifically prevents the formation of disulphide bonds in 
nascent protein out with the ER, while allowing disulphide bonds to form within the ER. 
Furthermore, it is shown that the arrangements of disulphide bonds that form within 
translocated proteins are consistent with previously reported findings using cells. Evidence is 
also presented indicating that prevention of disulphide bonds out with the ER by G6P is 
mediated by biochemically supporting the thioredoxin reductive pathway thus indicating 
support of the RRL redox system by G6P. These findings are of importance as they show 
that the G6P-optimised RRL system is a superior method for investigation of disulphide bond 
formation and protein disulphide interactions than the previously reported RRL systems. 
3.3 Results 
3.3.1 Investigation of disulphide bond formation within the ER using a RRL translation 
system is problematic as disulphide bonds form in proteins synthesised in the 
absence of a source of ER 
Previous investigations have indicated that disulphide bond formation during RRL translation 
reactions could be prevented be the addition of certain metabolites capable of generating 
NADPH within the lysate (Jackson et al, 1983b). In particularly, G6P has been indicated to 
be especially effective in this role (Jackson et al, 1983b).  As a preliminary experiment we 
translated mRNA encoding HA in the presence of 0.2mM G6P (Fig 3.1). This G6P 
concentration had been used in a previous study by Jackson et al and it was indicated that 
less disulphide bond formation occurs during translation reactions using gel-filtered RRL if 
this concentration of G6P was present (Jackson et al, 1983b).  
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Figure 3.1: HA synthesised in a RRL translation system undergoes extensive disulphide bond 
formation even in the absence of a source of ER. mRNA encoding influenza HA was translated for 60 
min using a RRL translation system. SP cells were present in the indicated samples while G6P was 
present in all samples at a concentration of 0.2mM. The reducing agent dithioltheriotol (DTT) was 
added to the loading buffer of the indicated samples before running on the SDS-PAGE gel. DTT 
abolishes the disulphide bonds presents within the proteins of the sample. As such, comparison 
between samples with and without DTT allows the disulphide dependent gel mobility shifts to be 
observed. It can be seen that HA only becomes glycosylated in the presence of SP cells. However, 
unlike what occurs in vivo it can be seen that disulphide bonds are formed even in the absence of 
the source of ER provided by the SP cells. The formation of disulphide bonds out with the ER 
interferes with the specific analysis of ER disulphide bond formation. N.B.: All lanes shown are from 
the same SDS-PAGE gel. HA: unglycosylated reduced hemagglutinin, Gly HA: glycosylated reduced 
hemagglutinin, DB Gly-HA: disulphide bonded glycosylated hemagglutinin, DB HA: disulphide bonded 
unglycosylated hemagglutinin. 
When translated in the absence of an added source of ER, HA was synthesised as a single 
major translation product (Fig. 3.1, lane 2).  In the presence of SP cells an additional higher 
molecular weight was observed (Fig 3.1, lanes 1). This higher molecular weight band has 
previously been observed (Marquardt et al, 1993) and is due to the addition of 7 glycans to 
HA that is processed in the ER. HA also contains 6 disulphide bonds. It is known that 
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formation of disulphides results in a reduction of the hydrodynamic radius of a protein 
resulting in faster gel mobility (Wilkins et al, 1999). It was however seen that disulphide 
bonds formed in the presence of 0.2mM G6P even in the absence of SP cells (Fig 3.1, lane 
4). This result showed that the formation of disulphide bonds out with the ER had not been 
prevented and indicated that conditions of the lysate during the reaction were oxidising. 
3.3.2 G6P prevents the formation of disulphide bonds out with the ER in proteins 
synthesised with a RRL translation system 
As disulphide bonds formed in our preliminary experiment using 0.2mM G6P we 
hypothesised that the concentration used may not be optimal to completely prevent 
disulphide bond formation. We therefore added a range of G6P concentrations to determine 
if disulphides are prevented by G6P at higher concentrations.  
We carried out RRL translation reactions for the substrates HA, PPL and cVIMP-cys, in 
which G6P was titrated at various concentrations (Fig 3.2). Each of these proteins has 
different properties and disulphide arrangement. All three of these proteins are targeted to 
the ER, however only PPL is soluble within the lumen as HA and cVIMP-cys both contain 
transmembrane domains (Christensen et al, 2012; Teilum et al, 2005; Webster et al, 2013). 
Furthermore, of these transmembrane proteins only the cysteine residues of HA are 
exposed to the ER lumen as the two cysteine residues of cVIMP-cys are exposed to the 
cytosol. The substrates also differ in the number of intrachain disulphides they form with HA, 
PPL and cVIMP-cys forming six, three and one intrachain disulphides respectively. Due to 
these differences the use of these three substrates allowed for a thorough analysis of the 
effect of G6P on disulphide formation. 
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Figure 3.2: The addition of G6P prevents the formation of disulphide bonds out with the ER in 
proteins synthesised with a RRL translation system. Translation reactions were carried out for 60 
min with mRNA encoding HA (A), PPL (B) and cVIMP-cys (C, D) in the presence of the indicated 
concentrations of G6P. No source of ER was present. It can be seen that a concentration of 0.5mM 
G6P prevents the formation of disulphide bonds in each of the substrates. HA: non-disulphide 
bonded haemagglutinin, DB HA: disulphide bonded haemagglutinin, PPL: non-disulphide bonded 
preprolactin, DB-PPL: disulphide bonded preprolactin, cVIMP-cys: non-disulphide bonded cVIMP-cys, 
DB: disulphide bonded cVIMP-cys.  
Analysis of the gel mobility of the translated proteins under non-reducing conditions indicates 
that each of these substrates formed disulphide bonds at low concentrations of G6P. 
Formation of these disulphides was however prevented in all three cases by a G6P 
concentration of 0.5mM.  
In the case of HA the disulphides that formed with low G6P concentrations appeared to be 
predominantly intramolecular as evident from the formation of smeared bands of slightly 
faster mobility than full length HA (Fig 3.2A). This indicated that at low G6P concentrations 
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the HA of these samples were made up of a mixed population of HA molecules with varying 
numbers and/or arrangements of internal disulphide bonds. Interestingly, the extent of HA 
intrachain disulphides can be seen to gradually decrease as concentrations of G6P 
increased from 0.01-0.5mM. This suggested that formation of the disulphides in nascent HA 
is highly sensitive to the oxidation conditions of the RRL. It also indicated that the banding 
pattern of nascent HA could be used as a reporter of the oxidising conditions of the lysate. 
It can be seen that when translated at low G6P concentrations that PPL formed three 
populations which could be categorised by the type of disulphides (Fig 3.2B, lanes 2-4). One 
population consisted of a large proportion of the synthesised PPL with equivalent mobility to 
the reduced form of the protein (PPL). A second population was of faster mobility which 
correlated with the previously reported mobility of intrachain disulphide bonded prolactin 
(DB-PPL) (Kaderbhai & Austen, 1985) which most likely indicated that a long range 
disulphide had formed in the protein (though not necessarily the C88 to C204 long range 
disulphide of native bovine prolactin) (Wallis, 1974). A third population consisted of several 
higher molecular species indicating that the PPL had formed various interchain disulphide 
bonds either between PPL molecules and/or between PPL and other proteins of the lysate. 
Both the intrachain and interchain disulphide bonds were abolished at a G6P concentration 
of 0.5mM G6P with the disappearance of these disulphides occurring abruptly between 
concentrations of 0.2mM and 0.5mM rather than gradually over a larger concentration range 
as had been observed with HA.  
The third substrate we used was cVIMP-cys (Fig 3.2 C-D). cVIMP-cys is a variant of the ER 
membrane protein VIMP that was created by the research group of Lars Ellgaard (University 
of Copenhagen) (Christensen et al, 2012). The cVIMP-cys construct contains only the 
cytosolic region of VIMP and contains one disulphide bond. The gel shift caused by the 
formation of the intrachain disulphide in purified cVIMP-cys has been reported (Christensen 
et al, 2012) and matches the corresponding shift for intrachain disulphide bonded cVIMP-cys 
observed with our assay. When translated in our RRL system under varying concentrations 
of G6P it can be seen that under non-reducing conditions at G6P concentrations less than 
0.5mM all of cVIMP-cys is either intrachain disulphide bonded or interchain disulphide 
bonded (Fig 3.2D, lanes 2-5). Unlike PPL and HA none of the cVIMP-cys remains in the 
reduced state suggesting the two cysteines of cVIMP-cys are particularly reactive. Similarly 
to PPL there is an abrupt difference in the disulphide bonding profile of cVIMP-cys between 
the G6P concentrations of 0.2 and 0.5mM. The entire population of cVIMP-cys is disulphide-
bonded at 0.2mM G6P while almost none of the protein is disulphide bonded at 0.5mM.  
These findings indicate that the addition of G6P to RRL prevents the formation of intra and 
interchain disulphide bonds in proteins translated with the system.  
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3.3.3 Complex sequences of ER localised disulphide bond formation can be observed 
using the G6P optimised RRL translation system 
Having prevented the formation of disulphide bonds in the translation system when a source 
of ER was absent, our next objective was to determine if disulphide bond formation would 
occur in the presence of ER and determine if these disulphides would form as they do in 
intact cells. For this experiment we again used the model substrate influenza HA as a report 
is available of disulphide bond formation in HA from pulse chase experimentation which we 
could use as a comparison with our results (Braakman et al, 1991). As before it could be 
seen that under reducing conditions a higher molecular weight band representing 
glycosylated HA was observed only when SP cells were present (Fig 3.3, lanes 1 and 2 and 
Fig 3.1, lanes 1 and 2). When HA was translated in the presence of 0.5 mM G6P and 
separated under non-reducing conditions, four disulphide-bonded forms of the glycosylated 
product were observed (Fig 3.3, lanes 3 to 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: ER localised disulphide bond formation of HA can be observed using a G6P optimised 
RRL translation system. Translation reactions programmed using mRNA encoding influenza HA was 
conducted in the presence 0.5mM G6P. Reactions proceeded for the indicated times and in the 
presence of SP cells where noted. ATCA was added to a concentration of 75 µM 5 min after initiating 
translation to prevent further translation initiation, thereby allowing distinct analysis of disulphide 
bond formation within a time synchronised set of nascent proteins. Four disulphide bonded 
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intermediates of glycosylated HA can be observed (IT1-3 and NT). The fastest mobility form of these 
intermediates (NT) accumulates over the course of the reaction. HA: unglycosylated reduced 
hemagglutinin, Gly HA: glycosylated reduced hemagglutinin, IT1-IT3: glycosylated hemagglutinin 
disulphide bonded intermediates 1 to 3, NT: native disulphide bonded hemagglutinin. 
A previously study investigated the disulphide bond formation of HA using a pulse chase 
assay with 2 different HA sequences and several different mammalian cell lines (Braakman 
et al, 1991).  In this study three different disulphide bonded HA forms where identified that 
were designated as IT1 and IT2 (disulphide bonding intermediates 1 and 2) and NT (native 
fully oxidized form) (Braakman et al, 1991). Consistent with this previous nomenclature we 
have designated the 4 disulphide bonded forms identified in our assay as IT1-3 and NT. The 
presence of four disulphide bonded forms within our assay would perhaps be expected as 
the Japan strain of HA which we use contains 4 long range disulphides (C19-C477, C57-
C288, C105-C149 and C292-C316) and two short range disulphides (C70-C82 and C484-
C488) (Gething et al, 1980). Long range disulphides generally cause greater changes in the 
hydrodynamic volume and hence gel mobility of proteins while short range disulphides have 
little effect on gel mobility and usually cannot be detected (McManaman & Bain, 2002). 
It can be seen from the time course shown in figure 3.3 that the low mobility disulphide 
bonded forms IT1 and IT2 are the most prominent forms at the earlier time points. However, 
these two forms gradually disappears over time while, simultaneous, the faster mobility 
forms of IT3 and NT become more prominent. At the final 90 min time point the majority of 
the disulphide bonded HA is in the fastest mobility NT disulphide bonded form. As the 
accumulation of the faster mobility forms is concurrent with the disappearance of the lower 
mobility forms it would appear that either formation of new disulphides and/or isomerization 
of disulphides over the time course are occurring and thus converting the slower mobility 
forms into the faster mobility forms. As the NT forms is the final form that the HA eventually 
reaches it would appear that this represents the mature disulphide bonded form. 
It is interesting to note that while the study by Ineke Braakman et al identified 3 HA 
disulphide bonded forms in each of their HA pulse chase assays the relative mobility of what 
they called the IT2 form varied between the cell types used in their assay (Braakman et al, 
1991). In experiments using either HeLa or CHO cell IT2 was found to run at mobility slightly 
faster than IT1, consistent with the mobility of IT2 in our assay. In other experiments using 
CV-1 and 3T3 cells IT2 was observed to run closer to the NT form, consistent with the 
mobility of IT3 in our assay. Both of these pulse chase experiments used the same Japan 
strain of the HA sequence that we have used for our study and therefore sequence 
difference cannot account for the differences in disulphide bonding pattern. The 
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inconsistency in the number of HA disulphide bonded forms detected by Braakman et al 
(1991) and ourselves must therefore either be due the different cell types used between the 
two studies or differences in the assays used. As no completely comparable experiment has 
been conducted (such as using the same HA sequence, the same cell type and normalising 
certain variables between each assay) this cannot be determined at this point. Never the 
less both sets of results report disulphide bonded forms of HA with consistent mobilities that 
in both cases accumulate in the NT form.  
We conclude from this finding that disulphide bond formation of complex substrates such as 
HA within our G6P optimised RRL assay does appear to closely resemble cellular disulphide 
bond formation of the same substrate as detected by pulse chase assay. 
3.3.4 G6P prevents the formation of disulphides out with the ER by supporting the 
thioredoxin reductive pathway 
Our next objective was to determine the biochemical mechanism by which G6P prevents the 
formation of disulphide bonds out with the ER. We hypothesised that metabolism of G6P 
within the lysate was generating NADPH which was then supporting either the thioredoxin 
and/or the glutathione reductive pathways. One or both of these reductive pathways were in 
turn expected to be responsible for maintaining the thiol groups of the proteins synthesised 
in the lysate in a reduced state (Fig 3.4A). In order to test this hypothesis we sought to inhibit 
key enzymes supporting these reductive pathways. Namely, we choose to inhibit the 
enzymes G6P dehydrogenase (G6PD), thioredoxin reductase (TrxR) and glutathione 
reductase (GR) by using the inhibitors dehydroepiandrosterone (DHEA), auranofin and 
carmustine (also known as BCNU) respectively (Fig 3.4B). DHEA is an uncompetitive 
inhibitor of G6PD, auranofin appears to act as a non-competitive inhibitor of TrxR, while 
carmustine is an irreversible inhibitor of GR (Go et al, 2013; Liu & Sturla, 2009; Shantz et al, 
1989). Therefore, if the inhibition of these enzymes caused disulphide bonds to form out with 
the ER even in the presence of G6P then this would indicate that these enzymes were 
required components of the biochemical pathway utilised by G6P to prevent the formation of 
these bonds. 
 
 
 
 
 
 
68 
 
Figure 3.4: G6P prevents the formation of disulphides in nascent non-translocated proteins by 
supporting either the thioredoxin and/or glutathione reductive pathways. Inhibitors that target 
key enzymes of these pathways can be used to determine the enzymes involved in this reaction. 
(A) The conversion of G6P to 6-phophogluconolactone by the enzyme glucose-6-phosphate 
dehydrogenase (G6PD) is the first step of the pentose phosphate pathway and results in  the 
generation of NADPH from NADP (1) (Berg et al, 2007). The NADPH generated may then in turn 
support the maintaince of reduced thiol groups within nascent non-translocated proteins by 
supporting either the thioredoxin or glutathione reductive pathways. NAPDH maintains thiredoxin in 
a reduced state by biochemically supporting the action of thioredoxin reductase (TrxR). The reduced 
thioredoxin in turn may maintan the thiol groups of target proteins in a reduced state (2) (Fig 1.16) 
(Holmgren & Lu, 2010). Similarly, NADPH supports the conversion of glutathione disulphide to 
reduced glutathione (GSH) by the enzyme glutathione reductase (GR) (Fig 1.14). GSH is hypothesised 
to maintain protein thiol groups in a reduced state (3) (Lopez-Mirabal & Winther, 2008). (B) The key 
enzymes of these pathways, namely; G6PD, TrxR and GR are the targets of the inhibitors DHEA (1), 
auranofin (2) and carmustine (3) respectively (Frischer & Ahmad, 1977; Go et al, 2013; Gordon et al, 
1995). The structures of DHEA, auranofin and carmustine are as presented by Hamilton et al (2012), 
Roder and Thomson (2015), and Liu and Sturla (2009) respectively (Hamilton et al, 2012; Liu & Sturla, 
2009; Roder & Thomson, 2015). 
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It can be seen that inhibition of G6PD by DHEA caused disulphide bonds to form in HA even 
in the presence of 0.5mM G6P (Fig 3.5, lane 8). This supported the hypothesis that the 
NADPH generated by G6PD during the metabolism of G6P was required to support the 
reductive pathways of the lysate. While, it can be seen that disulphides form when DHEA is 
added the extent of disulphide formation was not as great as when G6P was absent (Fig 3.5, 
compare lanes 7 and 8). This is because DHEA is an uncompetitive inhibitor (Shantz et al, 
1989) and as such its addition will lower but not block the activity of the enzyme (Lehninger 
et al, 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: G6PD is required to maintain nascent protein thiol groups in a reduced state during 
G6P optimised RRL translation reactions. Translation reactions programmed with influenza HA were 
carried out for 60 min with either 0mM or 0.5mM G6P. DHEA dissolved in DMSO were added to the 
indicated samples to a final concentration of 272µM. The DMSO of samples in which DHEA was 
added made up 8% (v/v) of the total reaction volume. 8% DMSO was also added to the indicated 
samples in the absence of DHEA. It can be seen that disulphide bonds formed in the presence of G6P 
if DHEA was also added. This indicates the G6PD is required to mediate the prevention of disulphide 
bond formation in the presence of G6P. The radiolabeled signal of the sample in which DMSO was 
added is reduced suggesting addition of the solvent reduced translation efficiency. The presence of 
DMSO in the absence of DHEA did not however have any effect on disulphide bond formation. HA: 
reduced hemagglutinin, DB HA: disulphide bonded hemagglutinin.  
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We next targeted the enzyme TrxR for inhibition using the gold containing compound 
auranofin (Fig 3.6). A previous study has shown that incubation of purified TrxR with 
equimolar concentrations of auranofin causes near complete inhibition of the activity of the 
enzyme (Go et al, 2013). This thus indicates that auranofin acts as a non-competitive 
inhibitor of TrxR. Treatment of the RRL with auranofin caused disulphides to form in the 
presence of G6P, with the maximal levels of disulphide bonds forming at concentrations of 
20µM and above (Fig 3.6). This finding suggests that thioredoxin is responsible for 
maintaining the reduced state of nascent protein thiol groups within the RRL system in the 
presence of G6P. However, it has also been reported that auranofin can cause the inhibition 
of GR when used at micromolar concentrations (Gromer et al, 1998). The concentration of 
TrxR and GR in the RRL is unknown as neither the concentration of these enzymes within 
reticulocyte cells, nor the concentration of lysed cells per volume of lysate known. Therefore, 
it is not possible to estimate the expected concentration of auranofin required to inhibit the 
thioredoxin reductase of the lysate without causing inhibition of glutathione reductase. It 
therefore remained ambiguous whether the effect of auranofin on disulphide bond formation 
in the presence of G6P was due to inhibition of TrxR or GR. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: The TrxR inhibitor auranofin causes disulphide bonds to form during G6P optimised 
translation reactions. Translation reactions programmed with HA were conducted for 60 min in the 
presence of 0.5mM G6P. Auronofin was titrated with the reaction mixture at increasing 
concentrations. 4% of the total reaction volume of all samples was DMSO which was present to 
maintain the solubility of auranofin. It can be seen that disulphide bonds can observed even in the 
presence of 0.5mM G6P at concentrations of auranofin of 5µM and above. This suggests that TrxR is 
71 
 
required to mediate the prevention of disulphide formation in nascent proteins in RRL in which G6P 
is present. HA: reduced hemagglutinin, DB HA: disulphide bonded hemagglutinin. 
To resolve the ambiguity we next targeted GR for inhibition by carmustine. Carmustine is a 
potent inhibitor of GR and has been shown to prevent the reduction of GSSG to GSH (Ma et 
al, 2003). Therefore, if the effect of auranofin on disulphide bond formation was caused by 
inhibition of GR rather than TrxR we would expect to see a similar effect with carmustine. 
However, it can be seen that carmustine only had an effect on disulphide bond formation 
when used at a concentration of 3.66 mM (Fig 3.7). This concentration is far higher than the 
concentrations at which such an inhibitor would be expected to cause an effect (N.B. 
severely impaired cellular response to oxidative stress in cells have been detected following 
the addition of 120µM carmustine implying it is effective at this concentration) (Ma et al, 
2003). Furthermore, 3.66 mM concentration is also higher than the concentration (0.5 mM) 
of the G6P metabolite used in this reaction. This carmustine concentration is also close to 
the experimental limits as the inhibitor requires to be dissolved in ethanol at a concentration 
near its solubility limits (19.6 mg/ml) before being added to the reaction. As ethanol causes 
increasing inhibition of RRL translation (Wu, 1981) as it is added at higher concentrations it 
is not feasible to add large volumes of carmustine dissolved in the ethanol inhibitor to the 
reaction mixture. These results suggest that the effect carmustine had on disulphide bond 
formation at 3.66 mM was not due to inhibition of glutathione reductase but is most likely due 
to an effect of the carmustine chemical itself on disulphide formation when used at high 
concentrations. These findings also indicate that the effect on disulphide bond formation 
caused by auranofin treatment was due to auranofin inhibiting TrxR and not due to auranofin 
inhibiting GR.  
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Figure 3.7: The GR inhibitor carmustine only causes disulphide bonds to form during G6P 
optimised translation reaction reactions when present at milli molar concentrations. Translation 
reactions programmed with HA were conducted for 60 min in the presence of 0.5mM G6P. 
Carmustine was titrated at increasing concentrations. 4% of the total reaction volume of all samples 
was ethanol which was present to maintain the solubility of the inhibitor. Carmustine can be seen to 
only have an effect on the disulphide bond formation at HA when present at a concentration of 
3.66mM. HA: reduced hemagglutinin, DB HA: disulphide bonded hemagglutinin. 
In order to further verify our findings we tested the effect of combined inhibition of TrxR and 
GR (Fig 3.8). We hypothesised that if both the thioredoxin and glutathione pathways were 
involved in maintaining thiol groups in a reduced state in the presence of G6P then inhibition 
of both of these pathways would have a greater effect on disulphide bond formation than 
inhibition of each of these pathways alone. Once again it could be seen that auranofin had a 
clear effect on disulphide bond formation (Fig 3.8, lane 4) however, no enhanced effect was 
seen when both auranofin and carmustine were used in combination at concentrations of 
40µM and 1.83mM respectively (Fig 3.8, lane 6).   
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Figure 3.8: Combined inhibition of TrxR and GR in G6P optimised translation reactions by the 
addition of auranofin and carmustine does not cause greater formation of disulphide bonds than 
inhibition with these inhibitors individually. Translation reactions programmed with HA were 
conducted for 60 min in the presence of 0.5mM G6P. The solvents DMSO and ethanol were added to 
each sample to maintain solubility of the inhibitors auranofin and camustine. DMSO made up 2% of 
the reaction volume of each sample. The volume percentage made up of ethanol in each sample is 
indicated. Auranofin and carmustine were present in the samples at the concentrations indicated. It 
can be seen that auranofin and to a lesser extent carmustine cause disulphide bonds to form in the 
presence of G6P however this effect is not enhanced by addition of these inhibitors in combination. 
HA: reduced hemagglutinin, DB HA: disulphide bonded hemagglutinin. 
Our previous results had shown that the maximum effect of auranofin on disulphide bond 
formation of HA is achieved at 20µM (Fig 3.6). Therefore, the 40µM used for this experiment 
is in excess of that required to achieve maximal effect. Due to the aforementioned 
experimental limitations with the concentration at which we could add carmustine it was 
difficult to add carmustine at the concentrations at which it has an effect on disulphide bond 
formation in combination with auranofin. This is because auranofin required to be added 
dissolved in ethanol while carmustine must be added dissolved in DMSO and both ethanol 
and DMSO reduced translation efficiency when added at high concentrations to the 
translation reactions. Despite this we attempted to add carmustine and auronfin together at 
concentrations of 40µM and 3.66mM respectively. However as anticipated the translation 
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efficiency of this reaction was poor due to the high concentrations of both DMSO and 
ethanol present which resulted in a low intensity radiolabelled signal (Fig 3.8, lane 8).  Never 
the less, it can be seen from the low intensity signal that the extent of disulphide bond 
formation in the present of 40 µM auranofin and 3.66 mM carmustine was not greater than 
when 40 µM auranofin was used alone (Fig 3.8, compare lanes 4 and 8). 
The results of these experiments consistently indicate that the TrxR pathway is solely 
responsible for maintaining the thiol groups of HA in a reduced state during reticulocyte 
lysate translation reactions in the presence of G6P. The glutathione reductive pathway does 
not appear to make a contribution even when the thioredoxin pathway is inactivated. 
3.4 Discussion 
3.4.1 A modified RRL system for investigating disulphide formation 
In this chapter we have described a modified RRL translation system that can be used to 
investigate ER specific disulphide bond formation and disulphide interactions within nascent 
proteins in the ER. The addition of G6P to this system stabilises the lysate redox conditions 
and prevents the formation of disulphide bonds out with the ER. In the two subsequent 
results chapter this system is utilised to investigate two aspects of ER disulphide formation. 
In chapter 4 the contribution of enzymatic sources of de novo disulphide formation are 
analysed by inhibiting key enzymes involved in this process. In chapter 5 the disulphide 
interaction of PDI with nascent proteins within the ER is investigated. These subsequent 
investigations (and future studies investigating aspects of ER disulphide formation with a 
RRL system) can be conducted more effectively than would have been possible with a 
DTT/GSSG supplemented RRL system. This is primarily because the redox conditions of the 
G6P supplement RRL is stabilised in a physiological manner by supporting the reductive 
pathways of the lysate rather than the more artificial stabilisation achieved by the addition of 
DTT and GSSG.  
3.4.2 Use of DHEA, auranofin and carmustine inhibitors with a RRL system 
In this study we also investigated the biochemical route that G6P mediated the prevention of 
non ER disulphide bonds within a RRL translation system using the inhibitors DHEA, 
auranofin and carmustine. To our knowledge, this is the first such study to use these 
inhibitors with an in vitro translation system. As such the most relevant reports for 
comparison of the effects of the inhibitors come from studies in which they were used 
against purified proteins or cells. 
DHEA has been found to inhibit partially purified G6PD (5.1µg) in an uncompetitive manner 
with Ki values of approximately 15 to 20 µM depending on whether the NADPH or G6P 
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substrate concentrations were varied (Shantz et al, 1989). Furthermore, treatment of 3T3-L1 
mouse embryonic fibroblast cells with 250 µM has been found to decrease levels of 6-
phosphogluconate (a metabolite of pentose phosphate pathway), thus indicating successful 
inhibition of G6PD (Shantz et al, 1989). Our finding that treatment of RRL with a DHEA 
concentration of 272 µM resulted in a clear effect suggests that DHEA may have similar 
effective concentrations in lysate as with cells. 
It has been shown that incubating TrxR with auranofin at a 1:1 concentration ratio blocks the 
activity of the enzyme suggesting the compound acts a non-competitive inhibitor of the 
enzyme (Go et al, 2013). It has also been found that treatment of cells with auranofin in a 
concentration range between 0 and 100µM affects the oxidative state of thioredoxin in a 
dose dependent manner (Go et al, 2013). This is despite the fact that the cellular 
concentrations of TrxR are approximately 1uM (Go et al, 2013). This indicates the effective 
concentration for inhibition of TrxR by auranofin is different when the TrxR exists as a 
purified protein from when it is present in a cellular environment (or presumably in a quasi 
cellular environment such as RRL). It has been suggested that the difference between the 
effective concentrations of auranofin with purified proteins and in cells is due to the non-
specific binding of auranofin to glutathione and other thiols (Gromer et al, 1998). As such the 
concentration of free auranofin will be lower when used with cells than used with purified 
proteins (Gromer et al, 1998). We found in this investigation that treatment with RRL with 
20µM auranofin allowed disulphide bond formation to occur in the presence of G6P. 
However, as the concentrations of free auranofin are likely to be low in RRL (as with cells) 
this suggests that the lysate concentration of TrxR is lower than 20µM. 
Auranofin has also been found to inhibit purified GR at micromolar concentrations. However 
direct analysis of the effect of auranofin on purified thioredoxin reductase and glutathione 
reductase found the effective concentration of auranofin for inhibition of GR was 
approximately three orders of magnitude greater than that of TrxR (Gromer et al, 1998). This 
further supports our conclusion that effects detected by auranofin addition in our assay are 
due to TrxR inhibition and not GR inhibition. Furthermore it has also been found that addition 
of 20µM auranofin to cells caused only a small effect on GSH/GSSG ratio (Go et al, 2013). 
This suggests that addition of 20µM auranofin also would only have a small effect on lysate 
GSH/GSSG ratio.  
Carmustine has been shown to inhibit GR activity in vitro with 5nM of the enzyme being 
inhibited by the compound with an IC50 of 71µM (Liu & Sturla, 2009). Carmustine has also 
been found to inhibit GR activity and reduced GSH levels when injected into rats (Becker & 
Schirmer, 1995). Addition of 120µM carmustine to cells has been shown to dramatically 
reduce cell viability in following an oxidative challenge suggesting the glutathione reductive 
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pathway is compromised at this concentration (Ma et al, 2003). By contrast, we did not 
detect any effect of carmustine on the disulphide formation of HA unless added at 3.66mM 
which is far greater than the µM effective concentrations range used in these previous in 
vitro and in vivo studies. Both the addition of DHEA and auranofin caused effects within the 
RRL at similar concentrations to those reported in cellular studies. This suggests that the 
target enzymes of these inhibitors are present at comparable concentrations to those in 
cells. Therefore, the lack of an effect by carmustine within effective cellular concentrations 
further suggests that GR was not involved in preventing disulphide formation within the HA 
substrate. 
3.4.3 The influence of glutathione and thioredoxin on maintaining reduced thiols  
There has been considerable speculation and research effort in recent years in determining 
the functional roles of both the thioredoxin and glutathione redox systems within eukaryotic 
cells (Kojer & Riemer, 2014). Until recently it has been thought that both glutathione and 
thioredoxin play a role in the maintenance of thiol groups within the cytosol in a reduced 
state. (Lopez-Mirabal & Winther, 2008). A fairly recent paper in which yeast cells were either 
deprived of glutathione or exposed to toxic levels of glutathione found that under both 
conditions the cells suffered from impaired iron sulphur cluster synthesis but maintained thiol 
redox control (Kumar et al, 2011). This suggested that the primary role of the glutathione 
redox system within mammalian cells is in supporting iron sulphur cluster biogenesis and 
may play a secondary role to the thioredoxin redox system in maintaining thiol-redox control. 
Consistent with the finding, the evidence reported in this chapter suggests that the 
thioredoxin redox system is responsible for preventing disulphide formation within a G6P 
optimised RRL.  
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Chapter 4: Results 2: The enzymatic sources of 
de novo disulphide bond formation within the 
endoplasmic reticulum 
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4.1 Summary 
Disulphide bonds are introduced into nascent proteins within the ER by thiol-disulphide 
exchange reactions with the PDI family of enzymes. In order for this reaction to be 
maintained the catalytic disulphides of the PDI family members need to be regenerated by 
enzymes capable of de novo synthesis of disulphides. Ero1 and PrxIV are two enzymes that 
have been established as important generators of ER disulphides. Genetic studies have 
however found that mammalian cells are still viable and capable of disulphide generation in 
the absence of these enzymes. Several enzymes have been identified as potential additional 
contributors to ER disulphide formation. One of these enzymes, VKOR, has since been 
shown to contribute to disulphide formation in human hepatoma cells. We aimed to quantify 
the contribution of these sources of ER disulphide formation. We assessed this by analysing 
the disulphide formation of nascent PPL translated within a G6P optimised RRL translation 
system that was supplemented with a source of ER. We showed that DPMs depleted of 
luminal enzymes were incapable of forming disulphides within PPL indicating the luminal 
enzymes are essential for this process. We then investigated the effect of selectively 
inactivating enzymes involved in de novo synthesis of disulphides. We found that inhibition 
of Ero1 in DPMs resulted in substantial impairment of disulphide formation, however, this 
impairment could only be detected following a reductive challenge. By contrast, inhibition of 
VKOR in addition to Ero1 caused no further impairment of disulphide formation. These 
findings reinforce the perception that Ero1 is a key generator of ER disulphides but also 
suggest that alternative pathways capable of PDI oxidation may compensate for loss of 
Ero1. These results also suggest that the contribution VKOR makes to disulphide generation 
may be restricted to particular substrates or cell types.   
4.2 Introduction 
Disulphide bonds are introduced in nascent substrates within the lumen of the ER by the PDI 
family. The catalytic disulphides of the PDI family members are regenerated by enzymes 
capable of synthesising disulphide bonds de novo. Ero1 and PrxIV are both well established 
as de novo generators, however, several other enzymes such as VKOR, QSOX and GPx7/8 
also have been identified as potential generators of disulphides (Bulleid & Ellgaard, 2011). 
Key questions remain regarding these de novo sources: other than Ero1 and PrxIV, which 
enzymes may act as de novo generators? How large is the contribution that each of these 
sources make to disulphide formation and does this contribution vary between cell types? 
Does each of these sources have different target substrates? In order to answer the 
questions surrounding these disulphide sources it is useful to review studies that have 
investigated them. 
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Ero1 was originally discovered in yeast and was found to be essential for disulphide 
formation within this organism (Frand & Kaiser, 1998; Pollard et al, 1998). However, it was 
later found that loss of Ero1 in fruit flies, or the loss of both of the mammalian isoforms of the 
enzyme in mice resulted in a mild phenotype and did not substantially affect disulphide 
formation (Tien et al, 2008; Zito et al, 2010a). This suggested that other pathways to 
disulphide formation exist in higher eukaryotes. The search for other sources of disulphide 
generation led to the identification of PrxIV as an additional enzymatic source of ER 
disulphide generation (Tavender et al, 2010; Zito et al, 2010b). 
Similarly to Ero1, PrxIV knockout mice were found to display only a mild phenotype 
suggesting that disulphide formation is also possible in the absence of the PrxIV pathway 
(Iuchi et al, 2009). Following this finding, the effects of removal of both the Ero1 isoforms 
and PrxIV on disulphide formation pathways were assayed by the knockdown of PrxIV in 
mouse embryonic fibroblast (MEF) cells with disruptive mutations of the Ero1 genes (Zito et 
al, 2010b). This resulted in several interesting phenotypic features: the cells displayed 
severely diminished cell growth, had a more reducing environment and displayed impaired 
collagen secretion. MEF cells in which PrxIV was knocked down and Ero1 was knocked out 
were also less resilient to a DTT challenge than MEF cells in which Ero1 was knocked out 
but retained normal PrxIV expression. These findings suggested that the loss of both Ero1 
and PrxIV pathways has a more detrimental effect on cells than loss of either pathway alone, 
however, the continued viability of such cells suggests that disulphide formation was not 
completely abolished.  
In order to identify other de novo sources Rutkevich and Williams investigated the effect of 
functional loss of known and potential disulphide generating enzymes (Rutkevich & Williams, 
2012). This was assessed by knockdown of expression or inhibition of these enzymes in a 
human hepatoma cell line. The effect upon disulphide formation in albumin was then 
assayed by pulse-chase methodology. No impairment of disulphide formation was detected 
under these conditions unless the cells were first subjected to a brief DTT reductive 
challenge. When this reductive challenge was used it was found that knockdown of Ero1α+β 
resulted in impaired disulphide formation. Furthermore, knockdown of PrxIV, or inhibition of 
VKOR (both in addition to Ero1α+β knockdown) resulted in further impairment of disulphide 
formation. Knockdown of QSOX was not found to have any effect. This study was of 
importance because it provided strong evidence to support the common perception that Ero1 
is a major source of disulphides. In addition, the study provided the first in vivo evidence that 
VKOR contributes to ER disulphide formation. It was also observed that disulphide bond 
formation although impaired remained functional under all assay conditions tested indicating 
that some disulphide generators remained functional. It was noted that due to toxicity issues 
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it was not possible to assess the effect of knocking down Ero1α+β and PrxIV and well as 
inhibiting VKOR (Rutkevich & Williams, 2012).  
In order to further assess these de novo sources we investigated their influence in the 
generation of disulphide bonds within nascent PPL using ER sourced from DPMs and 
HT1080 SP cells. The ER of these sources was treated to remove their luminal components 
or to selectively inhibit the enzymes Ero1, PrxIV and VKOR. We then supplemented these 
manipulated ER sources to our G6P optimised RRL translation and assessed the effect 
upon the disulphide formation. This approach allowed us to assess the overall influence of 
the ER lumen to disulphide formation and also the contribution of these specific enzymes. 
4.3 Results 
4.3.1 Preprolactin is an effective substrate for analysis of disulphide formation 
We chose to use bovine PPL as the substrate for this investigation as it is a model protein 
for studies of protein folding and disulphide formation (Kaderbhai & Austen, 1985). Bovine 
PPL is also not glycosylated (Wallis, 1974). This is advantageous as it prevents our analysis 
of disulphide formation from being complicated by effects upon the glycosylation machinery. 
Initial analysis of the disulphide formation of the substrate was conducted in the presence of 
SP cells as well as DPMs (Fig 4.1). Under reducing conditions a faster mobility species 
corresponding to the signal peptide cleaved form was observed if a source of ER was 
present (Fig 4.1 compare lanes 1 and 2 of A and B). The signal sequence of bovine PPL 
constitutes the first 30 amino acids of the total 229 amino acids (Wallis, 1974). 
Consequently, its cleavage caused a large change in molecular weight resulting in a 
detectable shift in gel mobility of the protein. Under non-reducing conditions disulphide 
bonds remained intact and as such disulphide bonded prolactin can be observed (Fig 4.1 
lanes 3 to 8 of A and B). Only one intrachain disulphide bonded prolactin form was visible 
despite the fact that PPL forms three intrachain disulphides (Wallis, 1974). This is because 
only one of these disulphides is long range (Fig 1.19) and results in detectable change in gel 
mobility. The disulphide bonded prolactin was seen to form rapidly and remained stable 
throughout the course of the assay. 
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Figure 4.1: Prolactin forms a single detectable disulphide bonded species in the presence of a 
source of ER. mRNA encoding PPL was translated for the indicated times. ATCA was added to the 
lysate after 5 min to prevent further translation initiation, thereby allowing a time-synchronised 
analysis of the prolactin disulphide formation. The translation reactions were supplemented with 
either SP cells (A) or DPMs (B) to act as sources of ER. A single intrachain disulphide bonded 
prolactin species can be observed. PPL: Preprolactin, PL: Prolactin, DB-PL: intrachain disulphide-
bonded prolactin. 
4.3.2 ER luminal components are essential for disulphide formation of prolactin 
The majority of enzymes involved in ER disulphide formation reside in the lumen of the 
organelle. This includes most of the PDI family members as well as all of the enzymes 
regarded as known and potential sources of de novo disulphide synthesis with the exception 
of VKOR (Bulleid & Ellgaard, 2011; Kozlov et al, 2010). It has been shown that microsomes 
that are depleted of their luminal contents are impaired at forming disulphide bonds in 
nascent proteins translated within a RRL translation system (Bulleid & Freedman, 1988; 
Marquardt et al, 1993). We sought to verify this finding with our G6P optimised RRL system 
to confirm whether the luminal enzymes of the microsomes are indeed necessary for 
disulphide bond formation. 
Consistent with previous results (Bulleid & Freedman, 1990) we found that DPMs could be 
specifically depleted of luminal components by treatment with the detergent saponin (Fig 
4.2). Furthermore we showed that ER disulphide bond formation in nascent prolactin was 
prevented in a RRL supplemented with DPMs that were depleted of their luminal contents 
(Fig. 4.2C). This result shows that ER luminal enzymes are essential for disulphide bond 
formation of prolactin.  
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Figure 4.2: Disulphide formation of prolactin within the ER is prevented in the absence of ER 
luminal proteins. DPMs were treated with 0.5% (v/v) purified saponin to cause the release of their 
luminal contents. (A) Western blotting showed that saponin treatment caused release of luminal 
proteins such as PDI and ERp57 but not membrane proteins such as calnexin. (B) Coomassie blue 
staining shows the profile of proteins released and retained following saponin treatment. (C) It can 
be seen that when mRNA encoding PPL is translated in RRL supplemented with saponin treated 
microsomes no disulphide bond formation occurs. sn: supernatant and p: pellet fractions of DPM 
isolated by centrifugation following saponin treatmen, u: DPM that have not been treated with 
saponin, LD-DPMs: DPMs depleted of luminal components. 
4.3.3 Inhibition of Ero1 following a reductive challenge substantially impairs 
disulphide bond formation in DPMs 
Following the confirmation that the removal of the ER lumen prevents disulphide formation 
our aim was to determine the enzymes involved in this process and quantify their 
contribution. Our strategy was to inactivate key components of the ER disulphide bond 
formation machinery and to assess the effect upon disulphide bond formation of prolactin.  
It has been found that disulphide bond formation can be effectively assayed following a brief 
DTT reductive challenge (Braakman et al, 1992). The DTT treatment used in this technique 
causes all solvent accessible disulphides to be reduced. Therefore, disulphide bonds have to 
be generated de novo before they are introduced into substrates and cannot come from 
latent disulphides such as the catalytic disulphides of PDI family members. The method has 
been used in pulse chase experiments in which DTT is added to cells, removed; and then 
disulphide formation is analysed at time points following the removed of the reductant. This 
technique has been used to investigate ER disulphide formation machinery and ER redox 
dynamics (Appenzeller-Herzog et al, 2010; Cuozzo & Kaiser, 1999; Mezghrani et al, 2001). 
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Recently, it has been discovered that treatment of HT1080 cells with 10 mM DTT for 10 min 
causes complete inactivation of PrxIV (Cao et al, 2014). This inactivation occurs because the 
DTT treatment causes the thiol groups of certain catalytic cysteines of PrxIV to become 
irreversibly hyperoxidised to sulfinic acid groups (R-SO(OH)) which prevents the catalytic 
action of PrxIV. This hyperoxidation is thought to occur because Ero1 metabolises DTT 
(Gross et al, 2006; Tavender & Bulleid, 2010b) which causes hydrogen peroxide to be 
produced. The high hydrogen peroxide concentration then causes PrxIV hyperoxidaiton 
(Cao et al, 2014). The inactivation of PrxIV by DTT treatment also occurs with DPMs as well 
as HT1080 cells (Cao and Bulleid, unpublished data).  
The de novo disulphide generators Ero1 and VKOR can also be inhibited by the compounds 
QM295 and warfarin (Blais et al, 2010; Fasco et al, 1983) (Fig 4.3). QM295 has been shown 
to inhibit 200nM Ero1 in vitro with an IC50 of 1.9µM. Ero1 treated with the inhibitor in vitro 
was shown to be predominantly in the reduced state while untreated Ero1 is predominantly 
in the oxidised form. It was also shown that the Ero1 of mouse embryonic cells treated with 
50 µM of QM295 was also predominantly reduced while the enzyme was predominately 
oxidised in untreated cells. It was concluded that QM295 targets the reduced form of the 
enzyme and inhibits its activity by preventing re-oxidation (Blais et al, 2010). A concentration 
of 4 µM warfarin has been shown to inhibit approximately 80% of the VKOR present  in rat 
liver microsomes (Fasco et al, 1983). More recently, it has been shown that addition of 
warfarin 50 µM to human hepatoma cells in which Ero1 expression was knocked down 
resulted in impairment of disulphide bond formation in albumin (Rutkevich & Williams, 2012).  
Considering this information, we reasoned that through the use of these inhibitors and DTT it 
would be possible to selectively inactivate Ero1, PrxIV and/or VKOR as well as abolishing 
solvent accessible disulphides of DPMs. This was achieved by incubating DPMs with (or 
without) 50 µM QM295 and 50 µM warfarin and incubating the DPMs with 10mM DTT for 10 
minutes. QM295 and warfarin inactivate Ero1 and VKOR, while DTT treatment inactivates 
PrxIV and removes solvent accessible disulphides. The DPMs were resuspended in DTT 
free buffer before being added to RRL programmed with PPL mRNA. The effect on 
disulphide bond formation of PPL was then assayed (Fig 4.4). 
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Figure 4.3: Chemical structures of Ero1 and VKOR inhibitors, QM295 and warfarin. (A) QM295 has 
been shown to be a potent inhibitor of Ero1 in vitro and in vivo. The name of the inhibitor is derived 
from the fact it contains a quinone methide group and has a molecular mass of 295 (Blais et al, 
2010). (B) Warfarin is a drug commonly used as an anticoagulant. It targets the enzyme VKOR which 
is involved in the vitamin K cycle. Inhibition of VKOR by warfarin prevents regeneration of reduced 
vitamin K which is an essential cofactor for the blood clotting cascade (Rettie & Tai, 2006). The redox 
activities of VKOR are also implicated in supporting disulphide formation (Rutkevich & Williams, 
2012). Structures of QM295 and warfarin are as originally shown by Blais et al and Rettie and Tai 
respectively (Blais et al, 2010; Rettie & Tai, 2006) 
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Figure 4.4: Ero1 inhibition following a DTT reductive challenge causes severe impairment of 
disulphide formation of prolactin in DPMs. DPMs were either not treated with inhibitors (A), 
treated with QM295 (B), or treated with QM295 and warfarin (C). All DPMs were then exposed to 10 
mM DTT for 10 mins before being isolated by centrifugation and resuspended in fresh buffer. The 
microsomes were then added to RRL programmed with PPL mRNA for translation. Translation 
reactions proceeded for the indicated times before being treated with NEM. DTT added to the 
loading buffer of the indicated samples to allow DTT sensitive bands to be identified. It can be seen 
that when treated with the Ero1 inhibitor QM295 prolactin disulphide bond formation was 
substantially impaired. Each experimental condition was carried out 3 times and results similar to 
those shown were obtained with the repeats of each condition. PPL: Preprolactin, PL: non-disulphide 
bonded Prolactin, DB PL: Intrachain disulphide bonded prolactin ICDB PL: interchain disulphide 
bonded prolactin/prolactin aggregates. 
When treated with only DTT (and hence with PrxIV inactivation) the majority of the 
translocated prolactin became disulphide bonded and only a minority of the prolactin 
persisted in the non-disulphide bonded form. Addition of QM295 caused substantial 
impairment of disulphide bond formation with the majority of nascent prolactin being unable 
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to form disulphide bonds. Addition of the VKOR inhibitor warfarin, however, did not cause 
any obvious further reduction of disulphide formation and a minority of the translocated 
prolactin still remained in the disulphide bonded form (Fig 4.4). 
In order to quantify the effects on disulphide formation we repeated each experimental 
condition twice (3 replicates). We then conducted densitometry of specific gel bands for each 
of the results and made statistical comparisons between the results for each condition (Fig 
4.5). Comparison of the ratios of intrachain disulphides divided by the total translocated 
protein where made between each condition for each time point. The mean ratio of 
disulphide bonded/total translocated prolactin was substantially lower in DPMs treated with 
QM295 then DPMs that had not been treated with this inhibitor. Furthermore, it was found 
that difference in the ratio values between these two groups was statistically significant for all 
the time points assayed (t-test p values <0.05).There was however no statistical difference 
(t-test p values >0.05) for any time point between DPMs that had been treated with DTT and 
QM295, and the DPMs that had been treated with DTT, QM295 and warfarin. This result 
shows that Ero1, but not VKOR made a quantitatively large and statistically significant 
contribution to disulphide bond formation of prolactin within DPMs following a DTT 
challenge.     
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Figure 4.5: Densitometric analysis confirms that inactivation of Ero1 in DPM following a reductive 
challenge severely impairs prolactin disulphide bond formation. Triplicate results of the 
experimental data shown in Fig 4.4 were subjected to densitometric analysis. For every time point 
under non-reducing conditions the desitometric value of the intrachain disulphide prolactin band 
(DB PL) was divided by the value of the non-disulphide bonded prolactin band (PL) plus the value of 
DB PL. This gave a ratio of intrachain disulphides/total translocated prolactin. Data point and line 
colours represent the inhibitor treatment the DPMs were subjected to. DPMs not treated with 
inhibitors are shown in blue, those treated with QM295 are shown in yellow, while the DPMs 
treated with QM295 and warfarin are shown in red. Each data point shows the mean ratio of 
intrachain disulphides/total translocated prolactin at a particular time point. The mean value was 
calculated from the triplicates of each condition. The error bars shown are +/- one standard 
deviation. Statistical comparisons were made between the treatment conditions using the student’s 
t-test. Comparison between each time point of the DPMs treated with no inhibitors (blue) and those 
treated with QM295 (yellow) resulted in p=values ranging from 0.012 and 0.034 indicating statistical 
significant (p<0.05) between the two conditions. Comparison between the DPMs treated with 
QM295 (yellow) and those treated with QM295 and warfarin (red) resulted in p=values ranging from 
0.18 to 0.51 indicating no statistical significance (p>0.05). These findings indicate that inhibition of 
Ero1 following a DTT challenge resulted in a statistically significant impairment of disulphide bond 
formation. Additional inhibition of VKOR by warfarin resulted in lower mean ratios of intrachain 
disulphide bond formation as a proportion of total translocated protein, however, these values were 
not statistically significant.   
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It should be noted that under the assay conditions we also detected prolactin aggregates at 
the top of resolving gel that accumulated over the course of the reaction (Fig 4.4). 
Comparison of the 30 min time points under reducing and non-reducing conditions 
suggested that these aggregates were at least partially composed of interchain disulphide 
bonded (ICDB) prolactin. This ICDB/aggregate band was not included in analysis of the 
disulphide bonded/total translocated ratios. However, it can be seen that this is only a minor 
species over all time points except the 60 and 90 min time points. Therefore any skewing of 
our analysis by this product(s) is likely to be limited to these two time points only and do not 
affect the overall interpretations of our results.   
4.3.4 In the absence of a DTT treatment, inhibition of enzymatic sources involved in de 
novo synthesis of disulphide bonds in DPMs does not prevent disulphide formation 
We next investigated the effect of inhibition of sources of de novo disulphide formation in the 
absence a prior treatment of the DPMs with DTT (Fig 4.6). Under these conditions inhibition 
of Ero1 caused no detectable impairment of disulphide bond formation in nascent prolactin. 
Combined inhibition of VKOR as well as Ero1 only appeared to impair disulphide bond 
formation, at the later 60 and 90 min time points (Fig 4.7). It can be seen, however, that less 
disulphide bonded aggregates were observed at these time points when warfarin was 
added, which may have resulted in an apparent lower ratio of disulphide bonded/ total 
translocated prolactin. As a difference in disulphide bonded/total translocated ratios was only 
observed at these two later time points in which aggregation interferes with the analysis we 
concluded that the warfarin treatment had not caused additional impairment of disulphide 
formation. 
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Figure 4.6: In the absence of a DTT reductive challenge inactivation of Ero1 and VKOR in DPMs 
does not impair disulphide formation in prolactin. DPMs were isolated by centrifugation before 
being resuspended in the absence of inhibitors (A), in the presence the QM295 (B), or in the 
presence of QM295 and Warfarin (C). DPMs were then pelleted by centrifugation and resuspended 
in the absence of inhibitors before being added to RRL programmed withPPL mRNA for translation. 
50µM QM295 was also present in the lysate of the reactions shown in (B) and (C). 50µM warfarin 
was also present in the lysate of the reactions shown in (C). Translation reactions proceeded for the 
indicated times before being treated with NEM. DTT added to the loading buffer of the indicated 
samples to allow DTT sensitive bands to be identified. Inactivation of Ero1, or Ero1 and VKOR caused 
no observable effect on disulphide bond formation. PPL: Preprolactin, PL: non-disulphide bonded 
Prolactin, DB-PL: Intrachain disulphide bonded prolactin, ICDB PL: interchain disulphide bonded 
prolactin. 
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Figure 4.7: Densitometric analysis of inhibition of the enzymatic sources of de novo disulphide 
synthesis in DPMs in the absence of a reductive challenge. The experimental data shown in Fig 4.6 
was subjected to densitometric analysis to quantify the effect on disulphide bond formation caused 
by inactivation of de novo enzymatic sources of disulphide generation in DPMs in the absence of a 
reductive challenge. For each time point of each condition under non-reducing conditions the 
desitometric value of the intrachain disulphide prolactin band (DB-PL) was divided by the value of 
the non-disulphide bonded prolactin band (PL) plus the value of DB-PL. This gave a ratio of intrachain 
disulphides/total translocated prolactin. Data point and line colours represent the inhibitor 
treatment the DPMs were subjected to. DPMs not treated with inhibitors are shown in blue, those 
treated with QM295 are shown in yellow, while the DPMs treated with QM295 and warfarin are 
shown in red. The data shown is from analysis of one experiment for each experimental condition.  
Considering these results in conjunction with the results obtained with DTT treatment it can 
be seen that the two variables tested that had the greatest influence on disulphide formation 
were the inhibition of Ero1, and treatment with DTT. Disulphide formation can be seen to 
only be substantially impaired under conditions in which the DPMs had both been DTT 
treated and Ero1 had been inhibited by QM295. Warfarin treatment did not appear to cause 
any clear impairment of disulphide formation under any assay conditions. Interestingly, 
91 
 
disulphide bond formation although impaired was at least partially functionally under 
conditions in which Ero1, PrxIV and VKOR would be expected to be inactive. This suggests 
that inactivation of these enzymes was not complete or other luminal enzymes were 
generating disulphides.  
4.3.5 SP cells maintain the capacity to form disulphides even when de novo enzymatic 
generators are inactivated  
Following on from our findings with DPMs we next experimented with inhibition of enzymatic 
disulphide sources in SP cells. There were two purposes for using SP cells for this 
investigation. Firstly, we sought to determine if the SP cells would behave similarly to DPMs 
under the same assay conditions. Secondly, we aimed to utilise the SP cells to examine 
prolactin disulphide formation under conditions in which the expression of ER proteins had 
been altered. As SP cells are derived from tissue culture cells any manipulations that are 
made to ER protein expression of these cells in tissue culture remain once the cells have 
become permeabilised for use in the RRL translation system.  
Similarly to the DPMs, the SP cells were subjected to conditions designed to impair the 
disulphide formation apparatus of the ER (Fig 4.8). The most severe condition involved 
treatment with QM295, warfarin and DTT. To our surprise the SP cells showed no 
impairment of disulphide formation under any of the treatment conditions. We repeated the 
experiment with minor changes in assay conditions however the lack of impairment of 
disulphide bond formation in the SP cells was consistently observed (data not shown). This 
indicates a clear difference in behaviour between the DPMs and SP cells and indicates that 
the disulphide formation machinery of SP cells is more robust than that of DPMs. 
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Figure 4.8: Inhibition of enzymatic sources de novo sources of disulphide bond formation following 
a reductive challenge does not impair disulphide bond formation in SP cells. Translation of PPL 
mRNA was conducted in the presence of SP cells pretreated with or without the inhibitors QM295 
and warfarin and the reductant DTT. SP cells were incubated with 50µM of inhibitors for 5 min and 
then incubated with 10mM DTT for a further 10 min. The cells were then resupsended in fresh KHM 
buffer and added to RRL for translation reactions. The SP cells were either treated without any 
inhibitors or DTT (A), with DTT only (B), with QM295 and DTT (C), or with QM295, warfarin and DTT 
(D).  50µM QM295 was also present in the lysate of the reactions shown in (C) and (D). 50µM 
warfarin was also present in the lysate of the reactions shown in (D). It can be seen that unlike DPMs 
there was no impaired disulphide formation of PPL in SP cells in which the Ero1 and VKOR were 
inhibited and which had been subjected to a DTT reductive challenge. 
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4.4 Discussion 
4.4.1 ER luminal proteins are required for disulphide formation of prolactin 
In this study we showed that the luminal enzymes of the ER are required for disulphide bond 
formation of prolactin. We anticipated that removal of the of the luminal enzymes would 
either abolish or severely impair disulphide formation as the majority of the enzymes known 
to be involved in ER disulphide formation reside within the ER lumen. This includes the 
established de novo disulphide generators Ero1 and PrxIV, as well as most of the PDI family 
members (Bulleid & Ellgaard, 2011; Kozlov et al, 2010). Some of the less well characterised 
enzymes involved in disulphide generation do however reside in the ER membrane. This 
includes the five TMX proteins of the PDI family as well as the de novo disulphide generator 
VKOR (Kozlov et al, 2010; Rutkevich & Williams, 2012). Furthermore, it has been shown that 
VKOR forms mixed disulphides with TMX and TMX4 (Schulman et al, 2010). This thus 
suggested that a possible VKOR-TMX(4)-prolactin disulphide relay pathway may have still 
been functional. However, the lack of any prolactin disulphide formation under these 
conditions suggests that such a pathway does not function within the ER. There are two 
possible explanations for this. Firstly, VKOR may not be an effective generator of disulphides 
within these ER sources, or secondly, the TMX and TMX4 PDI family members may not be 
capable of introducing disulphides into prolactin. 
Two previous studies have investigated the contribution of ER luminal factors to disulphides 
bond formation of nascent proteins using DPMs depleted of their luminal contents within a 
RRL translation system (Bulleid & Freedman, 1988; Marquardt et al, 1993). A study by 
Bulleid and Freedman provided early evidence that PDI was involved in disulphide 
formation. DPMs depleted of luminal components by high pH, and hence lacking PDI, were 
shown to have reduced, but not complete absence, of disulphide formation of the substrate 
γ-gliadinn (a wheat storage protein) (Bulleid & Freedman, 1988). A subsequent study by 
Marquardt et al showed that DPMs depleted by treatment with the non-ionic detergent Nikkol 
were incapable of introducing disulphides into HA. (Marquardt et al, 1993). The complete 
lack of disulphide formation of HA in depleted DPMs suggests that HA, like PPL is probably 
not a downstream target of VKOR. As some disulphide bond formation still occurred in γ-
gliadin it is possible that this protein is a downstream substrate of VKOR. These studies and 
our own suggests that a VKOR-TMX(4)-substrate pathway does not operate with the 
substrates PPL and HA however γ-gliadin may be a substrate of such a pathway.  
 
 
94 
 
4.4.2 A VKOR disulphide generation pathway may be specific to particular substrates 
and/or cell types  
The luminal depletion experiments suggested that VKOR pathway could not introduce 
disulphide bonds into prolactin via the TMX or TMX4 enzymes within ER derived from dog 
pancreas tissue. VKOR has however also been shown to formed mixed disulphides with the 
luminal PDI family member ERp18 (Schulman et al, 2010). The findings therefore did not 
negate the possibility that VKOR could introduce disulphide to prolactin via ERp18. 
Furthermore, recent evidence from the Bulleid lab has also indicated that PDI family 
members may shuttle disulphide bonds amongst each other (Oka et al, 2015). Therefore, it 
also remained a possibility that VKOR could support the introduction of disulphides into its 
target PDI family members which could in turn transfer disulphide to PDI family members 
capable of introducing disulphide to prolactin. Our inhibitions studies provide further 
information regarding these possibilities. Inhibition of VKOR in DPMs (following a reductive 
challenge and inactivation of Ero1 and PrxIV) resulted in a lesser amount of disulphide 
formation of prolactin relative to the same conditions without the inhibition of VKOR. The 
decrease in disulphide formation was only slight and was not statistically significant which 
suggested that VKOR made either a small or no contribution to disulphide formation in 
prolactin within DPMs. This assay should have been sensitive to the detection of disulphide 
generation of VKOR as both Ero1 and PrxIV had been inactivated and therefore a large 
amount of the functional redundancy within the disulphide formation machinery should have 
been removed. Therefore, if VKOR was capable of supporting disulphide formation of 
prolactin, it would have been expected to be contributing a large proportion of the remaining 
disulphide generating capacity of the microsomes. As such, the lack of a clear effect upon 
VKOR inhibition shows it does not make a substantial contribution to prolactin disulphide 
formation within the ER of dog pancreas tissue.  
The lack of observable VKOR derived disulphide formation in DPMs is in contrast to a 
previous findings from Rutkevich et al that VKOR makes a contribution to the disulphide 
formation of albumin (Rutkevich & Williams, 2012). The study by Rutkevich and Williams 
was carried out using pulse chase methodology with a human hepatoma cell line. 
Functionally the experimental approaches used by ourselves and Rutkevich and Williams to 
detect VKOR disulphide bond formation activity are highly similar. Both involve assaying the 
disulphide formation of a substrate following a reductive challenge in an ER system in which 
Ero1 was inactivated and comparing the effect with inactivation of VKOR by warfarin. Aside 
from the methodological difference of using a pulse chase or in vitro system, the two primary 
biological differences are between the substrates used to assay the oxidative folding and the 
cellular source of the ER used. 
95 
 
This suggests two possible causes for the difference in the VKOR disulphide generation 
activity between our study and that of Rutkevich and Williams. Firstly, VKOR may only 
introduce disulphide bonds into a specific subset of downstream protein targets. These 
targets are likely to be substrates which the PDI family members TMX, TMX4 and ERp18 
interact with. It would be inferred from this hypothesis that albumin, but not preprolactin is a 
target of these PDI family members. A second possibility is that VKOR may be an important 
contributor to disulphide formation within particular tissues. It has been previously shown 
that VKOR mRNA is highly expressed in liver cells compared to other tissues and also that 
VKOR is up regulated in cancer tissues (Wang et al, 2005). It may be expected that VKOR 
disulphide generation activity is particularly high in human hepatoma cells in which the study 
by Rutkevich and Williams was conducted.  In any case, the findings of the study reported in 
this chapter imply that the contribution that VKOR makes as a de novo source of disulphide 
is not universal but is specific to particular substrates or cell types.  
4.4.3 Ero1 disulphide generation activity can only be detected following a reductive 
challenge 
Ero1 is commonly regarded as the primary generator of disulphides within the ER (Tavender 
& Bulleid, 2010a). However, in this investigation the disulphide generation activities of Ero1 
could only be detected in DPMs following a reductive challenge. This finding is consistent 
with those reported by Rutkevich and Williams in which it was found that the knockdown of 
Ero1 in human hepatoma cells only resulted in an impairment of disulphide formation of 
albumin following a reductive challenge (Rutkevich & Williams, 2012). Furthermore Zito et al 
detected a modest delay in the oxidative folding of IgM in cells derived from Ero1 knock out 
mice following a reductive challenge (Zito et al, 2010a). These findings consistently indicate 
that the ER maintains an effective capacity to introduce disulphides in the absence of Ero1. 
It has been considered that the alternative disulphide generators including PrxIV and VKOR 
may compensate for loss of Ero1 (Bulleid & Ellgaard, 2011). In this investigation however, 
prolactin disulphide formation in DPM still occurred under conditions in which Ero1, PrxIV 
and VKOR would be expected to be inactivated. However, ER luminal depletion did abolish 
the disulphide formation of prolactin. These findings indicate that the ER disulphide bond 
formation machinery is remarkably robust and suggest that alternative routes of disulphide 
generation from ER luminal sources may persist even in the absence of these three 
enzymes.  
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4.4.4 Inactivation of Ero1, PrxIV and VKOR does not impair disulphide formation in SP 
cells 
Curiously, we found that when using SP cells, impairment of disulphide bond formation of 
prolactin could not be detected even when the SP cells had been DTT treated and the 
enzymes Ero1, VKOR and PrxIV were inactivated. This contrasts the clear impairment of 
disulphide formation that we observed with DPMs under the same conditions. It also 
contrasts the findings of Rutkevich and Williams who detected impair disulphide formation of 
albumin in human hepatoma cells following a reductive challenge if Ero1 was knocked down 
(Rutkevich & Williams, 2012). However, the finding is somewhat consistent with the 
discovery that immunoglobulin secretion and disulphide formation proceeded normally in 
mice in which Ero1 was knocked out (Zito et al, 2010a). 
The findings of this chapter and other studies suggest disulphide bond formation machinery 
of the ER is fairly robust and resilient to loss of function of particular enzymes. Therefore the 
findings that inactivation of several de novo disulphide sources results in disulphide 
impairment in DPMs but not SP cells could be an important clue in elucidating the 
biochemical and molecular mechanisms that enable the disulphide formation to function in 
such a robust manner. There are several key differences between DPMs and SP cells that 
may be responsible for these different observations: they are derived from different cell 
types; the ER of SP cells remains as a single reticular membrane while that of DPM is in the 
form of vesicles, also, the ER of SP cells remains in contact with other cellular organelles 
including the mitochondria (Kornmann et al, 2009) while DPMs are isolated from other 
organelles. One possible hypothesis is that oxidising equivalents such as hydrogen peroxide 
could be supplied to the ER by the mitochondria and may also support ER oxidative folding. 
This hydrogen peroxide could perhaps support direct oxidation of PDI or protein substrates 
as has been shown to occur in vitro (Karala et al, 2009). Alternatively, the hydrogen peroxide 
may be supporting peroxidase enzymes that will still be active such as the glutathione 
peroxidases 7 and 8 (Nguyen et al, 2011). Such a suggestion is highly speculative at this 
stage but may warrant further investigation.  
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Chapter 5: Results 3: Analysis of mixed 
disulphide interactions between PDI and 
prolactin during and following translocation to 
the ER 
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5.1 Summary 
PDI is an ER luminal enzyme that plays a key role in the oxidative folding of nascent 
secretory proteins. We sought to investigate the interactions between PDI and nascent 
proteins during ER translocation. For this study we used a RRL system to translate mRNA 
encoding PPL or mRNA encoding PPL that stalled on the ribosome. Translation was carried 
out in the presence of HT1080 SP cells over expressing a substrate trapping PDI mutant. 
The translationally stalled PPL only partially translocated across the ER membrane while the 
non-stalled PPL was unhindered in its translocation to the ER. We immunoisolated 
translation product and showed that mixed disulphide species formed with PDI and 
translationally stalled prolactin as well prolactin that had translocated to the ER lumen. 
These results indicate that prolactin is a substrate for PDI and that PDI may interact with 
prolactin during translocation across the ER membrane. We also detected a change in the 
prolactin-PDI mixed disulphide species between stalled and luminal prolactin. This indicates 
that PDI may form additional interactions with prolactin following completion of translocation 
to the ER lumen. 
5.2 Introduction 
The folding of nascent secretory protein within the ER occurs in conjunction with the 
formation of disulphide bonds in a process known as oxidative folding. The PDI family of 
oxidoreductases play a key role in this process by catalysing the oxidation of thiols as well 
as the rearrangement and reduction of disulphides. In addition, the PDI family also acts as 
chaperones that bind unfolded and misfolded proteins to prevent their aggregation (Ali Khan 
& Mutus, 2014). Due to these roles the PDI family is of importance to our understanding of 
the maturation of secretory proteins and the molecular processes of protein folding diseases 
(Wilkinson & Gilbert, 2004).  
The enzyme PDI is the most extensively studied member of the PDI family. PDI has been 
analysed by structural, biophysical and cellular approaches. These studies have yielded 
significant insight into how the enzyme interacts with its substrates and supports the 
oxidative folding process. It is now understood that PDI is one of several enzymes that 
interact with and catalyses oxidative folding in secretory proteins. A current research goal is 
to understand the initial sequence of events of the interaction between PDI and its nascent 
substrates (Hatahet & Ruddock, 2009). In this study we analysed the mixed disulphide 
species that form between PDI and the substrate prolactin upon entry to the ER. In order to 
understand the current stage of PDI research it is useful to review some of the preceding 
studies. 
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The structure of PDI has been solved in yeast and humans (Tian et al, 2008; Tian et al, 
2006; Wang et al, 2013). The structure is made up of four domains that adopt a “horseshoe” 
or “U” shaped conformation. The outermost thioredoxin domains (designated a and a’) 
contain the CXXC catalytic motifs involved in thiol-disulphide exchange reactions. These two 
domains are bound to the internal domains (designated b and b’) which form a large 
hydrophobic cleft (Fig 5.1). Crystallisation of yeast PDI at high temperature (22°C) have 
shown that the a and a’ domains are highly flexible while the b and b’ domains are both rigid 
(Tian et al, 2008). Furthermore, it has been shown that the enzyme undergoes redox 
regulated conformational changes in which it adopts an open conformation while oxidised 
but a closed conformation when reduced (Wang et al, 2013). 
These findings have lead to a model for oxidation of substrates: It is proposed that the open 
conformation of the oxidised form facilitates interaction of PDI with reduced and unfolded 
substrates which bind to the hydrophobic cleft of the b and b’ domains. PDI then catalyses 
oxidative folding of the substrate and becomes reduced in the process. This in turn causes 
the PDI to adopt a more closed conformation and induces release of the substrate (Tian et 
al, 2008; Tian et al, 2006; Wang et al, 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Structure of PDI: The image shown was produced using DeepView and represents 
the structure of human PDI (4EKZ). Domains a, a’, b and b’ are shown in aqua, blue, orange 
and red respectively. The CXXC active sites in the a and a’ domains are indicated. The 
structure shown was solved by Wang et al by x-ray crysallography (Wang et al, 2013). 
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The interaction between PDI and a folded, partly folded and unfolded protein has been 
investigated by NMR spectroscopy (Irvine et al, 2014). This study used bovine pancreatic 
trypsin inhibitor (BPTI) as a substrate. Natively disulphide-bonded BPTI represented the 
folded form; BPTI in which all the cysteines were alkylated (and hence incapable of forming 
disulphides) represented the unfolded form; and a BPTI mutant capable of only forming two 
disulphides (rather than three) represented a partly folded form. Analysis of the interaction 
between PDI and these BPTI forms showed that PDI bound all three forms, however, the 
binding to the native BPTI was weaker than the binding to the unfolded or partly folded 
forms. These findings suggest that PDI preferentially interacts with substrates that have not 
completed folding (Irvine et al, 2014). This implies that PDI may interact with substrates in 
the early stages of translocation to the ER when protein substrates would still be in an 
unfolded state.  
The effect of PDI on both protein folding and disulphide formation has also been specifically 
analysed using a biophysical approach (Kosuri et al, 2012). This study involved unravelling a 
single molecule substrate by force generated by atomic force microscopy. The substrate was 
then allowed to interact with the catalytic a domain of PDI (PDIa) to form a mixed disulphide 
species. Following this the folding and disulphide bond formation of the substrate was 
analysed by unravelling the substrate with a further force pulse. The length of extensions of 
the substrate that were unravelled with each force pulse indicated if the substrate had folded 
or if it had folded and also formed a disulphide bonded. It was found that protein folding was 
not impeded by PDIa attachment but protein folding did appear to be the rate limiting step of 
disulphide formation. It was therefore concluded that protein folding drives PDI catalysed 
disulphide formation (Kosuri et al, 2012).  
The biological substrates of the PDI family members have been investigated by isolating the 
covalently bound mixed disulphide species that form during thiol-disulphide exchange 
reactions (Sevier & Kaiser, 2002) (Fig 5.2). These species are normally transient reaction 
intermediates, however it has been found that these species can be stabilised by mutating 
the CXXC catalytic motif of the thioredoxin domains. The N-terminal cysteine of this motif is 
responsible for targeting substrates while the C-terminal cysteine is primarily responsible for 
resolution of the mixed disulphide species that forms with a substrate (Walker et al, 1996). 
As such, mutation of the C-terminal residue to either an alanine or serine residue prevents 
resolution of the species by this mechanism and thus stabilises the species. This method 
has been used to capture and isolate mixed disulphide species between PDI family 
members and substrates. A specific procedure that has been used is to over express a PDI 
family member containing CXXA/S active site mutations and an epitope tag. The PDI and 
any substrate it is bound to can then be immumoisolated using an antibody that targets the 
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tag (Jessop et al, 2009b). This technique has allowed the identification of a number of 
substrate proteins of the PDI family and has also shown that certain substrates are the target 
of multiple PDI family members (Jessop et al, 2007; Jessop et al, 2009b; Oka et al, 2013). 
It has been reported that disulphide bond formation can occur both co-translationally and 
post-translationally with the substrates HA, and glycoproteins expressed in Semliki Forest 
virus (SFV) (Chen et al, 1995; Molinari & Helenius, 1999). The SFV proteins were also found 
to co-precipitate with PDI and ERp57.  This suggests that PDI family members may interact 
with substrates co-translationally by thiol-disulphide exchange reactions (Molinari & 
Helenius, 1999).  
These studies collective suggest a model in which PDI interacts with nascent unfolded 
substrates, both co-translational and post-translationally. This interaction catalyses the 
disulphide formation step of oxidative folding which leads to natively folded proteins with a 
low affinity for subsequent reactions with PDI.  
This model implies that PDI will interact with and form mixed disulphide species with its 
substrates during translocation to the ER lumen. To investigate this premise we analysed the 
interaction between PDI and nascent prolactin during translocation of prolactin across the 
ER membrane. Our approach was to use a RRL in vitro translation system in which we 
either expressed PPL or translationally stalled PPL in the presence of SP-cells expressing a 
substrate trapping PDI mutant. We then immunoisolated mixed disulphide species between 
PDI and prolactin. Translationally stalled PPL is only partially exposed to the ER lumen while 
the non-stalled prolactin is fully imported into the ER lumen. This approach has allowed us to 
analyse PDI interactions with prolactin during and following translocation into the ER. 
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Figure 5.2: Transfer of disulphide bonds by thiol-disulphide exchange reactions occurs via a 
transient mixed disulphide species. (A) Cysteine residues can be oxidised to form a disulphide bond 
within a protein substrate: (1) The thiol group of the protein substrate in the form of a thiolate anion 
carries out a nucleophilic attack on the disulphide bond of a CXXC catalytic motif of an 
oxidoreductase enzyme. (2) This leads to the formation of a transient mixed disulphide species. (3) 
The mixed disulphide species is resolved by a nucleophilic attack on the mixed disulphide conducted 
by the second cysteine of the CXXC motif of the oxidoreductase enzyme which, in the form of 
thiolate anion, attacks the mixed disulphide. This leads to the resolution of the mixed disulphide and 
the completion of the thiol-disulphide exchange reaction. (B) The reverse reaction can also occur in 
which disulphide bonds in a protein substrate are reduced to thiol groups. The reaction scheme 
proceeds by the opposite pathway to the reaction depicted in (A). (C) Transient mixed disulphide 
species can be stabilised using a mutant oxidoreductase enzyme in which the second cysteine of the 
CXXC catalytic motif has been mutated to a CXXA motif: The reaction proceeds as shown in (B) 
except that the mixed disulphide species cannot be resolved as the resolving cysteine of the CXXC 
catalytic motif is not present. S: Substrate in which disulphide formation or reduction is catalysed. E: 
Oxidoreductase enzyme catalysing formation or reduction of disulphide bonds. The figure shown is 
based upon a figure originally shown by Sevier and Kaiser (Sevier & Kaiser, 2002). 
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5.3 Results 
5.3.1 Optimised immunoisolation of prolactin-PDI mixed disulphide species 
Our first objective was to determine whether PDI and nascent prolactin interact by thiol-
disulphide exchange reactions. These reactions require a mixed disulphide species to be 
formed; therefore, we sought to capture and isolate this species. To achieve this we utilised 
a HT1080 cell line over expressing a substrate trapping PDI mutant (stPDI) in which the 
CXXC motif of both active sites had been mutated to CXXA (Jessop et al, 2009b). This 
CXXA mutation stabilises the normally transient mixed disulphide species that wild type PDI 
(wtPDI) forms with its substrates (Walker et al, 1996). This makes the species easier to 
capture. In addition to the CXXA mutations, stPDI is also V5 tagged; this thus enables 
immunoisolation of stPDI in conjunction to any prolactin that it is bound to (Fig 5.3). 
 
 
Figure 5.3: Method of detection of isolated prolactin-stPDI mixed disulphide species. Nascent 
prolactin is synthesised in a RRL system in the presence of SP cells generated from HT1080 cells 
transfected with stPDI. (1,2) stPDI may act as a reductase towards disulphides within prolactin 
causing a mixed disulphide species to form. As the CXXA motif of stPDI lacks a C-terminal cysteine 
this mixed disulphide species cannot be resolved efficiently. (3) The mixed disulphide species is 
further stabilised by treatment with the alkylating agent NEM which reacts with free thiols and 
prevents further reactions of these groups. (4) stPDI is specifically immunoisolated via its V5 tag, 
allowing isolation of stPDI bound to prolactin. (5,6) The isolated prolactin-stPDI species is maintained 
under non-reducing conditions, or reduced by the addition of DTT which caused the mixed 
disulphide between prolactin and stPDI to be broken. Samples may then be processed by SDS-PAGE 
gel electrophoresis and exposed to a phosphor image plate as described in the materials and 
methods.  PL: prolactin, PDI: stPDI. 
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An initial obstacle we had with the immunoisolation of prolactin-stPDI mixed disulphide 
species was that both PPL and PL bound non-specifically to the Sepharose beads used for 
the immunoisolation. This was problematic because it resulted in contamination from PPL 
that was not interacting with stPDI. The PPL remained bound to the beads even following 
the washing steps of the immunoisolation procedure (Fig 5.4A, lane 2). We discovered, 
however, that pre-incubating the Sepharose beads with 1% BSA prevented almost all non-
specific binding of the protein (Fig 5.4A, lane 3). This was thought to be due to BSA blocking 
the available non-specific binding sites on the Sepharose beads. This method allowed for 
very effective and specific detection of stPDI boud to prolactin in a mixed disulphide species. 
The specificity of the detection of this secies is clearly shown by the observation that 
prolactin could be isolated in samples reduced in loading buffer only if the V5 antibody was 
used in the immunoislation procedure (Fig 5.4B, compare lane 2 and 4). As the V5 antibody 
will specifically react with the V5 tag present on stPDI this result demonstrates that only 
prolactin bound to the stPDI was specifically detected.  
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Figure 5.4: Optimisation of immunoisolation of prolactin bound to stPDI: Optimisation of the 
conditions used for immunoisolation of prolactin bound to stPDI was required to prevent 
contamination of the immunoisolate from PPL binding to the Sepharose beads. Immmunoisolation 
using a V5 antibody was carried out on RRL samples in which mRNA encoding PPL had been 
translated for 30 min in the presence of SP cells generated from cell cultures of HT1080 cells 
transfected with stPDI. DTT was added to all samples following the immunisolation procedure. The 
DTT abolished any mixed disulphides between PL and stPDI allowing isolated prolactin to be 
examined.  The effect that varying specific factors of the immunoisolation procedure had upon the 
binding of PPL contaminants to the beads was examined.  (A) Pre-treating the protein A conjugated 
Sepharose beads with 1% BSA prevented the vast majority of PPL binding to the beads. Use of the 
stringent RIPA buffer for washing and binding steps was less effective than the IP buffer as it did not 
reduce PPL binding to the beads but instead reduced the desired immunisolation of PL bound to 
stPDI. (B) The immunoisolation procedure was conducted with and without V5 antibody to confirm 
that that the PL isolated by this procedure was from PL bound to stPDI. PL was only immunoisolated 
when V5 antibody was present. The effect of using RIPA buffer instead of IP buffer on the washing 
but not binding steps was examined. There was no observable difference between using these 
different buffers on the immunoisolation. PPL: preprolactin, PL: prolactin, BSA: bovine serum 
albumin, PC: preclear protein A Sepharose beads, F: final protein A Sepharose beads. 
5.3.2 Analysis of prolactin disulphide formation in the presence of stPDI 
Having optimised the immunoisolation procedure our next objective was to assess how the 
presence of stPDI affects disulphide formation of prolactin and to specifically analyse the 
prolactin-stPDI mixed disulphide species that forms. 
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In order to assess the effect of stPDI on prolactin disulphide formation we compared the 
output of PPL translation in the presence SP cell expressing stPDI with our previous findings 
with untransfected SP cells (compare Fig 5.5A with Fig 4.1A). With both cell types, the 
reduced samples of the translation products showed the expected bands of full length PPL 
and signal cleaved PL. Under non-reducing conditions a faster mobility band corresponding 
to native disulphide bonded prolactin (DB-PL) was also observed with both sample sets. 
However, in the presence of SP cells expressing stPDI, only a fraction of the prolactin 
molecules were in the DB-PL form, while in untransfected cells all of the prolactin was in this 
form. This suggested that in the presence of stPDI only a minority of the prolactin molecules 
had completed the oxidative folding process and achieved a native disulphide configuration. 
Several additional bands were also observed in the presence of stPDI. These comprised one 
band of the same mobility as reduced prolactin and several bands of higher molecular 
weight species. The presence of a subset of the prolactin molecules in the apparent reduced 
form indicated that the long range disulphide between cysteines 88 and 204 (signal 
sequence included in numbering) had failed to form suggesting that these molecules may 
have misfolded. The observation of several higher molecular weight DTT sensitive bands 
indicated that a large fraction of the prolactin was interchain disulphide bonded to other 
molecules. As these bands were only observed in the presence of stPDI we expected a 
large fraction of these mixed disulphide species to be composed of prolactin bound to stPDI.  
V5 immunoisolation indicated that a substantial amount of the PL was indeed in a mixed 
disulphide species with stPDI (Fig 5.5B). Surprisingly, rather than one prolactin-stPDI 
species we detected multiple forms with a large range in SDS-PAGE gel mobility. The range 
of prolactin-stPDI forms observed corresponded to the mobility of many of the prolactin 
interchain disulphide species observed in the translation output (compare lane 2 of Fig 5.5A 
with Lane 2 of Fig 5.5B). This indicated that the prolactin-stPDI species accounted for a 
large proportion of the observed interchain disulphide bonded prolactin forms. We had 
anticipated that there would be one prolactin-stPDI form with the approximate gel mobility of 
80kDa species as this is the sum of the individual molecular weights of PL (22.7kDa) and 
PDI (57.1kDa). Indeed the V5 immunoisolation shows a single strong band of approximately 
this size. However, the presence of other forms indicates that the prolactin-stPDI species 
isolated are not all homogenous and most likely include species that are also interacting with 
other proteins.   
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Figure 5.5: Prolactin forms a mixed disulphide with PDI. (A) mRNA encoding PPL was translated for 
30 min in the presence of SP cells generated from cell cultures of HT1080 cells over expressing stPDI. 
(B) Immunoisolation using a V5 antibody was carried out using RRL translation samples produced 
under the conditions described in (A). PPL: preprolactin, PL: prolactin, DB-PL: Intramolecular 
disulphide bonded prolactin. 
5.3.3 Mixed disulphide species between prolactin and PDI can be detected with wtPDI 
as well as stPDI 
We next investigated if it was possible to isolate trapped prolactin-PDI mixed disulphide 
species using SP cells generated from untransfected HT1080 cells and HT1080 cells over 
expressing wtPDI. We found that mixed disulphide species could be trapped using SP cells 
derived from wtPDI over expression cells but not untransfected cells (Fig 5.6). This 
suggested that a high concentration of PDI is required for these mixed disulphide species to 
be detected. This is perhaps not surprising as it may be expected that at any one time only a 
fraction of the prolactin molecules are in a mixed disulphide interaction with PDI. Indeed, a 
previous study in yeast cells found that only a fraction of the substrate carboxypeptidase Y 
was in a mixed disulphide species with wtPDI at any one time (Frand & Kaiser, 1999). 
Therefore, if a higher concentration of PDI is present, it may be anticipated that the 
proportion of prolactin molecules interacting with the enzyme may be higher and thus a 
mixed disulphide interaction may be more readily detected. A comparison of PDI expression 
between untransfected HT080 cell and HT1080 cells over expressing stPDI confirmed the 
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PDI expression is substantially higher in cell lines over expressing PDI (Fig 5.7). This may 
explain why the interaction with prolactin could not be detected when only endogenous 
levels of PDI are present during the reaction. 
Interestingly, it can be seen that one prolactin-PDI species is prominent when stPDI over 
expressing SP cells are used; however, there are no prominent species when wtPDI over 
expressing SP cells are used (Fig 5.6, compare lanes 5 and 6). This indicates that this 
particular prolactin-PDI mixed disulphide species is stabilised when CXXA mutant PDI is 
involved in the interaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Prolactin-PDI mixed disulphide species can be detected in HT1080 cells over expressing 
wtPDI or stPDI but not in untransfected HT1080 cells expressing endogenous PDI only. mRNA 
encoding PPL was translated for 30 min in the presence of SP cells generated from cell cultures of 
either untransfected HT1080 (UT), HT1080 over expressing wtPDI (WT) or HT1080 cells over 
expressing stPDI (ST). V5 immunoisolation was then carried out on all samples.  
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Figure 5.7: PDI expression in untransfected HT1080 cells and HT1080 cells over expressing stPDI. 
Western blotting was carried out on samples of 50,000 cells from either untransfected HT1080 (UT) 
or HT1080 cells over expressing stPDI (ST). The nitrocellulose membrane shown was cut into 3 
sections; one horizontal cut was made just above the 46kDa marker shown and one vertical cut was 
made to the immediate right of lane 2. This allowed the membrane to be probed with 3 different 
primary antibodies without any issues from cross-reactivity between the antibodies. Lanes 1 and 2 
were probed with an anti-PDI antibody; lanes 3 and 4 were probed with an anti-V5 antibody. The 
lower half of all lanes was probed with an anti-GAPDH antibody. It can be seen that stPDI is over 
expressed in transfected cells relative to the endogenous wtPDI. Equal loading is shown by the 
GADPH loading control. N.B. The molecular weight of stPDI is slighter larger than that of wtPDI due 
to the V5 tag present on stPDI. 
5.3.4 Translationally stalled prolactin is only partially exposed to the ER lumen 
Our next objective was to determine if PDI interacts with prolactin during translocation to the 
ER lumen. In order to investigate this interaction we generated a mRNA sequence encoding 
PPL in which the stop codon of the sequence had been removed. The stop codon of a 
mRNA sequence is required to allow the protein synthesised to be released from the 
ribosome.  In the absence of a stop sequence the protein remains bound to the ribosome via 
the terminal tRNA. Photocrosslinking experiments with PPL have shown that approximately 
30 amino acids of the sequence occupies the ribosome exit tunnel while approximately 50 
amino acids of the sequence transverse the Sec61 translocation (Mothes et al, 1998). We 
reasoned that our translationally stalled preprolactin (tsPPL) would have the three N-terminal 
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cysteine residues exposed to the ER lumen, however the three C-terminal cysteines of the 
sequence would be shielded from the lumen by the channel of the ribosome (Fig 5.8). 
Crucially, the prolactin would be unable to form the long range disulphide between cysteines 
88 and 204 that forms in natively folded prolactin (Wallis, 1974) and which is thought to be 
responsible for the gel-shifted disulphide bonded prolactin (Fig 4.1).  
 
Figure 5.8: Exposure of cysteine residues to the ER lumen of translationally stalled preprolactin. 
(A) Diagram showing all 7 cysteine residues of the bovine preprolactin sequence and the cysteines 
exposed to the ER lumen when mRNA encoding tsPPL is expressed. The native disulphide pairing of 
cysteine residues from PPL that is not stalled is also shown. (B) Diagram illustrating the positioning of 
cysteine residues relative to the ribosome and Sec61 translocon in tsPPL. N.B. The PPL signal 
sequence (SS) contains one cysteine residue a position 24 however the SS is removed during entry to 
the ER. 
5.4.5 Translationally stalled prolactin is unable to form a long range intramolecular 
disulphide bond 
We examined the disulphide bond formation of tsPPL (Fig 5.9). As predicted we found that 
the stalled sequence was indeed incapable of forming a long range intrachain disulphide 
bond. This was apparent as no fast mobility DTT-sensitive prolactin band was visible 
indicative of such a long range disulphide. The translationally stalled prolactin appeared to 
be reasonably stable as the majority of the prolactin had the same mobility as the reduced 
form over the course of the 90 min experiment. This suggested that the translated sequence 
remained bound to the ribosome throughout the reaction.  
A fraction of the stalled prolactin appeared to accumulate at the interface of the resolving gel 
over the course of the reaction. Comparison of reducing and non-reducing lanes indicated 
that this material was DTT sensitive suggesting it contained disulphides (Fig 5.9 compare 
lanes 1 and 2). The lack of gel mobility suggested it was aggregated material and therefore it 
was designated as interchain disulphide bonded prolactin aggregates. The gradual 
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accumulation of this material may indicate the misfolding and aggregation of neighbouring 
stalled prolactin chains. This is likely to be a consequence of prolonged stalling of the 
prolactin oxidative folding process. 
A faint higher molecular weight doublet was visible throughout the reaction. This doublet was 
visible when tsPPL but not PPL mRNA was translated. We reasoned that this doublet was 
caused by tsPPL still bound to tRNA. The ester bond that connects peptides and tRNA is 
known to be easily hydrolysed, particularly at basic pH such as the basic pH of SDS-PAGE 
gels (Bresler et al, 1968; Kirchdoerfer et al, 2007). We therefore reasoned that the that the 
ester bond of the majority of stPPL had become hydrolysed following the translation reaction 
while a minority of the stPPL had remained bound throughout the analysis procedure. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: Translationally stalled preprolactin is prevented from forming a long range intrachain 
disulphide bonds. mRNA encoding tsPPL was translated in the presence of untransfected HT1080 SP 
cells for the indicated times. ATCA was added to a concentration of 75 µM 5 min after incubating the 
translation mixture at 30°C to prevent further translation initiation. This allows the disulphide bond 
formation of time synchronised set of nascent translationally stalled prolactin to be analysed. PPL: 
Preprolactin, PL: non-disulphide bonded prolactin, tRNA-(P)/PL: tRNA bound preprolactin/prolactin, 
ICDB PL: interchain disulphide bonded prolactin aggregates. 
We found that translationally stalled prolactin could be effectively released from the 
ribosome by treatment with the ribonuclease enzyme RNase A (Fig 5.10). The release of 
stalled prolactin was evident for two reasons. Firstly, no tRNA bound PPL was visible in 
treated samples, and secondly a fraction of the prolactin formed a long range intrachain 
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disulphides following the treatment indicating that C-terminal cysteines had become 
accessible to the ER lumen.  
While we observed that in RNase A treated samples about half of the prolactin had formed a 
long range intrachain disulphide we also noted that half of the prolactin remained at the 
same gel mobility as reduced prolactin. This suggested the this prolactin had either not 
formed disulphide bonds or had only formed short ranged disulphide bonds that had no 
detectable effect on gel mobility. This indicates that the disruption of the protein translocation 
and the oxidative folding process caused by the stalling and release of the prolactin may 
have made incorrect intrachain disulphide pairing and/or misfolding more likely. One 
possible explanation for this is that the prolonged exposure of only the three N-terminal 
cysteines to the ER lumen increased the likelihood of non-native disulphide pairings between 
these cysteines. Possible non-native pairings could have occurred between cysteines 31 or 
41 with cysteine 88 (refer to Fig 5.8). This in turn may have prevented the formation of the 
long range disulphide between 88 and 204 and as such prevented the formation of a 
detectable long-ranged disulphide bonded. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10: RNase A treatment causes release of translationally stalled prolactin from the 
ribosome. mRNA encoding tsPPL was translated in the presence of DPMs for 20 min. RNase A was 
then added to the indicated samples and these samples were incubated at 30°C for a further 20 min. 
PPL: preprolactin, PL: prolactin, DB-PL: intrachain disulphide bonded prolactin, tRNA-(P)/PL: tRNA 
bound preprolactin/prolactin, ICDB PL: interchain disulphide bonded prolactin aggregates. 
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5.4.6 PDI interacts with luminal exposed cysteines of prolactin during translocation of 
the protein to the ER 
Mixed disulphide species were successfully isolated when tsPPL was translated in the 
presence of SP cell expressing stPDI (Fig 5.11). This shows that stPDI was capable of 
interacting with the three N-terminal cysteines of prolactin during translocation of the 
molecule to the ER lumen. Two mixed disulphide species were observed when prolactin was 
stalled; a faint slow mobility form, and a prominent fast mobility form. Following release of 
the stalled prolactin both of these forms were observed as major bands. These two mixed 
disulphide species were also both observed as major bands if non-stalling prolactin was 
translated.  
The increase in intensity of the slow mobility form following release of stalled prolactin may 
indicate that a second form of prolactin-PDI interaction gains in stability as the C-terminal 
proportion of the molecule enters the ER lumen. Alternatively, this second slower mobility 
form may only be capable of forming at later stages of translocation or following entry to the 
ER lumen. If this were the case, the observation of this form as a faint band when stalled 
prolactin was translated may be due to a minority of the prolactin protein becoming released 
to the lumen without the addition of RNase A. 
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Figure 5.11: stPDI forms mixed disulphide species with prolactin during and following 
translocation to the ER lumen. (A,B) mRNA encoding either tsPPL (1) or PPL (2) was translated for 20 
min in the presence of HT1080 SP cells over expressing  stPDI. RNase A was added to the indicated 
samples to cause release of the tsPPL. Prolactin-stPDI mixed disulphide species were captured 
following the translation reaction by V5 immunoisolation.  
Surprisingly the multiple stPDI-prolactin observed in earlier experiments were not observed 
under the same conditions with this experiment (Compare Fig 5.5B lane 2 and Fig 5.6 lane 6 
with Fig 5.11B lane 3). One possible cause for this experimental variation was the use of a 
new batch of RRL for this experiment which was not used for previous experiments. Each 
batch of RRL is produced from different rabbits and as such there is some small variation in 
the composition of each lysate. A consistent feature of each of these results was a major 
band of approximately 80kDa in size. As the other multiple bands observed in the earlier 
experiments are relatively weak compared to this major band it may be that these different 
stPDI-prolactin forms are sensitive to the subtle variations in biochemical and molecular 
composition between the lysates. Further experimentation with this approach will give a 
clearer indication of the different species of this interaction.  
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5.5 Discussion 
5.5.1 PDI acts as a reductase of prolactin during translocation to the ER 
In this study we identified that prolactin is a substrate of PDI. We detected this interaction by 
using a substrate-trapping PDI mutant which allowed the isolation of mixed disulphide 
species between prolactin and PDI. Interactions between PDI and PPL have been detected 
using a cross-linking approach in a study by Klappa et al (1995) (Klappa et al, 1995). While 
the cross-linking approach of Klappa et al (1995) was indicative of a general interaction 
between PDI and PPL the isolation of mixed disulphide species in this study indicates that 
the two molecules engage in thiol-disulphide exchange reactions. 
The stPDI mutant used in this investigation targets disulphide bonded substrates with which 
it forms mixed disulphide species. The reaction steps involved in forming these mixed 
disulphide species matches the reaction steps of substrate recognition and interaction of 
endogenous PDI family members acting in a reductase functional role (Sevier & Kaiser, 
2002). This therefore suggests that PPL is a substrate of reductase enzymatic activity of 
PDI. 
A previous investigation made a comparison of the mixed disulphide species isolated from 
the lysates of several cells lines over expressing PDI family members with CXXA substrate 
trapping mutations (Jessop et al, 2009b). It was found that each PDI family member formed 
mixed disulphide species with a distinct set of substrates. Only a few mixed disulphide 
interactions were detected for PDI which implied it may only have a few substrates in its role 
as a reductase (Jessop et al, 2009b). The results of this chapter indicate that prolactin is part 
of the small subset of secretory proteins which are reductase targets of PDI. 
Prolactin also formed mixed disulphide in the ER of SP cells over expressing wtPDI. The 
transfected wtPDI is not biased towards oxidase or reductase reactions and acts in the same 
manner as endogenous PDI. Therefore, the observation of mixed disulphides with wtPDI 
indicates the interaction of stPDI with prolactin was not merely an aberration caused by the 
active site mutations within the enzyme.  
Prolactin-stPDI interactions were observed with translationally stalled prolactin and an 
additional prominent mixed disulphide species was detected following translocation to the 
ER. This indicates that reduction of disulphides by stPDI can occur during the ER 
translocation process but suggests that complete translocation of a substrate may allow 
additional interactions between the enzyme and substrate to occur. 
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5.5.2 Native disulphide bonded prolactin may still form in the presence of stPDI 
The CXXA mutations of the stPDI used in this investigation prevent resolution of mixed 
disulphide species by a C-terminal cysteine (Sevier & Kaiser, 2002). Despite this substrate 
trapping, analysis of prolactin disulphide formation in the presence of stPDI indicated that a 
large fraction of the nascent prolactin was capable of forming native intrachain disulphide 
bonds. This shows that not all of the nascent prolactin was locked in a mixed disulphide with 
stPDI when the reaction samples were analysed.  
There are two possible pathways that may have allowed native disulphide formation in the 
presence of stPDI. Firstly, endogenous wtPDI may have catalysed disulphide formation in 
the correctly folded fraction of prolactin. The prolactin that achieved correct folding may then 
have had a low affinity for subsequent interactions with stPDI (Irvine et al, 2014), allowing it 
to remain as a monomeric species. Secondly, it is likely that the prolactin-stPDI species that 
form are resolved at a slow rate by reaction with glutathione. Resolution of substrate 
trapping species by such a reaction has been suggested previously (Dick & Cresswell, 2002; 
Walker & Gilbert, 1997). This model of reaction resolution is supported by the finding that a 
glutathione redox buffer increases the catalytic rate of PDI mutants containing only a single 
active site cysteine by 20 to 40 fold (Walker & Gilbert, 1997). Therefore, the prolactin that 
was observed in a monomeric natively disulphide bonded form may have been freed from 
prior interaction with stPDI by this mechanism of reaction resolution. 
5.5.3 PDI may interact with its substrates in conjunction with other enzymes 
In two experiments we observed a multiple prolactin-stPDI species with a large range of gel 
mobility. These species remain intact following heating in SDS-PAGE buffer but were 
sensitive to DTT indicating that these species contain interchain disulphides. 
There are several explanations as to why multiple prolactin-PDI mixed disulphide bands may 
be detected. First, PDI has two active sites and could be in mixed disulphide species with 
one or two molecules at any one time. Potentially, this could allow PDI to form mixed 
disulphide with one or two prolactin moleceuls, or one prolactin molecule and another protein 
within the ER such as Ero1. Secondly, the prolactin and PDI molecules may have varying 
amounts of internal disulphide bonding which would affect their hydrodynamic volume and 
thus affect their mobility on the gel. And thirdly, the PDI enzyme may be acting in an enzyme 
complex containing other oxidoreductases such as Ero1, ERp57 or GPx7. Other studies 
have also indicated that such complexes may form (Di Jeso et al, 2005; Frand & Kaiser, 
1999; Molinari & Helenius, 1999; Wang et al, 2014). 
In summary, the results of this chapter show that PDI interacts with prolactin during and 
following translocation to the ER. This finding suggests that the interactions between PDI 
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family members and their substrates during oxidative folding begin as the substrates 
translocate to the ER lumen. The relative intensities of different prolactin-PDI species were 
shown to change following release of a stalled prolactin to the ER lumen. Evidence 
suggestive of multiple higher molecular weight mixed disulphide species comprising prolactin 
and PDI was also observed. This suggests a complex sequence of interactions between 
prolactin, PDI and possible other components. Further investigation with this approach may 
allow greater elucidation of the nature of these interactions. 
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Chapter 6: Discussion 
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6.1 General discussion 
6.1.1 Cell free protein synthesis systems capable of disulphide bond formation 
In this thesis we have described a modified RRL translation system in which the G6P 
concentration has been optimised to allow specific detection of ER disulphide bond 
formation and mixed disulphide species. This system was designed to be used as tool for 
investigation of the biological processes involved in disulphide formation within the ER. This 
system is an improvement to the DTT/GSSG RRL systems that have commonly been used 
for these types of investigations (Kaderbhai & Austen, 1985; Marquardt et al, 1993). 
Cell-free protein synthesis (CFPS) systems remains a common experimental tool which 
continues to be developed for use in a range of applications (Chong, 2014). The 
modifications that we have made to our CFPS system bears some relation to other modified 
systems, albeit for different purposes. We found that the addition of G6P to our RRL was a 
useful modification as it biochemically supported redox control of thiol groups within the 
lysate. In a separate development G6P (along with other metabolites of the glycolytic 
pathway) has also been identified as an effective energy source to add to E.coli lysate 
systems (Calhoun & Swartz, 2005; Kim et al, 2007). The addition of G6P to this E.coli 
system is one of many modifications that have been made with the goal of optimising the 
E.coli lysate for use as a low cost and versatile system to produce protein for commercial 
applications (Carlson et al, 2012). With this goal in mind, G6P is used as a energy source for 
E.coli lysate as it is substantially cheaper than traditional energy sources such as 
phosphoenolpyruvate or creatine phosphate (Calhoun & Swartz, 2005). 
Our RRL system is optimised to assay the formation of disulphide bonds within 
supplemented sources of ER. CFPS have also been generated in which the conditions are 
optimised for disulphide bond formation in the absence of ER (Goerke & Swartz, 2008; 
Ryabova et al, 1997). Such systems have been developed for a range of purposes including, 
the preparation of disulphide bonded proteins for structural and functional analysis (Matsuda 
et al, 2013), and also more specific purposes such as the testing of the effects of protein 
sequence changes on the binding or recombinant antibodies (Ryabova et al, 1997). Another 
focus of such systems is to optimise the production of disulphide bonded proteins for 
commercial goals such as the production of proteins for therapeutic or vaccination purposes 
(Goerke & Swartz, 2008; Kim & Swartz, 2004). These non-ER disulphide production CFPS 
achieve disulphide bond formation by the addition of a mixture of oxidised and reduced 
glutathione as well as the addition of oxidoreductase enzymes such as PDI or Dsb family 
members (Kim & Swartz, 2004; Ryabova et al, 1997; Yin & Swartz, 2004).  
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While there are parallels between our RRL systems and these other CFPS there are also 
important distinctions between each system. A central focus of the commercial CFPS that 
produced disulphide bonded proteins is to optimise low cost protein production (Carlson et 
al, 2012). On the other hand the central focus of our system is to resemble as closely as 
possible the cellular processes of maturation of secretory protein within the ER in order to 
study these processes in a physiologically relevant context. Due to these differing goals 
each of these CFPS has separate developmental paths. 
6.1.2 The redox state of PDI family members in intact cells and in SP cells 
The redox status of the PDI family members is of importance as it relates to the readiness of 
these enzymes to carry out their dual roles as either oxidase or reductase enzymes (Jessop 
& Bulleid, 2004). ERp57, ERp72, P5 and PDI-R have been found to reside in a 
predominantly reduced state within HeLa and HT1080 cells while PDI is in a partially 
reduced/oxidised state in these cells (Jessop & Bulleid, 2004; Mezghrani et al, 2001). 
Molteni et al conducted a direct comparison of the redox state of PDI in intact and semi-
permeabilised (SP) HeLa cells. It was shown that PDI was in a predominately oxidised state 
in the SP cells compared to the partial reduced/oxidised state of the intact cells (Molteni et 
al, 2004). However, exposure of the SP cells to 10mM GSH caused the redox state of these 
enzymes to become more reduced. It was, therefore, reasoned that the influence of cytosolic 
GSH upon the ER causes PDI to be maintained in a more reduced state in intact cells 
(Molteni et al, 2004). 
The most common experimental application of SP cells is their use in CFPS systems. It is 
tempting to make inferences from the findings of Molteni et al regarding the redox state of 
PDI in SP cells when used in an in vitro translation. Based upon their evaluation it would be 
expected that the redox state of PDI when used in a CFPS system would match the redox 
state in an intact cell if used in a system in which redox homeostasis is biochemically 
supported, such as with our G6P optimised RRL system. The reasoning behind this is as 
that the lysate of such a system would support NAPDH production and therefore contain 
reduced glutathione. The influence of the reduced glutathione from the lysate would cause 
the PDI of the SP cells to remain in a reduced state. This reasoning is supported by the 
finding by Jackson et al that addition of G6P to gel-filtered RRL supports generation of GSH 
(Jackson et al, 1983a). 
6.1.3 Functional overlap between the enzymatic pathways of PDI oxidation 
It has been shown that there are multiple enzymes within the ER that are capable of 
oxidising PDI or other PDI family members (Bulleid & Ellgaard, 2011). While Ero1 is 
generally regarded as the primary ER oxidase it has been shown that its deletion from fruit 
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flies or mice has a mild phenotype and does not substantially effect disulphide formation 
(Tien et al, 2008; Zito et al, 2010a). Indeed, in our experiments we only detected impairment 
of the disulphide bond formation of PPL in DPMs if both Ero1 and PrxIV had been 
inactivated and the microsomes had been subjected to DTT treatment immediately prior to 
the reaction. This is consistent with cellular experiments that have indicated that both a brief 
DTT treatment and functional loss of Ero1 or PrxIV are required to detect impaired 
disulphide formation (Rutkevich & Williams, 2012). These findings suggests a remarkable 
level of resilience and plasticity within the oxidative pathways of the ER and also suggests 
that the multiple disulphide bond formation pathways may confer a level of functional overlap 
allowing for loss of individual pathways to be compensated for.  
The fact that this resilience of the oxidative pathways was observed in our DPM 
supplemented RRL assay is interesting as it is not possible for loss of single pathways to be 
compensated for by up regulation of other compensatory pathways as might occur in genetic 
studies in cell culture or animal models. This suggests that in the DPM there is sufficient 
functional overlap in the pathways of oxidising PDI family members to allow no functional 
impairment to be detected in the absence of a DTT challenge when Ero1, PrxIV and VKOR 
activity are lost. It could be argued that this may be a specific feature of cells with a high 
secretory output. Indeed the pancreatic cells from which DPMs are derived have a 
particularly high secretory load and may be better equipped to handle functional loss of 
individual oxidase pathways. However, no impairment was observed with HT1080 SP cells 
which are not professional secreting cells arguing against this explanation. 
6.1.4 Nascent secretory proteins may begin oxidative folding upon translocation to 
the ER  
We showed in chapter 5 that PDI interacts and forms a mixed disulphide species with 
nascent prolactin during and following translocation of the protein across the ER membrane. 
It has also been reported that PDI assists in the oxidative folding by acting as a “place 
holder” of nascent proteins that allows proteins to fold into conformations that facilitate 
catalysis of disulphide bond formation at the active sites of PDI (Kosuri et al, 2012). A recent 
NMR study indicated that PDI interacts strongly with unfolded proteins substrates and 
weakly with folded substrates (Irvine et al, 2014).  
Considering these findings and our own, it would appear that PDI and possibly other PDI 
family members interact with nascent unfolded proteins upon entry to the ER. These 
interactions catalyse oxidative folding leading to natively folded proteins. Weaker interactions 
between PDI and possibly other family members may continue following completion of the 
protein folding.  
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6.2 Future experiments 
6.2.1 Comparison between ER disulphide formation in cells and in G6P optimised RRL  
We have shown that our G6P-optimised RRL translation system is a useful experimental tool 
for investigations with a focus on disulphide bond formation. However, in order to further 
evaluate how effective this system is as a tool for investigating ER maturation processes it is 
important to determine how closely the system resembles these processes within cells. This 
should be achievable by comparison of the disulphide bond formation within our RRL system 
with those formed in cells under equivalent conditions. 
We noted that disulphide bond formation of HA within our RRL system closely resembles the 
disulphide bond formation of HA that has been identified in a pulse chase assay by 
Braakman et al (Braakman et al, 1991). Comparison of our results with those of Braakman et 
al however shows there to be a difference in the number of disulphide bonded HA 
intermediates detected by these two methods. These experiments did differ in several 
variables; most crucially, different cell types were used between the experiments. In addition 
the assays were conducted under different temperatures, and also the HA from the pulse 
chase assay was isolated with a HA antibody which may preferentially bind to particularly 
disulphide bonded forms. A comparison should be made between these two assays under 
the same conditions in order to definitively determine how similar the disulphide formation 
observed in our assay is to that which occurs in cells. 
6.2.2 Identify the cellular or substrate specificity of the VKOR disulphide generation 
pathway  
A current research goal is to characterise the various enzymatic pathways that contribute to 
disulphide formation within the ER (Bulleid & Ellgaard, 2011). A study by Rutkevich and 
Williams identified for the first time that VKOR (in addition to Ero1 and PrxIV), is capable of 
generating disulphides in cells (Rutkevich & Williams, 2012). However, contrary to these 
findings, our investigation of the de novo sources found that VKOR made no detectable 
contribution to disulphide formation.  
As the VKOR disulphide formation pathway is still relatively new to the field, the 
circumstances in which it contributes to disulphide formation remains to be fully 
characterised. The differences between our findings and that of Rutkevich and Williams 
could be explained by a possible specificity of the VKOR pathway towards particular 
substrates. Alternatively, the extent of the contribution that VKOR makes to disulphide 
generation may differ widely amongst cells of different tissues. 
123 
 
In our study, we analysed the disulphide formation of prolactin within microsomes generated 
from dog pancreas tissue. The Rutkevich and Williams study analysed disulphide formation 
of albumin in a human hepatoma cell line. The expression of VKOR mRNA varies widely 
amongst different tissues. It is especially highly expressed in the liver and is also 
unregulated in cancer tissues (Wang et al, 2005). If the extent of VKOR disulphide 
generation activity is strongly related to tissue expression then it would be expect that VKOR 
activity would be particularly high in the hepatoma cell line use by Rutkevich and Williams. A 
direct comparison of the disulphide activity amongst different sources would be needed to 
evaluate this. 
The findings of Rutkevich and Williams showed a circumstance in which the VKOR pathway 
is active (i.e. with an albumin substrate in hepatoma cells). Therefore, a comparison of 
VKOR activity amongst different sources of ER and with different protein substrates would 
be necessary to determine how wide spread VKOR activity is. Such a comparison could be 
made using the assays systems we described in chapter 4, programmed with mRNA of 
different substrates (including albumin) and containing microsomes derived from particular 
cell types (including hepatoma cells). 
6.2.3 Identify factors supporting a robust ER disulphide formation pathway in cells 
Our results in chapter 4 showed that disulphide formation was substantially impaired in 
DPMs in which the enzymes Ero1, and PrxIV had been inactivated if the DPMs had also 
been subjected to a reductive challenge. By contrast, no impairment of disulphide formation 
in HT1080 SP cells was detected under the same conditions. This indicates that the 
disulphide formation machinery of SP cells is more robust than that of the DPMs. This is of 
interest as our findings and that of other studies now indicate that the disulphide formation 
within the ER of cells is a robust process that remains functional even if key enzymes 
involved in the process are absent or inactive (Bulleid & Ellgaard, 2011; Rutkevich & 
Williams, 2012). Therefore, elucidating the factors that are responsible for impairment of 
disulphide formation in DPMs but not SP cells could allow us to understand the factors that 
allow disulphide formation to function in a robust manner within cells. 
We noted several key factors that may account for the observed difference between HT1080 
SP cells and DPMs. 
1. DPMs and HT1080 SP cells are derived from different tissues. 
2. The ER of SP cells is a single reticular membrane while the ER of DPMs is in 
vesicles. 
3. The ER of SP cells is in contact with other organelles (including the mitochondria) 
while the DPMs are isolated from organelles. 
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As hydrogen peroxide (H2O2) has been shown to support PDI oxidation in vitro (Karala et al, 
2009) we also hypothesised that H2O2 derived from the mitochondria may support ER 
disulphide generation . 
The particular factor that is responsible for the observed differences could be determined by 
supplementing our disulphide impairment assay with two different sources of ER: Namely 
microsomes, or microsomes associated with mitochondria; both of which would be derived 
from an HT1080 cell line.  If disulphide impairment failed to occur with HT1080 microsomes 
it would indicate that tissue specific ER differences were responsible for the observed 
differences between DPMs and SP cells. If disulphide impairment did occur it would indicate 
that either being part of a reticular membrane and/or being associated with other organelles 
supports disulphide generation.  
Microsomes associated with mitochondria are also known as mitochondrial associated 
membranes (MAMs). It has been shown that MAMs can be isolated from tissue cultures cells 
through a series of centrifugation steps (Wieckowski et al, 2009). Supplementing our assay 
with MAMs would indicate if the disulphide formation of the ER is supported by mitochondrial 
activity. If the MAMs are shown to support disulphide formation it could subsequently be 
determined if an active electron transport chain (ETC) plays a role in this process. This could 
be achieved by treatment of the MAMs with cyanide which is known to inhibit the ETC (Berg 
et al, 2007).  
6.2.4 Further investigation of the interactions between PDI and nascent prolactin  
In chapter 5 we showed that PDI interacts with nascent PPL as a reductase during and 
following translocation of the protein to the ER lumen. We have identified the following 
objectives for further investigation of the interaction of PDI family members with nascent 
prolactin. 
Objectives 
1. Analyse the interactions between nascent chain prolactin and other PDI family 
members. 
2. Compare the interactions between PDI and stalled prolactin containing different 
amounts of cysteines exposed to the ER lumen. 
3. Analyse the kinetics of interactions between PDI and nascent chain during and 
following folding.  
The assay we used for the identification mixed disulphide species between prolactin and PDI 
is applicable for use with all PDI family members or with other secretory protein substrates. 
Cell lines expressing substrate-trapping mutants of different PDI family members could be 
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used for such an assay. Such cell lines have been generated previously within the Bulleid 
lab and used in an investigation by Jessop et al to evaluate the substrate targets of PDI 
family members (Jessop et al, 2009b). These cell lines could be used to generate SP cells 
and identify interactions with other PDI family members and prolactin during translocation to 
the ER lumen. 
We detected mixed disulphide species between PDI and prolactin that depended upon 
whether the prolactin was translationally stalled or whether the prolactin had been released 
to the ER lumen. We noted that the translationally stalled prolactin had only three cysteine 
residues exposed to the ER lumen while the released prolactin had all six of its cysteine 
residues exposed. It would therefore be interesting to determine if the change in PDI 
interactions we observed following release of the prolactin were due to greater exposure of 
cysteines to the ER lumen or due to a change in the possible interactions with PDI following 
completion of translocation of prolactin to the lumen. This could be determined by creating a 
longer translational stalled prolactin construct which contains a C-terminal region containing 
random coil. The additional C-terminal region could occupy the ribosome and Sec61 
translocon tunnels thus allowing the entire prolactin region of the molecule to be exposed to 
the ER lumen. The interactions between PDI and the C-terminal extended translationally 
stalled prolactin could be compared when the protein is in the stalled and released forms. If 
a change in interaction was still observed upon release of this construct it would indicate that 
PDI interacts different with prolactin following completion of translocation. On the other hand 
if the stalled and released C-terminal extended prolactin have the same interactions with PDI 
it would indicate the interaction of PDI with the nascent prolactin is related to the number of 
cysteine residues exposed. 
A study using NMR to analyse the interactions between PDI and its substrates reported that 
PDI interacts strongly with unfolded substrates and weakly with substrates that had 
completed folding (Irvine et al, 2014). As such, it would be predicted that a high proportion of 
nascent prolactin molecules would be in a mixed disulphide interaction with PDI during the 
early stages of a RRL translation reaction programmed when the protein had not yet 
achieved native folding. It would then be expected that the proportion of prolactin molecules 
interacting with PDI would become lower following completion of folding. This interaction 
could be assayed by carrying out an ATCA time synchronised prolactin translation in the 
presence of SP cells expressing substrate trapping PDI. The prolactin-PDI mixed disulphide 
species formed during early time points of this reaction could then be analysed and the 
relative intensities of the isolated species compared. This would allow the intensity of the 
PDI interactions with nascent prolactin to be followed from the unfolded to folded state. 
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There are also several interesting subsequent experiments that could be conducted with this 
approach. For example, it could be examined if there is a difference in the time-dependent 
mixed disulphide species of prolactin-PDI interactions detected with SP cells over 
expressing wtPDI or stPDI. A difference between these PDI forms may be expected as 
mixed disulphide species with stPDI are stabilised, also stPDI favours a reductase function 
compared to wtPDI which has no bias to acting as an oxidase or reductase. This interaction 
could also be assayed at higher incubation temperatures which would promote misfolding 
and aggregation of the nascent prolactin. As such it may be expected that under such 
conditions prolactin would interact more strongly with PDI as the enzyme would target 
misfolded proteins as a chaperone and may be required for reduction of aberrant 
disulphides. 
6.2.5 Evaluate the influence of cytoplasmic redox factors on oxidative folding within 
the ER 
It occurs to us that the G6P optimised RRL translation system that we have described here 
is potentially an effective system for investigating the influence of external redox factors on 
oxidative folding within the ER. There a two main reasons for this. Firstly, we have shown 
that within this system, disulphide bond formation occurs specifically within sources of ER 
(DPMs or SP cells) but not within the lysate. This indicates that within the lysate the ER of 
these sources remains a distinct environment for oxidative folding. Secondly, the lysate itself 
is quasi cellular in nature and contains constituents and factors of the cytosol which can be 
manipulated by inhibition of specific enzymes. We have shown that inhibition of particular 
enzymes of this lysate that biochemically support the redox systems can lead to loss of thiol 
redox control. Therefore, this system provides a means to investigate oxidative folding within 
a source of ER that is exposed to an external redox environment that can be specifically 
manipulated.   
Several important studies have analysed the influence of the redox buffer glutathione upon 
oxidative folding (Chakravarthi & Bulleid, 2004; Molteni et al, 2004; Tsunoda et al, 2014). It is 
useful to review the findings of these studies to understand how best to further the research 
on this topic.   
Molteni et al investigated the influence of external glutathione on disulphide formation within 
the ER (Molteni et al, 2004). In this study, oxidative folding of immunoglobulin J chain (JcM) 
was assayed within the ER of intact or SP cells suspended in DMEM. It was found that the 
rate of disulphide bond formation of JcM following a DTT reductive challenge was faster 
within SP cells than intact cells. However, if 10mM GSH was added to the DMEM disulphide 
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bond formation within the SP cells resembled that of intact cells. This suggested that 
cytosolic GSH can influence the oxidative folding within the ER (Molteni et al, 2004). 
In a related study, Chakravathi and Bulleid investigated the effect of depleting intracellular 
glutathione levels on oxidative folding (Chakravarthi & Bulleid, 2004). The method they used 
was to culture cells in the presence of buthionine sulfoxide (BSO), which is an inhibitor of γ-
glutamylcysteine synthetase. The cells were subjected to a brief DTT reductive challenge 
after which oxidative folding of tissue plasminogen activator (tPA) was assayed by pulse 
chase methodology. The BSO-treated cells were substantially depleted of glutathione with 
less than 1mM GSH being present in the treated cells compared to the ~13mM GSH present 
in non-depleted cells. It was found that the glutathione depleted cells had a faster rate of tPA 
disulphide bond formation. However this did not result in an increased rate of formation of 
native disulphide bonded tPA. This suggested that the reductive but not the oxidative 
pathway was impaired by glutathione depletion. No difference in the oxidative folding of tPA 
between BSO treated and non-treated cells was detected if the cells were not first treated 
with DTT before the pulse chase assay (Chakravarthi & Bulleid, 2004). 
Recently, a study by Tsunoda et al has investigated the role of glutathione on disulphide 
formation using a different approach (Tsunoda et al, 2014). In this study, the glutathione 
degrading enzyme ChaC1 was specifically expressed within the ER lumen of HeLa cells to 
depleted the organelle of this chemical. The oxidative folding of low density lipoprotein (LDL) 
receptor was then assayed by pulse-chase methodology. The LDL receptor was chosen for 
analysis in this study because it contains multiple disulphides, many of which have been 
shown to require rearrangement (Jansens et al, 2002). Hence reduction reactions would be 
required for native disulphide configuration to be achieved. It was found that there was no 
detectable difference in oxidative folding of LDL receptor between cells in which the ER was 
depleted of reduced glutathione or those in which glutathione levels were not altered 
(Tsunoda et al, 2014). This indicates that glutathione is not essential for the ER reductive 
pathway. 
It should be noted that in the study by Tsunoda et al the cells were not treated with DTT 
before the chase analysis was conducted. Therefore, it can be concluded that in absence of 
a reductive challenge the depletion of ER luminal glutathione had no detectable on the 
oxidative folding of the LDLR. These results are therefore consistent with the experiments of 
Chakravarthi and Bulleid, which only detected a phenotype of glutathione depletion on 
oxidative folding of tPA when the cells were first briefly treated with DTT before chase 
analysis was conducted (Chakravarthi & Bulleid, 2004).  
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Analyses of these reports suggest that glutathione may act in the ER reductive pathway but 
alternative electron donors may also facilitate this reaction and compensate for loss of the 
chemical. It has also been hypothesized that the thioredoxin system may also influence ER 
redox processes; this prospect remains to fully explored (Bulleid & van Lith, 2014). Several 
possible mechanisms for glutathione or thioredoxin mediated effects on ER oxidative folding 
have been suggested (Fig 6.1) (Bulleid & van Lith, 2014). These proposed pathways 
suggest that glutathione or thioredoxin is involved in supporting a disulphide reduction 
pathway by supporting the reduction of PDI family members. Further investigation of the 
influence of glutathione and particularly thioredoxin upon ER oxidative folding will indicate 
which of these potential pathways operate in cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Hypothesised mechanisms of PDI reduction. (A) Glutathione mediated reduction: PDI 
may be reduced by GSH either generated by an ER resident glutathione reductase or imported into 
the ER lumen by a protein channel. (B) Thioredoxin mediated reduction: PDI may be reduced by an 
ER resident thioredoxin reductase or by the transfer or reducing equivalents from cytosolic 
thioredoxin, via an ER membrane oxidoreductase. It should be noted that a critical components of 
each of these possible models remain to be identified. These components are the ER resident 
glutathione reductase, the ER localised GSH transporter, the ER resident thioredoxin reductase or 
the suggested ER membrane oxidoreductase. The above figure was adapated from a figure shown by 
Bulleid and Van Lith (Bulleid & van Lith, 2014). 
129 
 
Our RRL system could be used to answer to two important questions on this topic. 
1) Does external reduced thioredoxin influence ER oxidative folding and if so how does 
its influence compare with that of glutathione?  
2) Can external oxidising equivalents influence disulphide bond formation within the ER 
lumen in the absence of ER luminal enzymes? 
It may be possible to achieve the first objective using the translation substrate HA. We found 
that when we analysed the disulphide bond formation of HA that formation of the native 
disulphide form was a lengthy process that involves multiple intermediates. Clearly the 
oxidative folding of a multi-disulphide bonded protein such as HA is a complex and lengthy 
molecular process that most likely involves disulphide reduction steps as well as thiol 
oxidation. If external redox factors strongly influence ER oxidative folding then it would be 
expected that perturbing these external redox factors during the oxidative folding of HA may 
have a detectable effect.  
The disulphide bond formation of an ATCA time synchronised cohort of HA molecules could 
be analysed in RRL in which the redox pathways of the lysate have been manipulated. A 
preliminary experiment could study oxidative folding in a lysate devoid of G6P and as such 
lacking NADPH generation and hence support of the glutathione and thioredoxin redox 
pathways. Subsequent experiments could specifically inhibit glutathione or thioredoxin 
reductase by treatment of a G6P supported lysate with carmustine or auranofin. This would 
thus investigate the specific contribution of external reduced glutathione or thioredoxin to the 
HA oxidative folding. In each case the specific disulphide bond formation events could be 
analysed by NEM treatment of samples and processing by SDS-PAGE electrophoresis and 
autoradiography.  
Considering the previous findings of Molteni et al and Charkravarthi and Bulleid 
(Chakravarthi & Bulleid, 2004; Molteni et al, 2004) it is likely that an effect on oxidative 
folding will be detected when the GSH concentration is reduced, but only if the SP cells are 
first subjected to a DTT reductive challenge. The effect of reduction of reduced thioredoxin 
on ER oxidative folding remains untested and therefore it cannot be predicted if there will be 
an effect. However, we showed in chapter 3 a clear affect on disulphide formation of HA in 
RRL lacking a source of ER if the thioredoxin pathway was impaired. The lysate is 
biochemically similar to cellular cytosol. Therefore, an effect that would or wouldn’t be 
detected within the ER could be clearly contrasted to this clear effect that occurs externally 
of the organelle. 
We have shown in this thesis that disulphide bond formation is prevented from occurring 
within luminal depleted DPMs. The experiment we carried out was conducted in the 
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presence of G6P optimised RRL. Therefore, thiol redox control would have been maintained 
within the external lysate during the reaction. It would be interesting to determine if 
disulphide bonds would form within luminal depleted DPMs in the presence of RRL in which 
G6P is not added. As we have shown thiol redox control would be lost in such lysate. It 
remains to be determined if disulphide bond formation would still be prevented within luminal 
depleted DPMs under such conditions. If disulphide bond formation were to occur it would 
suggest that the transfer of external oxidising equivalents to the DPM lumen allows the 
formation of ER disulphide bonds even in the absence of ER luminal enzymes. If disulphide 
bond formation was still prevented within the luminally depleted DPMs it would indicate that 
the DPM luminal environment remained distinct from that of the lysate. This would imply that 
oxidising equivalents could not travel freely from the lysate to the DPM lumen or that a DPM 
membrane protein catalyses reactions to maintain distinct redox conditions within the ER. 
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